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SOMMAIRE
Ce travail décrit le développement postnatal des courants postsynaptiques
excitateurs (CPSEs) dans les neurones épineux moyens (MS) du noyau accumbens
(nAcb) du rat in vitro ainsi que les effets neuromodulateurs de l’acétylcholine (ACh) et
de la dopamine (DA) en utilisant la technique whole-cell patch-cÏamp.
Les CPSEs, évoqués par une stimulation électrique, ont été enregistrés dans plus
de 500 neurones du nAcb pendant le développement postnatal à partir du jour de la
naissance (jour postnatal 0; P0) jusqu’à P71. Un CPSE a été identifié dans tous les
neurones enregistrés et à tous les âges, démontrant que des synapses excitatrices
fonctionnelles étaient déjà présentes dans le nAcb le jour de la naissance. Dans la
majorité de neurones (80%), les CPSEs avaient deux composantes distinctes. La première
atteignait un maximum entre 4 et 2lms après le début de stimulus, avait une relation ‘R
VM linéaire et était sensible au CNQX. La seconde composante pouvait être mesurée
entre 20 et 138 ms après le début de stimulus, avait une relation IR-VM en y avec un
maximum autour de —40 mV et était sensible à l’APV. Ces caractéristiques montrent que
la composante précoce des CPSEs étaient médiée par des récepteurs de type AMPA/KA
tandis que la deuxième était médiée par des récepteurs de type NMDA.
Pendant les premiers jours suivant la naissance, l’amplitude des CP$Es était
relativement petite. Par la suite, les CPSEs ont augmenté progressivement jusquTà la fin
de la deuxième semaine postnatale. À partir de ce moment, l’amplitude de la composante
précoce s’est stabilisée jusqu’à l’âge adulte alors que celle de la composante tardive a
commencé à diminuer pour devenir virtuellement nulle dans les préparations provenant
d’animaux âgés de plus de 3 semaines. Le rapport entre l’amplitude de la composante
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tardive et celle de la composante précoce a augmenté graduellement durant les deux
premières semaines et a par la suite diminué de façon marquée. Ces résultats suggèrent
que l’expression de CPSEs médiés par les récepteurs NMDA est prédominante durant la
deuxième semaine du développement postnatal dans le nAcb.
Nous avons trouvé que l’Adi produisait deux effets médiés par différents types
de récepteurs sur les CPSEs. L’ACh diminuait les CPSEs en agissant sur des récepteurs
muscariniques tandis qu’elle augmentait les CPSEs en agissant sur des récepteurs
nicotiniques. Cependant, l’effet excitateur produit par l’activation des récepteurs
nicotiniques était généralement masqué par les effets inhibiteurs muscarmniques en
absence d’un antagoniste de ces derniers. Donc, l’activation des interneurones
cholinergiques dans le nAcb pourrait produire une excitation nicotinique rapide et une
inhibition muscarmnique plus lente.
La DA, par une action sur les récepteurs de la famille Dl, produisait une
diminution importante du rapport entre les CPSEs médiés par des récepteurs NMDA et
ceux médiés par les récepteurs AMPAJKA en inhibant davantage les CPSEs médiés par
les récepteurs NMDA. En effet, l’inhibition produite par la DA sur les CPSEs NMDA
était comparable à celle produite par l’APV, un antagoniste spécifique des récepteurs
NMDA. Les effets de la DA sur les CPSEs ne semble pas impliquer la protéine kinase A
ni la protéine kinase C, parce que cette action était résistante aux inhibiteurs de protéines
kinases H89 et Ro-32-0432.
Les agonistes cholinergiques et dopaminergiques ont changé le rapport des
réponses à des stimuli pairés (paired pulse ratio) sans toutefois modifié la conductance
membranaire ni la réponse des neurones au glutamate en présence de TTX, suggérant que
Vleurs effets sur les CPSEs étaient principalement médiés par des mécanismes
présynaptiques. Cependant, les effets postsynaptiques de l’ACh et et de la DA ont pu être
masqués par la présence de QX-314 dans la pipette d’enregistrement car cette substance
bloque certains canaux ioniques K et Na qui auraient pu être modulés par l’Adi et la
DA.
En résumé, cette recherche démontre que les réponses synaptiques médiées par les
récepteurs NMDA atteignent leur maximum pendant la seconde semaine du
développement postnatal et pourraient jouer un rôle important dans les processus
développementaux dépendant de l’activité. La modulation des CPSEs NMDA et
AMPAJKA pendant cette période par la DA et l’ACh suggèrent que ces substances
pourraient jouer un rôle déterminant aussi pendant cette période.
Mots-clés : CPSE, développement postnatal, Acétylcholine, dopamine, récepteur
AMPA!KA, récepteur NMDA, noyau accumbens, courant postsynaptique excitateur
SUMMARY
This work describes the postnatal development of excïtatory postsynaptic currents
(EPSCs) of medïum spiny neurons (MS) in nucleus accumbens (nAcb) suces of rat as
well as the modulations of two classic neurotransmitters dopamine (DA) and
acetylcholine (ACh) on EPSCs using whole-cell patch-clamp technique.
EPSCs were evoked by local electricai stimulation in 509 nAcb neurons during
postnatal development from the day of birth (postnatal day 0; P0) to P71. An EPSC was
found in ah recorded neurons of ail ages, showing that functional excitatory synapses
were aiready present in the nAcb on the day of birth. In majority of neurons (80%) the
EPSCs had two distinct components: an early component with a peak between 4 and 21
ms after stimulus onset, linear IR-Vm and sensitive to CNQX and a late one that was
found from 20 to 138 ms after stimulus onset, had a V-shape IR-Vm relationship with a
peak around —40 mV and sensitive to APV. These characteristics demonstrate the eariy
and late components of the EPSC were mediated by AMPA and NMDA receptors
respectively. During the first few days after birth, the amplitudes of both early and late
components of the EPSCs were relatively smail and then started to increase untii the end
of the second postnatal week. Whereas the early component of the EPSC appeared to
stabilize from that point on, the late component began to decrease in samples from
animais aging more than 3-week-old. In addition, the ratio between the amplitudes of
late and early components followed a developmental pattem gradualiy increased during
the first two postnatal weeks followed by a decrease dramatically. Together, these results
show that there is a dominant expression of NMDA receptor-mediated EPSC during the
postnatal development in nAcb.
vii
Two remarkable differential actions of ACh were found on the EPSCs by two
types of ACh receptors. ACh depressed EPSCs through muscarinic Ml receptors,
whereas it enhanced EP$Cs through nicotinic receptors, suggesting that nAcb cholinergic
interneurons may produce a fast nicotinic excitation and slow muscarinic inhibition.
However, nicotinic receptor-mediated effects were usually masked by muscarinic
receptor-mediated actions in our experimental condition in vitro. Moreover, we also
found that the inhibitory effects of ACh on NMDA receptor- but not on AMPA receptor
mediated EPSCs significantly increased during the first two postnatal weeks.
DA, through an action on D1-like receptor, distinctly decreased the ratio of
NMDA receptor- to AMPA receptor-mediated EP$Cs, rnimicked the effect of APV on
EPSCs and abolished almost completely NMDA receptor-mediated EP$Cs with minimal
effect on AMPA receptor-mediated EPSCs. The DA-induced depression of EPSCs did
not involve either protein kinase A or protein kinase C, because this action was resistant
to the protein kinase inhibitors H29 and Ro-32-0432.
Both cholinergic and dopaminergic agonists altered the ratio of paired-pulse
stimulation-evoked EPSCs, but did not change input conductance of membrane of MS
neurons. Also both of transmitters had no effect on glutamate injection-evoked EP$Cs in
the presence of TTX and QX-3 14, suggesting their modulation on EPSCs is mainly
presynaptic in the postnatal development of nAcb. However, in accordance with the
effect of QX-3 14 on membrane potentials during the modulation of ACh, and distinct
change in the ratio of NMDARIAMPAR-EPSCs during the modulation of DA, it is
suggested that there are postsynaptic effects of ACh and DA either in the nAcb during the
postnatal development. This work shows that NMDA receptor-mediated synaptic
vil’
responses are dominant during postnatal development and that DA and ACh effectively
modulate NMDA receptor-mediated currents, indicating that NMDA receptor-mediated
synaptic events may play important roles in postnatal development. The modulations of
NMDA receptor- and AMPA receptor-mediated EPSCs by DA and ACh may be
important for activity-dependent developmental processes or other plasticity in the nAcb.
In addition, quite significant modulation of NMDA receptor-mediated EPSCs by ACh
and DA during postnatal development could be important for the study in the etiology of
schizophrenia.
Key words: Nucleus accumbens, Excitatory postsynaptic currents, Postnatal
developrnent, Cholinergic and dopaminergic modulation, NMDA receptor, AMPA
receptor, Pre and postsynaptic modulations.
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CHAPTER I
2INTRODUCTION
1. Overview
The nucleus accumbens (nAcb) is an important point of convergence for different
afferents originating in limbic structures (Lopes da Silva, 1984; Pennartz and Kitai, 1991;
Pennartz et al., 1994; O’Donnell and Grace, 1995; Finch, 1996). Several of these
pathways are thought to be glutamatergic and to provide an excitatory drive by activating
NMDA andlor AMPA!KA receptors necessary to trigger firing activity in nAcb neurons
(Kombian and Malenka, 1994). In addition, the nAcb receives a dense dopaminergic
input from the ventral tegmental area (VTA), and this system lias been implicated in drug
addiction and other neuropsychiatric disorders (Ungerstedt, 1971; Schiistrom et al.,
1 998a,b). The nAcb also contains a small population of cholinergic interneurons, whicli
play an important role in modulating glutarnatergic transmission (Sugita, et al., 1991;
Hersch, et al., 1994; Zhang and Warren, 2002; de Rover et al., 2002).
The nAcb lias been proposed to serve as an interface between the limbic system
and the extrapyramidal motor system (Mogenson et al., 1980; Mogenson and Yim, 1981;
Poweli and Leman, 1976; Yang and Mogenson, 1984; Yim and Mogenson, 1982).
Studies have provided evidence for the involvement of the nAcb in a number of functions
including motivation (Mogenson et al., 1980; Robbins and Everitt, 1996; Swerdlow and
Koob, 1987), attention (Solomon and Staton, 1982; van den Bos et al., 1991), and reward
(Apicella et al., 1991; Colle and Wise, 1988; Robbins and Everitt, 1996; fantin and
Bottecchia, 1984; OÏds, 1990). Recent studies have shown its involvement in learning
and plasticity (Parkinson et al., 2000). Moreover, the nAcb may be involved in mediating
some of the therapeutic actions of antipsychotic drugs that inactivate the mesencephalic
3dopaminergic ceils that project to this region when administered chronically (Chiodo and
Bunney, 1983; White and Wang, 1983). Chaotic neurotransmissions in the nAcb could
be a critical determinant in some neuropsychiatrie disorders, including schizophrenia,
Tourett’s syndrome and drug addiction (Koob and Nestier, 1997; Wise, 1998).
furthermore, selective loss of cholinergic interneurons in the nAcb has also been
observed in schizophrenia (Hoit et al., 1999) and Alzheimer’s disease (Lehéricy et al.,
1989). Additionally, an alteration of dopaminergic transmission is thought to play a key
role in psychiatrie disorders (Sokoloff et al., 1992), such as, dopaminergic hyperfunction
has been implicated in schizopbrenia (Gray et al., 1995; Joyce, 1993; Joyce and Meador
Woodruff, 1997). Interest in understanding cholinergic and dopaminergic mechanisms in
controlling or regulating motor and psychological function in mammals has been growing
since acetylcholine (ACh) and dopamine (DA) were postulated to play a role in the
pathophysiology described above.
Ionotropic glutamate receptors-mediated events including excitatory postsynaptic
currents (EPSC) play a crucial role in synaptogenesis and formation of neuronal circuitry,
as well as in synaptic plasticity including long-term potentiation (LTP) and long-term
depression (LTD). However, excessive activation of glutamate receptors might induce
excitotoxic neuronal celi death, which is thought to contribute to neurodegeneration
(Choi, 1992; Lipton and Rosenberg, 1994). Defects in glutamatergic transmission in the
nAcb are thought to be involved in the pathophysiology of schizophrenia (Carlsson and
Clarlsson, 1990a, b; Olney and Farber, 1995; Meador-Woodruff and Healy, 2000).
However, during postnatal development, the characteristics of EP$C and its modulation
4by classic neurotransmitters ACh and DA in the nAcb remain largely enigmatic. The
present thesis atternpts to provide some answers to these questions.
2. Anatomical and functional characteristics of the nucleus accumbens
Because of its similarities including cytoarchitecture, neurochernistry and afferent
and efferent connections with the dorsal striatum, the nAcb is usually considered as a
ventromedial extent of the striatum or the ‘ventral striatum” (Heimer and Wllson, 1975;
Heimer et al., 1997; Swanson and Cowan, 1975). Based on studies of its connectivity
and distribution of neurotransmitters and chemical markers, the nAcb can be divided into
two teilitories (Groenewegen and Russchen, 1984; Heimer et al., 1991; Brog et al., 1993;
Zahm and Heimer, 1993). The portion ofthe nAcb surrounding the anterior commissure
is known as the core where enkephalin and opioid receptors are rich, and strong
immunoreactivity for calcium-binding protein, calbindin D28k (CaB) is found. The
rnedio-ventral region of the nAcb is called the sheil in which dense concentrations of
substance P (SP), dynorphin, and tyrosine hydroxylase (TH) overlaping enkephalin- or
CaB-poor zones are exhibited (Zahm and Brog, 1992; Jongen-Relo et al., 1994).
[Figure 1. The anatomical location ofthe nAcb]
2.1. Composition oftlie nucleus accumbens
2.1.1. Innervations and projections
The major afferents of the nAcb arise primarily from limbic structures including
the prefrontal cortex (PfC), hippocampus, basal amygdaloid complex and midline
thalamic nuclei (Groenewegen et al., 1982, 1987; Jayaraman, 1985; Kelley and
Figure 1. An anatomical indication ofthe nAcb and its subterritories
A. A parasagittal section of rat whote twain. B. A drawing shows mainly parts offorebrain
to match the sagittal section. nAcb, nucleus accumbens (highlight areas); aca, anterior
commissure; VP, ventral pallidum; CPu, caudate-putamen. The circles flhled with white color
indicate the sites where recordings were done in nAcb. The circles fllled with black color show
the places in which ttie stimuli were given for evoked responses. C. Coronal section through the
forebrain ofthe rat showing SP immunoreactivity. Note that a border between the core(Co) and
the dorsally adjacent main part ofthe striatal complex, CPu can not be identifled, whereas the
border between the Co and the shell(Sh) is distinct (arrowheads). (Paxions and Watson, 1986;
De Olmos and Heimer,1999).
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6Domesick, 1982; KeIIey and Stinus, 1984; Kelley et al., 1982; Krayniak et aI., 1981;
Newman and Winans, 1980; Phillipson and Griffiths, 1985; Meredith et al., 1990). These
inputs are ail thought to be glutamatergic. The nAcb also receives inputs from the ventral
pallidum, dopaminergic VTA, serotonergic median raphe nucleus, and the noradrenergic
celi group located in the nucleus ofthe solitary tract (Groenewegen et al., 1987; Brog et
al., 1993; Berendse et al., 1992). The output of the nAcb is GABAergic and is primarily
directed to the ventral pallidum (Hakan et al., 1992; Yang and Mogenson, 1985; Zahm
and Heimer, 1990), which is involved in the activation of voluntary movements (Heirner
et al., 1994; $werdlow and Koob, 1987). This input-output organization suggests that the
nAcb somehow provides a centre for Ïimbic integration with motor systems driven by the
ventral pallidum (Beninger et al., 1983; Lopes da Silva et al., 1984; Mogenson et al.,
1980). In addition, the nAcb also projects to the VTA and the media! part of the
substantia nigra pars compacta (Heimer et al., 1991; Mogenson et al., 1983; Nauta et al.,
1978; Swanson and Cowan, 1975).
The core of the nAcb has been reported to receive its main cortical input from the
prelimbic PFC (Brog et al., 1993; Sesack et aÏ., 1989; Berendse et al., 1992; Montaron et
al., 1996), and dorsal subiculum (Brog et al., 1993). It also appears to project to the
dorsal portion of the ventral pallidum (Zahm and Heimer, 1990; Heimer et al., 1991).
The sheli receives its major inputs from the infralimbic PFC and the ventral subiculum
(Kelley and Domesick, 1982; Brog et al, 1993; Yang and Mogenson, 1984; Sesack and
Picel, 1990; Aylward and Totterdel!, 1993) and sends projections to the ventro-medial
part ofthe ventral pallidum.
[Figure 2. Diagram with inputs and outputs ofthe nAcb]
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Figure 2. Diagram with inputs and outputs of the nAcb
Schematic representation of the input-output relationships of clusters of neurons in the nAcb.
A. Different clusters of neurons (ensembles?) receive different combinations of converging
inputs and project to distinct targets, including the ventral pallidum, the lateral hypothalamus,
and the ventral mesencephalon. B. The various (limbic) cortical and subcortical structures
that project to the nAcb are strongly and, in a number of cases, reciprocally interconnected.
Note that the nAcb, via the ventral pallidum and the mediodorsal thalamic nucleus is involved
in a closed thalamocortical-basal ganglia loop. nAcb, nucleus accumbens; MD, mediodorsal
thalamic nucleus; P’vÇ paraventricular thalamic nucleus. (Groenewegen et al., 1999).
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82.1.2. Neuron types
As described in series of remarkable studies of the neostriatum (Bolam et al.,
1984; Kawaguchi, 1992, 1993; Kawaguchi et al., 1989, 1990), the nAcb also consists of
five different types of neurons in accordance with the neurochemical, morphological and
physiological characteristics (Chang and Kital, 1985; Hedreen, 1981). Two types ofthe
celis have been described with some details (Sesack and Pickel, 1990; O’Donnell and
Grace, 1993). They are the GABAergic medium spiny (MS) neurons, which are the only
identified projection neurons in the nAcb, and the large aspiny (LA) neurons, which are
cholinergic intemeurons. In addition to MS neurons, two other types of GABAergic
interneurons have been identified: the fast spiking (FS) neurons and cairetinin containing
fleurons. A third type, identified as the low threshold spike (LTS), which could also be
GABAergic, contains somatostatin, neuropeptide Y and NO as co-transmitters.
2.1.2.1. MS neurons
The principal neurons in the nAcb are the projection MS neurons (8-15 tm),
which make up approximately 95% of all neurons (Chang and Kital, 1985). MS neurons
appear to use GABA as one oftheir primary neurotransmitters (Fisher et aI., 1986) along
with several peptides as co-transmitters such as $P and neurotensin (Penny et al., 1986).
MS neurons are by far the most frequently encountered celi type during physiological
recordings and are recognizable by their strikingly large inward rectification during
application of hyperpolarizing current pulses and their low RMP (around —80 mV).
When recorded in vivo, MS neurons show a pattem of spontaneous activity consisting of
long periods of silence separated by brief episodes of firing. Intracellular recordings in
vivo in the nAcb (O’Donnell and Grace, 1995; Yim and Mogenson, 1988; Finch, 1996)
9have shown that the suent and active episodes correspond to two different stable states of
the membrane potential 10-20 mV apart: a hyperpolarized suent state around -$0 mV and
a depolarized active state around -60 rnV. The shifis in membrane potential are relatively
rapid (5 mV/s or more), of large amplitude, appear spontaneously in vivo and can last
100-500 ms. MS neurons fire only during the depolarized state with the spikes often
occurring in bursts.
In nAcb suces maintained in vitro, the RMP of M$ neurons is around -$0 to -90
mV, corresponding to that of the hyperpolarized periods seen in vivo in normal animais
and no depolarizing episodes are observed (Belleau and Warren, 1995, 2000). Because in
the preparations in vitro neurons receive much iess synaptic input than they do in vivo, it
is unlikely that the membrane potential on MS neurons is maintained by barrages of
inhibitory postsynaptic potential (IPSP). This suggests that the hyperpolarized state
observed in vivo is flot due to tonic inhibition, but rather because of a lack of excitation.
furthermore, Belleau and Warren (1995) found that GABAA receptor mediated IPSPs are
depolarizing at RMP in vitro, showing that the hyperpolarized membrane potential of MS
neurons is below the chloride ion equilibrium and may not resuit from GABAA mediated
inhibition. Following lesion or reversible inactivation of subicular inputs in vivo, MS
neurons remains in the hyperpolarized state. This suggests that the depolarized state
requires the integrity of hippocampal inputs in the nAcb (O’Donnell and Grace, 1995).
2.1.2.2. LA neurons
LA neurons are actually a group of giant cholinergic cells. This neuronal subtype
has long been recognized as a separate cell type since it has a large somatic size (20-
10
60 cm) and an extensive aspiny dendritic tree that is much larger than those of MS
neurons (Meredith et al., 1989; Kawaguchi, 1992; Zhou et aÏ., 2002). An important step
for their identification as intemeurons was the discovery that they were the only source of
ACh and choline acetyltransferase (ChAT) in the nAcb, since ventral and dorsal striatum
inputs are devoid of any other cholinergic afferent (McGeer et al., 1971; Bolam et al.,
1984). The RMP of LA neurons is more depolarized and doser to firing threshold than
that of M$ neurons. Consequently, they will fire more readily when injected with
depolarizing current. Their firing pattems show littie adaptation, but their firing
ftequency is limited by a large and long afierhyperpolarization (Beleau and Warren,
2000). Presumably, when they fire action potentials, they release ACh, which in turn
modulate the excitability of the other neuronal elements of the nAcb by acting on ACh
receptors. LA neurons are recognizable by their time-dependent rectification causing a
large depolarizing sag in response to hyperpolarizing current pulses and the presence of a
large and long duration spike afterhyperpolarization. The axonal fields of LA neurons
are also more extensive than that of other accumbal neuronal elements and make most of
their synapses with MS neurons (Izzo and Bolam, 198$; Phelps et al., 1985). In the
dorsal striatum, LA neurons also receive convergent excitatory postsynaptic potentials
(EP$Ps) from cortical and thalamic stimulations (Wilson et al., 1990; Lapper and Bolam,
1992) that are probably mediated by both NMDA and AMPA types of glutamatergic
receptors (Kawaguchi, 1992).
2.1.3. Synaptic framework in the nucleus accumbens
In the nAcb, DA and glutamate, which come from extrinsic sources, and ACh and
GABA from local circuit fleurons, are all capable of in±luencing the activity of accumbal
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MS neurons. In the core region, the inputs onto spines and distal dendrites generally
arise from extrinsic sources, whereas the synapses situated more proximally on dendrites
or perikarya corne frorn intrinsic sources (Meredith, 1999). By contrast, in the caudal
medjal sheli M$ neurons receive a mixture of intrinsic and extrinsic contacts, both
distally and proximally. An important part of the intrinsic innervation of MS neurons is
from other MS ceils or from the local circuit neurons, such as LA neurons.
The primary asymmetrical input is from excitatory, presumably glutamatergic
axons of cortical and thalamic origins. Inputs to both the core and sheli regions arise
frorn the amygdala and prefrontal area (Sesack and Pickel, 1992; Jolmson et al., 1994).
The lateral or medial entorhinal areas project prirnariÏy to the core, whereas the
hippocampus innervates neurons primarily in the shell (Meredith, 1999; Meredith et al.,
1993). Neurons in both midline and intralaminar thalarnic nuclei project topographically
to the core and sheÏl, where they make asyrnmetrical contacts with dendrites and spines
(Groenewegen et al., 1991; Meredith et al., 1993; Dube et al., 1988). Extrinsic inputs
frorn dopaminergic centres, or intrinsic contacts such as those containing ACh provide
additional but minor asymmetrical axospinous innervations to MS neurons.
Glutarnatergic nerve terminals make asymmetrical synaptic contacts with MS neurons,
and asymmetrical synaptic specializations occur most commonly on the heads of
dendritic spines and symmetrical inputs, along dendritic shafis, at the necks of spines, and
on perikaryal membranes (Bolam, 1984; Meredith et al., 1993).
MS neurons also represent the main synaptic target of LA neurons (Graybiel,
1990; Izzo and Bolam, 1988). Cholinergic nerve terminals frequently form symmetrical
synapses on their perikarya, dendrites and spines of MS neurons (Meredith and Chang,
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1994), whereas the DA terminais are aiways found in a position proximal to those with
glutamate, and, as such, are effective in gating signais from widely separated cortical
areas. However, ultrastructural studies of cholinergic neuron innervation in the nAcb
also suggest that ACh might regulate the release of other transmitters via presynaptic
rnechanisms, through a non-junctional or volumic mode of transmission (Contant et al.,
1996).
The converging projections from glutamatergic and dopaminergic sources have
been shown to synapse concurrently on dendrites of the same MS output neurons and
axo-axonal juxtaposition between converging terminals bas also been found (Bouyer et
ai., 1984; Totterdel and Smith, 1989; Sesack and Pickel, 1990). Neuroanatomicai
investigations demonstrate clearly that most dopaminergic afferents end directly on the
MS neurons (freund et al., 1984), although cholinergic interneurones do also receive
some dopaminergic inputs (Chang, 1988; Kubota et al., 1987).
[Figure 3. A diagram with synaptic organization]
2.2. Membrane properties of MS neurons during postnatal development
The morphologicai and functional maturation of the nAcb probably depends on
the interaction between the maturation of its neuronal elements and its innervation by
extrinsic glutamatergic and other neuromodulatory inputs. It is iikely that the disturbance
of one or the other of these elements during a critical developmentai period could lead to
pathological states (Lipska et al., 1993, 1998; Weinberger and Lipska, 1995). Recent
findings by Beiieau and Warren (2000) reveaied that around the time of birth and during
the first postnatal weeks, the membrane and firing characteristics of MS neurons are quite
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Figure 3. A diagram with synaptic organization
Schematic diagrams of the synaptic wiring of
typical cote (A) and sheil (B) neurons in nAcb.
Rectangular boxes surround extrinsic inputs, and
dotted unes surround connections that originate
tocaily, either from other medium spiny neurons
(MSNs) or local circuit neurons (LCNs).
Enkephalin (ENK)-positive terminais end
signiflcantly more often on spine necks in the sheli
than in the core. Excitatory amino acids (EAA) are
used by cortical and thalamic (thai) inputs.
Tyrosine hydroxylase (TH) represents the presumed
dopaminergic input. Note that proximal synapses in
the cote arise predorninately from local neutons
(principal and intemeurons) and distai connections.
ChAT-immunoreactive neurons, which are ptesumabiy cholinergic, receive cortical inputs (EAA) onto
distal small dendrites but thalamic aiso (EAA) terminais proximaiiy on the celI body or proximal dendrites.
ChAT-positive endings contact other ChAT-positive dendrites. The cholinergic interneurons aiso contact
the dendrites ofMSN (C). GAD, glutamate decarboxylase; hippo, hippocampus (Meredith, 1999).
to extrinsic target
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different from those observed later. These characteristics changed rapidly during first 3
postnatal weeks, at which point they resembie those found in aduits. Both whole-cell
membrane resistance and membrane time constant decreased more than four-foid during
this period. During the first postnatal week, the current-voltage relationship of ail
encountered MS neurons was linear over a wide range of membrane potentials above and
below RMP. Through the second postnatal week, the proportion of neurons displaying
inward rectification in the hyperpolarized range increased steadily. Afier P15, ail
recorded MS neurons displayed significant inward rectification. At ail ages, inward
rectification was blocked by extracellular cesium and tetra-ethylammonium (TEA) but
flot by 4-aminopyridine (4-AP), suggesting that inward rectification was mediated by the
same currents in young and mature MS neurons. M$ neurons fired single and repetitive
N&’/K action potentials as early as Pi. Spike threshold and amplitude remained constant
tbroughout development in contrast to spike duration, which decreased significantly over
the same period. Depolarizing current pulse from rest showed that immature MS neurons
fired action potentials more easily than their older counterparts.
The resuits suggest that young and adult nAcb MS neurons integrate excitatory
synaptic inputs differentiy because of differences in their membrane and firing properties.
These findings provide important insights into signal processing within nAcb during this
critical period of development (Belleau and Warren, 2000).
Characteristics such as absence of inward rectification and consequent higher
input resistance have aiso been demonstrated in cat M$ neurons in dorsal striatum during
the neonatal period (Cepeda et al., 1991). The maturation of these properties has a
similar time course in both species, becoming essentially aduit-like by the end of the third
15
postnatal week. Tepper and colleague (199$) found that the proportion of neurons that
exhibited inward rectification increased steadily throughout postnatal development and
reached a plateau by the end of the third postnatal week but stiil had not reached aduit
levels by the fifih postnatal week in rat striatum. The investigations from various groups
have suggested that K currents were responsible for inward and outward rectification in
MS neurons (Nisenbaum et al., 1994; Nisenbaum and Wilson, 1995; Belleau and Warren,
2000). In addition, the mean RMP of MS neurons in the nAcb are —60 mV during the
first postnatal week and below —$0 mV after P21 (Belleau and Warren, 2000).
Compared to adults, membrane input resistance of MS neurons in neonatal rats is
higher in the nAcb. However, input resistance decreased with postnatal development in
MS neurons in the nAcb is closely correlated with inward rectification. The concomitant
decrease in input resistance with age implies an increase in ion channel density. Cells
displaying inward rectification display significantly more negative RMP than that of
neurons lacking inward rectification (Belleau and Warren, 2000).
Despite their more depolarized membrane potential, no spontaneous activity in
MS neurons in neostriatum in younger animals has been observed in vitro (Tepper et al.,
1998; Napier et al., 1985; Tepper and Trent, 1993).
Discrete up and down states, as described in adult MS neurons in vivo (O’Donnell
et al., 1999; Stem et aÏ., 1997; Wilson and Kawaguchi, 1996) are absent in young
neonates. A nominal condition for the appearance of membrane potential bistabiÏity in
MS neurons is the presence of a more negative RMP such as that found in vitro in mature
MS neurons (Tepper et al., 199$). The functional differences between young and mature
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MS fleurons could be important throughout a period during which activity-dependent
development and stabilization of synaptic inputs is probably occurring in the nAcb. The
nAcb receives putative excitatory glutamatergic input from various sources that are flot
fully developed at birth, so the nAcb is likely to complete its development in parallel with
those structures (Belleau and Warren, 2000).
3. An overview of ionotropic glutamate receptors and their properties
Glutamate receptors mediate most of the excitatory synaptic transmission and
play a crucial role in synaptogenesis and formation of neuronal circuitry as well as in
synaptic plasticity including LTP and LTD. However, excessive activation of glutamate
receptors might induce excitotoxic neuronal celI death and is also thought to contribute to
neurodegeneration following a wide range of neurological insuits including ischemia,
trauma and epileptic seizures (Lipton and Rosenberg, 1994; Ozawa at al., 199$). The
glutamate receptors are divided into two distinct groups, ionotropic and metabotropic
receptors (Nakanishi, 1992; Seeburg, 1993; Hollmann and Heinemann, 1994). The
ionotropic receptors are further subdivided into three groups: u-amino-3-hydroxy-5-
methyl-4-isoxazolepropionate (AMPA), kainate (KA) and N-methyl-D-aspartate
(NMDA) receptor channels on the basis of agonist specificities. However, since neither
agonist nor antagonist clearly distinguished between AMPA and KA receptors in earlier
time, they were ofien collectively referred to as non-NMDA receptors. AMPA receptors
mediate the majority of fast excitatory synaptic transmissions (Hollmann and Heinemann,
1994; Borges and Dingledine, 199$; Dingledine et al., 1999). KA receptors contribute to
postsynaptic responses at excitatory synapses and can also modulate presynaptic
neurotransmitter release at some synapses (Frerking and Nicoil, 2000), whereas NMDA
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receptors are crucial for the induction of specific forms of synaptic plasticity and play
important roles in modulating synaptic strength, ceil death and in several
neuropsychiatric disorders (Hollmann and Heinemaim, 1994; Dingledine et al., 1999;
Malenka and NicolI, 1999). The metabotropic receptors are coupled to G-proteins, and
regulate the production of intracellular messengers (Ozawa et al., 199$).
3.1. Glutamatergic receptors-mediated EPSCs
At most central synapses, both AMPA and NMDA receptors are activated during
synaptic transmission. Several lines of evidence suggest that AMPA and NMDA
receptors are co-localized and commonly activated by glutamate liberated into the
synaptic cleft (Jones and Baughman, 1991; Clements et al., 1992). EP$Cs commonly
have both AMPA and NMDA receptor-mediated components. The AMPA receptor
mediated EP$C (AMPAR-EPSC) bas rapid kinetics of channel gating, whereas NMDA
receptor-mediated EPSC (NMDAR-EPSC) has much siower rise and decay times relative
to the AMPAR-EPSC (Hestrin et aI., 1990; Lester et al., 1990; Keller et al., 1991).
According to these different kinetics, it is believable that the AMPA receptor has a
relativeÏy low affinity for glutamate and becomes unbound very quickly afier the
clearance of the transmitter, whereas the NMDA receptor has much higher affinity,
resulting in prolonged binding during which the channel can open repeatedly (Hestrin et
al., 1990; Lester et al., 1990; Lester and Jahr, 1992).
3.2. AMPA receptors
AMPA receptors are ligand-gated channels usually considered to be permeable to
Na and K and mediate fast excitatory synaptic transmission in central neurons
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(Hollmann and Heinemann, 1994). AMPA receptors are encoded by four genes
designated G1uRÏ through GIuR4 and exist in Ca2timpermeable and Ca2-permeable
forms. AMPA receptors assembled from G1uR1, G1uR3 and G1uR4 alone or in
combination are permeable to Ca2 and have doubly rectifying current-voltage
relationships. The presence of G1uR2 subunits render heteromeric AMPA receptor Ca2-
impermeable (Hollmann et al., 1991, 1989; Verdoorn et al., 1991; Nakanishi, 1992;
Seeburg, 1993; Hollmann and Heinemann, 1994). G1uR2 subunits forming channels with
other GIuR subunits are Ca2timpermeable and electrically linear or outwardly rectifying
(Pellegrini-Giampietro et al., 1997). The dominance of the G1uR2 subunit in determining
permeability to Ca2 and other divalent ions is attributed to the presence of a positively
charged arginine in place of a glutamine residue within the M2 domain (Hume et al.,
1991; Bumashev et al., 1992). Thus, the GIuRY and GluR3 to GIuR2 ratio may be taken
as a predictor of formation of Ca2-permeable AMPA receptors (Pellegrini-Giampietro et
al., 1992). Different studies have demonstrated marked developmental changes in
glutamate receptor subunit expression in rat brain (Pellegrini-Giampietro et al., 1991;
Standley et al., 1995). In the neocortex, striatum and cerebellum, the
G1uR1+GIuR3/GÏuR2 ratio is high at early postnatal stages and decreases monotonically
2+
with age, suggesting that a larger proportion of Ca -permeable channels is formed
during early neonatal than during aduit life. In the hippocampus, the ratio increases from
P7-P21, afier which time it declines. Thus, the synthesis of G1uR2 could provide a
developmental mechanism regulating Ca2 permeable AMPA receptors at crucial times
(Pellegrini-Giampietro et al., 1997).
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2,3-benzodiazepines act as AMPA receptor-selective antagonists. 0f these
compounds, the drug GYK153655 stands out as the most selective (Paternain et al., 1995;
Wilding and Huettner, 1995). Quinoxalinediones such as 6-cyano-7-nitroquinoxaïine-
2,3-dione (CNQX) and 6,7-dinitroquinoxaline-2,3-dione (DNQX) are potent competitive
antagonists at non-NMDA receptors (Honoré et al., 1988). In addition, 2,3-Dioxo-6-
nitro- 1,2,3 ,4-tetrahydrobenzo [f] quinoxaline-7-sulfonmide (NBQX) is a potent, selective
and competitive AMPA receptor antagonist.
3.2.1. AMPA subunits and flip or flop isoforms during development
Each of the GIuRÏ-G1uR4 subunits exists in two different forms, “flip” and
“flop”, created by alternative spiicing of a 115-base pair region immediately preceding
the M4 segment (Sommer et al., 1990). DeveloprnentaÏ and regional differences in
expression of the alternative spiice variants, flip and flop, have been demonstrated using
in situ hybridization histochemistry (Sommer et al., 1990; Monyer et al., 1991).
AMPA receptor subunits are expressed predominantly in the flip form in
embryonic brains. The flop form is expressed at low levels prior to P8, and gradually
increases throughout the brain, reaching aduit levels by P14, and then co-expresses with
the flip form in several structures. Thus, excitatory neurotransmission in the adult brain
appears to be mediated mainly by AMPA receptors carrying the flop module. AMPA
receptors of the flip form are more resistant to desensitization than those of the flop form
(Partin et al., 1995; f leck et al., 1996), whereas receptors ofthe flop form show a faster
desensitization rate than those with the flip form (Mosbacher et al., 1994). Recently,
Seifert et al. (2000) have observed that the lowest sensitivity of AMPA receptors to KA
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and NBQX began at P18, and suggested that these changes reflect a lower abundance of
G1uR1 at that developmental stage. A decrease of potentiation of receptor currents by
cyclothiazide (CTZ), a selective AMPA receptor modulator to distinguish functionally
between flip/flop variants, an acceleration of the recovery from CTZ potentiation and a
faster and more complete desensitization of glutamate-evoked currents suggest an up
regulation of flop spiice variants with increasing age in P3-45 rats in hippocampal CAl
neurons (Seifert et al., 2000). Several unes of evidence suggest that a reduction in flip
form expression is likely to explain the developmental changes of AMPA receptor
kinetics (Lawrence and Trusseil, 2000).
3.3. KA receptors
The KA receptors are encoded by two gene families, KAI/KA2 and GIuR5-7.
Both of which have signfficant structural homology to AMPA receptors, U1uR1-4
(Contractor et al., 2000). KA receptors that contain edited G1uR5 subunits display a
significantly reduced Ca2 permeability, a linear or slightly outwardly rectifying current
voltage relationship and a single low conductance as well as a highly significant increase
in the permeability to chloride ions (Chittajallu et al., 1999). KA receptors contribute to
the EPSCs in response to glutamate and have been proposed to modulate synaptic
transmission through an inhibitory presynaptic action (frerking and NicolI, 2000;
Frerking et al., 2001). In the nAcb, functional KA receptors are abundantly expressed
and can be activated by exogenous application of KA, but they do flot directÏy participate
in glutarnatergic synaptic transmission evoked by electrical stimulation of cortical
afferent fibers in the MS neurons. Activation of KA receptors in the nAcb inhibits
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excitatory synaptic transmission including AMPAR- and NMDAR-EPSCs via a
presynaptic mechanism (Casassus and Mulle, 2002; Crowder and Weiner, 2002).
Selective antagonists for KA receptors including NS-102, GYK152466, GYKI
53655, LY29355$ and LY294486 are providing novel pharmacological tools to allow the
differentiation not only between AMPA and KA receptors but also between individual
KA receptors comprising or containing G1uR5 subunits (Chittajallu et al., 1999).
3.4. NMDA receptors
The NMDA receptor is a heteromeric protein complex constituting a cationic
channel and several modulatory sites. It is a ligand-gated and voltage-dependant channel,
which is highly permeable to Ca2. NMDA receptors are characterized by voltage
dependent block by Mg2, and at RMP it remains largely blocked by Mg2. In addition to
the membrane depolarization required to remove the Mg2 block, NMDA receptors
require the simultaneous binding of both glutamate and the co-agonist glycine for
efficient gating (Ravenscrofi and Brotchie, 2000). Tonic currents through the receptor
only occur when the neuronal membrane is depolarized (Mayer et al., 1984; Nowak et al.,
1984) with a high permeability to Ca2 (MacDermott et al., 1986; Mayer and Westbrook,
1987) and slow gating kinetics, i.e., NMDAR-synaptic transmission occurs slowly and
lasts for a prolonged period compared to AMPAR-currents (Lester et al., 1990). During
synaptic transmission, EPSC generated by NMDA receptor activation occurs with slow
rise and an exceptionally slow decay time, which exceeds that of AMPAR-EPSC by
several orders of magnitude. NMDA channels first open about 1 Oms afier glutamate is
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released into the synaptic clefi, and then last hundreds of milliseconds until glutamate
unbinds from the receptor (Behe et al., 1999; Dzubay and Jahr, 1996).
In extemal medium containing physiological concentrations of Mg2 (1 mM),
the NMDAR-current is maximal between —20 and —30 mV, and is reduced at more
hyperpolarized potentials despite the increased electrical driving force. The inward
current is negligible at —$0 mV, and the I-V relationship of the NMDA response thus
exhibits a clear negative siope conductance between —$0 and —30 mV. The negative
slope conductance is eliminated by removing Mg2 from the extemal solution (Mayer et
al., 1984; Nowak et al., 1984).
3.4.1. Glycine, a co-agonist
Glycine is a co-agonist of the NMDA receptor (Johnson and Ascher, 1987). The
NMDA response is markedly potentiated by glycine in cultured central neurons. NMDA
responses were flot detected without glycine in the external solution. This implies that
glycine is not simply a strong potentiator of the NMDA response, but is absolutely
necessary to enable the NMDA receptor channel to enter the open state, it thus plays a
role as a co-agonist. However, NMDA responses are stili detectable because of the
presence of endogenous glycine. 7Cl Kyn could almost completely abolish NMDA
responses by competitively displacing glycine from its binding site (Kemp et al., 1988;
Vyklicky et al., 1990).
3.4.2. NMDA receptor subunits and developmental regulation
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The NMDA receptor consists of a NRI, NR2 and two NR3 subunits. The NR2
includes NR2A, NR2B, NR2C and NR2D subunits (Hoiimann, 1999; Moriyoshi et ai.,
1991; Das et al., 1998; Ikeda et ai., 1992; Kutsuwada et al., 1992; Meguro et ai., 1992;
Monyer et ai., 1992; Ishui et al., 1993). Ail NMDA receptors appear to function as
heteromeric assembiies composed of multiple NR1 subunits in combination with at ieast
one type of NR2. The NR3 subunit does flot form ftmctionai receptors aione, but co
assembles with NR1/NR2 complexes (Das et ai, 1998; Perez-Otano et ai, 2001).
The time course of decay of NMDAR-EPSCs and the apparent affinity of the
receptors for glutamate are both strongiy influenced by the identity of the NR2 subunits
invoived. The functionai properties of NMDA receptor channels such as the degree of
voitage-dependent Mg2 biock and deactivation kinetics depend on which of the four
NR2 is assembied. Diheteromeric NMDA receptors containing NR2A or NR2B subunits
generate ‘high-conductance’ channel openings with a high sensitivity to biockade by
Mg2, whereas NR2C- or NR2D-containing receptors give rise to ‘low-conductance’
openings with a iower sensitivity to extracelluiar Mg2. The deactivation times follow the
sequence: NR2A<2C2B«2D. Thus, a brief application of glutamate onto NR1/NR2A
assembiies generates a macroscopic current with a deactivation time constant of tens of
ms, compared with severai seconds for NR1/NR2D receptors (Monyer et al., 1994;
Wyllie et ai., 1998; Vicini et al., 199$).
The NR2 subunits are regulated developmentaiiy in rodent brains (Watanabe et
al., 1992; Monyer et ai., 1991). NR2B and NR2D subunits predominate in the neonatal
brain, but over the course of development these are suppiemented with, or replaced by
NR2A and in some regions by NR2C subunits (Monyer et ai., 1994; Akazawa et ai.,
24
1994). At embryonic stages, the NR2B subunit is found in most brain regions, whereas
the NR2D subunit is present in the diencephalon and brainstem. Soon afier birth, NR2A
mRNA is found in most regions, whereas NR2C appears later and is predominant in the
cerebellum (Monyer et al., 1994; Akazawa et al., 1994). A general trend shows that the
contribution ofNR2B subunit is decreasing during development, which is associated with
an increasing contribution of NR2A-containing NMDA receptors to synaptic current.
Additionally, when NR2A is expressed, it almost aiways co-expresses with NR2B at P3-
P9 ages in some brain regions. Neurons expressing NR2A subunit mRNA have faster
NMDAR-EPSCs than celis not expressing this subunit, regardless of postnatal age.
Expression of NR2A subunit mRNA in cortical neurons at even low levels seems
sufficient to alter the NMDA receptor time course. Generally, the proportion of celis
expressing NR2A and displaying fast NMDAR-EPSCs increase developmentally (Flint et
al., 1997).
3.4.3. Components of subunits determine properties of NMDA receptors
Mg2 inhibition of NMDA currents (Nowak et al., 1984) is almost exclusively
displayed by receptors containing NR1/NR2A or NR1/NR2B subunits (Kutsuwada et al.,
1992; Monyer et aI., 1992). NMDA receptors containing NR2C exhibit a low sensitivity
to Mg2, which would be expected to allow these NMDA receptors to operate at more
negative membrane potentials than conventional NR2A/B-containing receptors. This
difference may explain, in part, the ability of antagonists with moderate selectivity for
NR2AJB- or NR2C!D-containing receptors to differentially block LTP and LTD in the
hippocampus (Hrabetova et al., 2000). In external solution containing 1 mM Mg2, the
current response was largest at —25 mV in the NR2A/B two-receptor channels, whereas it
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was around —45 mV in the NR2C/D two receptor channels. Furthermore, the blockage by
Mg2 on the inward current is much stronger in the range between —25 and —20 mV for
the former than the latter (Monyer et al., 1994). The main functional properties, such as
the sensitivity to Mg2 and ifenprodil, and the time course of synaptic current suggest that
most receptors are composed ofNRl and NR2B subunits (Plant et al., 1997).
Recent studies found that NR1 subunits also strongly influence NMDA receptor
properties. For example, the pH sensitivity of NMDA receptors is determined by the
presence of exon 5 of the NR1 subunits. At physiological pH, spiice variants that include
exon 5 are fiully active, whereas those lacking exon 5 are partially blocked (Traynelis et
al., 1995). Most importantly, it lias been shown that spiicing of exon 5 can influence the
deactivation properties of NMDA receptors (Rumbaugh et al., 2000). Unlike NR2A-
containing receptors (Vicini et al., 199$), the deactivation time of recombinant NR2B-
containing receptors is dependent on whether or not NR1 contains the exon 5 insert. The
deactivation rate is roughiy four times faster for NRI-lb/NR2B (exon-5-containing)
receptors than for the NR1-YaJNR2B (exon-5-iacking) receptors. This observation may
well be relevant to the change in time course of the NMDAR-EPSC decay that occurs at
many synapses during development (Laurie and Seeburg, 1994).
A graduai replacement or suppiementation of NR2B by NR2A during postnatal
development has been implicated in the speeding of NMDAR-EPSC decay—a
phenomenon ofien linked with the ability of neuronal circuits to exhibit experience
dependent synaptic plasticity (Constantine-Paton and Cline, 199$). for example, the
NMDAR-EPSCs in the visual cortex are sensitive to NR2B-selective antagonists,
ifenprodil, when the NMDAR-EPSC decay is slow at P3-P5. This sensitivity is lost by
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P7 when the NMDAR-EPSC decays more rapidly. Therefore, to test EPSC sensitivity to
ifenprodil has been a reliable indicator for NR2B subunit-containing NMDA receptors.
Reversibly, NR2A/NR2B subunits ratio appears to be an indicator of NMDAR-EPSCs
decay (Quinlan et al., 1 999a).
Investigation suggests that native nAcb NMDA receptors are composed of
NR1/NR2B and maybe to a lesser extent ofNRl/NR2A subunits, although a combination
of these three subunits is also possible (Chazot and Stephenson, 1997; Le Greves et al.,
1997).
3.4.4. Single channel properties during development
The native NMDA receptor channel has 5O pS conductance levels when open
and 4OpS sublevels in various central neurons (Nowak et al., 1984; Jahr and Stevens,
1987; Ascher et al., 1988). farrant and colleagues (1994) have shown that the single
chaimel properties of the NMDA receptor in cerebellar granule celis markedly changes
during early developrnent. At an early stage (before P13), most openings were of the
5OI4OpS state. In contrast, the majority of channel openings (65%) were to the lower
conductance state (—33I2OpS) at P19-23. Expression studies have shown that both
NR1/NR2A and NR1/NR2B NMDA receptors have 5O/4O pS openings (Stem et al.,
1992; Tsuzuki et al., 1994), whereas NRÏ/ NR2C and NR1/NR2D receptor openings
have lower conductance (—35/2O pS) (Stem et al., 1992; Wyllie et al., 1996). These
resuits strongly suggest that changes in single channel properties of the NMDA receptor
during early developrnent is due to developmental changes in expressions of the NR2
subunits. These findings are consistent with the resuits from cerebellar granule ceils in
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which at P7 the single channel conductance of the NMDA receptor is predominantly
-50/40 pS. At P30, the iow-conductance (—34/1 8pS) channels become dominant, and
very few high-conductance chaimels are detected (Takahashi et ai., 1996).
It is most likeiy that the high-conductance channeis are produced predominantly
by NR1/NR2B and NR1/NR2A combinations in immature and mature animais,
respectively, since in situ hybridization studies have shown that NR2A is expressed
relatively late postnataliy whereas NR2B is expressed transiently during the eariier stage
in cerebeliar granule celis (Watanabie et ai., 1992; Monyer et ai., 1994).
D-2-amino-5-phosphonovalerate (D-APV), 7-chlorokynurenic acid (7C1 Kyn),
Mg2, and MK-$01 are different NMDA receptor antagonists (Ozawa et ai., 199$).
Additionally, Ifenprodii and a group of reiated compounds, such as, Haloperidol and
CP 101, 606 are selective antagonists of NR2B-containing NMDA receptors, whereas
PPDA is a competitive inhibitor ofNR2C and NR2D subunits (Culi-Candy et ai., 2001).
Ifenprodii seiectively block NR2B-containing NMDA receptors in a non-competitive,
voltage-independent, activity-dependent manner (Constantine-Paton and Cime, 199$;
Moriyoshi et ai., 1991; Sugihara et al., 1992).
4. Cholinergic receptors
The neurotransmitter ACh is reieased from vesicies in presynaptic nerve terminais
and influences functionai and behaviorai states through its actions at metabotropic
muscarinic ACh receptors (mAChRs) andlor ionotropic nicotinic ACh receptors
(nAChRs) (Guo and Chiappineiii, 2000). f ive mAChR subtypes (M1-M5) have been
identified by molecular cioning (Cauifieid and Birdsall, 199$). Although a number of
2$
subunits of neuronal nAChRs (u2-Œ9, f32-f34) have been cloned, and several subtypes of
nAChRs are known in brain, a complete nomenclature has flot yet been achieved due to
the numerous combinations of these subunits that can form native nAChRs (Sargent,
1993). Responses mediated by nAChRs are aiways excitatory, occur rapidly, and are
blocked by d-tubocurarine. In contrast, muscarinic responses can be either excitatory or
inhibitory, depending on the mAChR subtype mediating the response and the type of G
protein to which the mAChR is coupled (Brown et al., 1997; felder, 1995). These
responses have longer latency of onset and can be blocked by atropine or scopolamine.
In some brain regions, mAChRs are co-localized with nAChRs, suggesting that
cholinergic modulation is complex in the CN$ (Quirion et al., 1994). One important
function of ACh receptors (AChRs) localized on or near presynaptic terminals is its role
in modulating neurotransmitter release (Caulfield, 1993; Wonnacott, 1997).
4.1. Cellular localization of cholinergic receptors
4.1.1. Muscarinic ACli receptors
Ml receptors are distinctly expressed in the nAcb (Mash and Potter, 1986; Biake
et al., 1991; Kohler et al., 1995; Kushida et al., 1995; Adem et al., 1997).
Immunocytochemistry and in situ hybridization studies of mAChRs in the neostriatum
including nAcb suggest that probabiy all neurons express mAChRs but different types of
neurons appear to express different types of mAChRs. Studies agree that Ml mAChR is
the most abundant, being detected in the soma of 7$-85% neurons displaying the
characteristics of MS neurons (Bemard et al., 1992; Hersch et al., 1994; Weiner et al.,
1990). M4 receptors are found in a subset of putative MS neurons: ail those containing
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substance P and 39% of those containing enkephalin (Bemard et ai., 1992), suggesting
that a subset ofMS fleurons express only Ml receptors whereas others express both Ml
and M4 receptors. At subcellular leveis, immunocytochemicaiiy labeled Ml receptors
were enriched in spiny dendrites, at postsynaptic densities and on a small number of axon
terminais forming asymmetrical synapses. M4 receptor protein was also found on axon
terminais that formed asymmetrical synapses (Hersch et al., 1994). These findings are
interesting since neostriatal asymmetricai synapses are known to originate primariiy from
giutamatergic cortical, thalamic, and subthaiamic afferents. This iocalization suggests the
presence of postsynaptic mAChRs close to synapses using excitatory amino acids as their
primary neurotransmitter.
Most somatostatin (putative LTS intemeurons) and neurotensin containing
neurons express Ml receptor gene but only a few express M4 receptor mRNA. In
contrast to Ml receptor, M2 receptor protein was found in only 2.5% of neostriatal
neurons and those had characteristics of LA neurons. Many of these were found on axon
terminais, usually making symmetricai synapses with somata, dendritic shafis and spines
whereas a minority contacted terminais forming asymmertrical synapses on spines or
dendrites (Hersch et al., 1994). In situ hybridization studies showed that, in addition to
M2 receptors (Bemard et al., 1992; Weiner et ai., 1990; Yan and Surmeier, 1996), a large
proportion of putative cholinergic neurons also contained M4 receptor mRNA while
some may have contained Ml mRNA (Bemard et al., 1992; Yan and Surmeier, 1996).
M3 receptor protein was only found in a distinct population of smail dendrites and some
axon terminais forming asymmetrical synapses. These findings indicate that mAChR
proteins are concentrated postsynaptically on non-cholinergic and cholinergic neurons.
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In addition, each receptor subtype is also found on presynaptic terminais making both
asymmetrical and symmetrical synapses, suggesting that ACh probably modulate
neurotransmitter release and that M2 receptors are the predominant muscarinic
autoreceptor (Hersch et al., 1994). Other studies also suggested that ACh varicosities in
the nAcb were presumably involved in a non-j unctionai or volumic mode of transmission
(Contant et al., 1996).
4.1.2. Nïcotinic ACh receptors
Both anatomicai and neurochemical studies in the mid-1980s suggested that
nAChRs were localized at presynaptic sites within the peripheral nervous system and
CNS (Schwartz et al., 1984; Clarke et al., 1986; Vizi and Somogyi, 1989). Light and
electron microscopic studies, using radiolabled nAChR Ïigands and immunological
probes, revealed the presence of nAChR binding sites over the length of individual nerve
fibers and provided evidence for the anterograde shipment of nAChRs to synaptic
terminais (Ciarke et al., 1986; Torrao et al., 1996; Wonnacott, 1997). Furthermore,
studies looking at nAChR distribution following the destruction of presynaptic
projections provided strong anatomicai evidence for the localization of nAChRs on
presynaptic terminais (Clarke et al., 1986; Torrao et al., 1996). These findings have
recently received elegant confirmation in experiments using irnmuno-gold labeling of
neuronal nAChRs to demonstrate that a7 subunits were located on presynaptic terminais
within the PfC (Lubin and Aokie, 1998).
It is now clear that nAChR genes are expressed in neostriatal neurons, especiaily
the Œ3 and 2 subunits, with a restricted and heterogeneous pattern (Wada et ai., 1989).
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The localization of nAChRs in presynaptic structures in the CNS has received important
support from studies using synaptosomes preparations from a variety of brain regions
indicating that nAChRs are present in presynaptic membrane not from only the nAcb but
also other parts of CNS, including striatum, PfC, hippocampus, thalamic, and
hypothalamic nuclei (Wonnacott, Ï 997).
4.1.2.1 Subunit composition offunctional nicotinic ACh receptors
With the binding of ACh or other agonists, nAChRs allow cations to flow through
an intrinsic channel, generally resulting in depolarization of the neuron. To date, 13
different neuronal nAChR subunits (a2-ulO and f32- f34) have been identified (Le Novère
and Changeux, 1995). The neuronal nAChR subunits can be divided into subfamilies
based on sequence homology and phylogeny (Le Novère and Changeux, 1995), as well as
pharmacological and physiological properties. al-u6 combined with f32-f34 would
comprise one family and Œ7-Œ8 would comprise the second. u9 has distinct
pharmacological properties and is likely to be part of a third family. functionally,
nÀChRs can be divided into those containing the f32 subunit which combine with
different Œ subunits, forming receptor with the highest affinity for nicotine (Picciotto et
al., 1995), and those containing the f34 subunit which also combined with various cL
subunits, forming receptors with 10-100 times Iower affinity for nicotine (Luetje and
Patrick, 1991). f34/cL3 subunit-containing nAChRs are highly expressed in the peripheral
nervous system and appear to be essential for fast synaptic transmission in the autonomic
ganglia (Xu et al., 1999). In contrast, the subtypes of nAChR expressed most commonly
in the brain are made of f32/cL4 subunits and Œ7 subunits and bind to a-bungarotoxin
(flores et al., 1992; Hill et al., 1993; Wada et al., 1989; Zoli et al., 1995).
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5. Muscarinic ACh receptors and synaptic transmission in the nucleus accumbens
Over the last ten years, the use of in vitro brain suce preparation to record single
nAcb neuron and the availability of more selective pharmacological compounds to isolate
the function of various neurotransmitter receptors have enabled researchers to understand
the contribution of different transmitters in the generation and modulation of the neuronal
activity in the nAcb.
5.1. Activities of muscarinic receptors modulate the function of MS neurons
Each identified neuronal population in the nAcb is under the direct control of the
ACh neurons through the expression of mAChRs, in particular the Ml receptor (Adem et
al., 1997; Kohler et al., 1995; Bemard et al., 1992). 0f five subtypes of mAChRs, the
Ml, M3 and M5 receptors subtypes activate phospholipase C (PLC) that release inositol
1 ,3,5-triphosphate (1P3) and diacylglycerol (DAG) from membrane phospholipid
(Berridge and Irvine, 1984). Conversely, the M2 and M4 receptor subtypes inhibit
adenylate cyclase tAC) (Hulme, 1990). Application of muscarinic cholinergic agonists
has been found to produce either excitatory or inhibitory effects on the MS neurons.
5.1.1. Modulation of ionic conductance by activating muscarinic ACh receptors
Muscarine predominantly reduces inward rectifier conductance and causes
membrane depolarization of MS neurons. These effects are competitively antagonized by
pirenzepine, a selective Ml receptor antagonist, indicating involvement of the Ml
receptor in nAcb M$ neurons (Uchimura and North, 1990; Hsu et al., 1996).
Additionally, carbachol can aÏso act at Ml muscarinic receptors to reduce the membrane
K conductances and excite MS neurons (Hsu et al., 1996).
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In vitro studies in rat corticostriatal suce preparations show that low concentration
of muscarine which does flot alter the membrane potential and input resistance of MS
neurons, increases excitability by enhancing the membrane depolarization and inward
current produced by the application ofNMDA but not ofAMPA (Calabresi et al., 1998).
This facilitatory effect is not affected by TTX, suggesting a postsynaptic site of action,
and is mimicked by neostigmine. This indicates that endogenous ACh may also enhance
responses to NMDA. The pharmacological analysis of this phenomenon also suggests
the involvement of Ml receptors. In fact, this facilitatory action has been antagonized by
pirenzepine and mimicked by McN-A-343, a selective Ml receptor agonist.
InterestingÏy, McN-A-343 also increases the duration of the glutamate-mediated EPSPs
elicited by the stimulation of corticostriatal fibers. However, this occurs only in the
absence of Mg2 ions from the externat bathing solution, suggesting the involvement of a
NMDA component in corticostriatal synaptic potentials. This provides further
confirmation that Ml receptor activation might selectively exert a positive and
modulatory role on NMDAR-potentials. Additionally, muscarinic agonists have been
reported to decrease the responsiveness of dorsal striatal neurons to excitatory inputs
(Dodt and Misgeld, 1986; Akaike et al., 1988; Malenka and Kocsis, 198$). In cultured
rat dorsal striatal neurons, Akins et al. (1990) found that muscarinic agonists shifted the
voltage-dependence of the A-current activation and inactivation towards more negative
membrane potentials, in addition to increasing its peak conductance. Thus, in the
presence of muscarinic receptor agonists at reÏatively hyperpolarized membrane
potentials, this allowed the A-cunent to suppress excitatory inputs and further slow the
discharge rate.
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High-voltage-activated Ca2 current through striatal MS neurons appear to be
another postsynaptic target of mACbR agonists. Current-clamp experiments performed
on rat striatal suces show that the activation of mAChRs significantly reduces the
duration of Ca2 dependent plateau potentials (Misgeld et al., 1986). More recently,
whole-cell patch-clamp experiments with acutely isolated striatal neurons showed that
rnAChR agonists reduce Ca2 currents via two distinct signaling pathways depending on
pertusis-toxin-insensitive G proteins and is responsible for the inhibition of L-type Ca2
channels (Howe and Surmeier, 1995).
5.2. Activation of muscarinic receptors modulate glutamate release
In the nAcb, the depression of excitatory synaptic transmission mediated by
presynaptic mAChRs has also been demonstrated (de Rover et al., 2002; Pennartz and
Lopes da siiva, 1994; Sugita et al., 1991). Stimulus-evoked EPSPs can reversibly be
attenuated by muscarine or carbachol, and this action is completely antagonized by
atropine or pirenzepine, indicating that the effect of muscarinic receptor agonist on
EPSPs is mediated by Ml receptor. Carbachol induces no alteration of glutamate-evoked
depolarization while suppressing EPSPs in the same neuron, suggesting the involvement
of a presynaptic mechanism in muscarinic inhibition (Peimartz and Lopes da siiva, 1994).
The action of mAChRs activation on the release of excitatory and inhibitory
transmitters has also been studied. Both glutamate- and GABA-mediated synaptic
potentials are reduced in a dose-dependent manner by mAChR agonists. A heterogenous
population of mAChRs seems to be involved in this cholinergic action on glutamatergic
and GABAergic nerve terminais. Sugita et al. (1991) have shown that muscarine and
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ACh inhibited the release ofboth excitatory arnino acids and GABA through M3 and Ml
receptors in the nAcb, respectively via distinct presynaptic mechanisms.
In the striatum, early studies in vivo demonstrated that iontophoretically applied
ACh to striatal neurons produced both excitatory and inhibitory effects: ACh increased
the spontaneous firing rate but reduced the EPSPs (Bemardi et al., 1976). Takagi and
Yamamoto (1978) reported that cholinergic agonist or physostigmine exerted inhibitory
effects on single unit activity induced by local stimulation ofthe striatum in vitro without
affecting glutamate-induced firing activity. These extracellular experiments suggest that
ACh and carbachol have presynaptic inhibitory effects on striatal neurons (Takagi and
Yamamoto, 1978).
5.3. ACh release regutated by muscarinic ACh receptors in LA neurons
lames and Cubeddu (1987) reported that muscarinic agonists limited ACh release
in the dorsal striatum. Later, two different physiological actions of mAChR activation
have been described on LA intemeurons. Both actions resulted in the inhibition of LA
neurons activity, confirming that ACh regulates its own release via the activation of
muscarinic autoreceptors. The first action ofmAChRs activation described in cholinergic
intemeurons is the inhibition of both N- and P-type Ca2 channels mediated by M2
receptors via the stimulation of a G-protein dependent intracellular pathway (Yan and
Surmeier, 1996). As Ca2 channels take part in the regulation of neurotransmitter release,
the inhibition of these currents might, at least partially, explain the inhibitory effect of
ACh on its own release. More recently, the existence of a novel mechanism has been
proposed to underlie the mAChR-mediated modulation of ACh release in the dorsal
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striatum (Calabresi et al., 1998). Intracellular recordings from identified LA neurons in
vitro, combined with focal stimulation, reveals a mAChRs dependent IPSP, suggesting
that the release of endogenous ACh from presynaptic nerve terminals inhibits LA neuron
activity by activating muscarinic autoreceptors located in their somato-dendritic region.
This IPSP appears to be mediated by the opening of K channels since it was blocked by
barium and reversed at the K equilibrium potential. This inhibitory effect also appears
to be mediated by M2 receptors, as it is blocked by methoctramine, but flot by
pirenzepine. furthermore, the membrane hyperpolarization mediated by nerve-terminal
stimulation can be mimicked by the exogenous application of muscarine and
oxotremorine, but flot by McN-A343 (Calabresi et al., 1998).
6. Activation of nicotinic ACh receptors facilitates synaptic transmission in the CNS
It has been proposed that the rote of nAChRs in the CNS is to prirnarily modulate
synaptic transmission rather than to mediate it (Gray et al., 1996; McGehee et al., 1995).
Several effects of nicotine in the brain appear to be mediated through the
neurornodulatory potentiation of different neurotransmitters including norepinephrine,
DA, GABA, serotonin, ACh, and glutamate (MacDermott et al., 1999; McGehee and
Role, 1996; Wonnacott et al., 1989).
6.1. Facilitation of glutamate release by presynaptic nicotinic ACh receptors
Nicotinic facilitation of glutamate release has been reported in different areas of
the CN$ (Toth et al., 1993; McGehee et al., 1995; Guo et al., 1998; Radcliffe and Dani,
1998; Girod et al., 2000; Fisher and Dani, 2000; Reid et al., 2000; Schilstrom et al.,
2000). Nicotine lifts extracellular glutamate levels in the nAcb (Reid et al., 2000) and the
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dorsal striatum (Toth et al., 1993). DMPP, a specific nAChR agonist, has also been
found to increase the frequency of CNQX-sensitive postsynaptic currents in CN$ via
presynaptic action on nAChRs located on glutamatergic terminais (Bordey, et al., 1996).
In addition, nAChRs have been found expressing on glutamatergic terminais in olfactory
bulb culture, where they have been shown to modulate glutamate release and
subsequently modulate excitatory transmissions (Aikondon, et al., 1996). Studies have
shown that nicotine not only enhances AMPAR-synaptic transmission (McGehee et al.,
1995), but NMDAR-synaptic transmission (Aramakis and Metherate, 1998) as well in the
CNS during postnatal development by presynaptic mechanisms. $everal lines of
evidence also suggest that ACh may directly or indirectly influence the excitability of
neurons in the nAcb (Gauchy et al., 1991).
The addictive effects of nicotine are largely attributed to its efficacy in eliciting
DA release in the nAcb whereas the purported effects of nicotine on memory, attention,
and arousal may reside in its potent facilitation of glutamate release at hippocampal and
habenula-interpeduncular synapses (Dani, 2003; Mansvelder and McGehee, 2002;
Balfour, 2002; Vogt and Regehr, 2001; Shim et al., 2001; Radcliffe and Dani, 1998)
Characteristics of the presynaptic nAChRs that facilitate glutamate release
implicate different nAChR subtypes (Gray et al., 1996; McGehee et al., 1995; Guo et al.,
1998). The nicotine- and ACh-induced enhancement of evoked and spontaneous
glutamate release often appears to be mediated by a7-containing receptors. These sites
are gated by nanomolar concentrations of nicotine and are blocked by both MLA and
ŒBgtX. Furthermore, rapid, repeated high-dose exposure of glutamatergic synapses to
ACh could elicit a sustained potentiation of synaptic transmission (Girod et al., 2000).
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The selective, pharmacological targeting of Œ7-containing nAChR subtypes iS of
particular importance in view ofthe reported decreases in cholinergic projections and a7-
containing receptors in pathological conditions involving cognitive and/or attentional
deficits, such as Aizheimer’s disease and schizophrenia (Benowitz, 1996; Lindstrom,
1997; Lloyd et al., 199$).
6.2. Facilitation of dopamine release by presynaptic nicotinic ACh receptors
High density and affinity nAChRs are present on terminais of dopaminergic
projections to the nAcb (Clarke and Pert, 19$5). Recent studies have consistentiy
demonstrated that nicotine elicits DA release in the nAcb by activating nAChRs (Sziraki
et ai., 1999; Jolmson et al., 2000; Seppa and Ahtee, 2000; Gaddnas et al., 2002; $him et
al., 2001; Green et al., 2001; De Villiers et al., 2002; Mogg et al., 2002). The role of
these nAChRs in regulating DA release was originally investigated in synaptosome
preparations (Rapier et al., 198$; 1990; Grady et al., 1992; Marks et al., 1993; E1-Bizri
and Clarke, 1994). Nicotine evoked and increased the firing of mesencephalic
dopaminergic neurons (Picciotto et aï., 199$; Pidoplichko et al., 1997) and stimuïated the
release of DA from nAcb by acting on f32-containing nAChR (Picciotto et al., 199$).
Nicotine elicits a robust increase in DA release from synaptosomes or suces that persists
for several seconds or minutes, depending on the concentration of applied nicotine
(Rapier et al., 1988, 1990; Roweli, 1995; Sacaan et ai., 1995). In addition, the activation
of nAChRs at the preterminal location of the axon elicits action potential firing that
consequently opens voltage-dependent Ca2 channels in the terminals to enhance
transmitter release. Biocking action potentials by TTX rernoves heterosynaptic
modulation of DA release by nicotine agonists (Marshail et al., 1996). Soiiakov and
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Wonnacott (1996) demonstrated further that voltage-gated Ca21 channels contribute to
nAChR-mediated facilitation of DA release.
Microdialysis in vivo demonstrated that nicotine can augment DA levels and may
be due in part to activation ofnAChRs on DA terminais. This is because nicotine-elicited
DA release cari be seen in purified synaptosome preparations from the nAcb that are
highly enriched in presynaptic elernents (Grady et al., 1992; Roweii, 1995; Wonnacott et
al., 1990). Although injection of a nicotinic agonist directly into the DA terminal fields
of the nAcb can stimulate DA release, the strongest effects of nicotine appear to be on the
DA cell bodies of the VTA (Mifsud et al., 1989). Nicotine self-administration also
resuits in the increased expression of Fos-related antigens in the nAcb (Merlo-pich et al.,
1997), which are transcription factors that may be involved in neuroadaptation foilowing
chronic treatment with drugs of abuse (KeIz et al., 1999; Nye and Nestler, 1996).
Nicotine reinforcement has been studied in knock out mice lacking the 22 subunit
of the nAChRs (Picciotto et al., 1998). In the absence of the 22 subunit, neurons in the
DA system are grossly normal, but nicotine fails to induce DA release in the nAcb, and
DA neurons in the VTA become unresponsive to nicotine. Nicotine self-administration is
also abolished in these mice, suggesting that the 22 subunit is an important component of
the nAChR mediating nicotine reinforcement.
Studies using glutamatergic receptor antagonists along with K7-selective subunit
antagonist, MLA in rats have suggested that K7 subunit-containing receptors localized
presynaptically on glutamatergic afferents in the VIA contribute to the stimulation of DA
release in the nAcb (Schilstrom et al., 1998a,b). It is worth mentioning that even afier
continuous 50-day administration, nicotine stili continues to activate nAChRs regulating
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accumbal DA release and mecamylamine reduced the DA output in nicotine-treated mice
(Gaddnas et al., 2002). Mecamylamine can fully antagonize the effect of nicotine in a
non-competitive way, while the antagonism by MLA and dihydro-f3-erythoidine (DHt3E)
can be reversed for nicotine-induced DA release (Clarke and Reuben, 1996). Blockade
of NMDA receptors in the VTA attenuates the enhancing effect of nicotine on
extracellular levels of DA in the nAcb. Moreover, pretreatment with MLA in the VTA
abolished nicotine-induced DA releasing in the nAcb, indicating a role for Œ7 nAChRs in
this mechanism (Mogg et al., 2002).
On the other hand, the effects of nicotine on evoking DA release have also been
demonstrated using different nAChR agonists. Epibatidine, an agonist of nAChR,
significantly increased DA output and elevated the concentration of DOPAC, and also
tended to elevate that of HVA in the nAcb. (Seppa and Ahtee, 2000). Nomicotine, a
tobacco alkaloid and an active nicotine metabolite, can stimulate DA release from nAcb
in a nicotinic receptor-mediated manner (Green et al., 2001).
In addition, finding nicotine-induced stimulation of major reward system of the
brain involving the activation of NMDA receptors (Shilstrom et al., 1 998a, b; Sziraki et
al., 1998) indicates the possible involvement of the nAChRs in psychiatric diseases such
as schizophrenia. Considering the nicotinic action of clinically used antidepressants, the
results also suggest that nAChR activation may be involved in major depression (Salin
Pascual and Drucker-Colin, 1998).
6.3. Facilitation ofACh release
Nicotine-induced ACh release has been reported in several areas of the CNS
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including interpeduncular nucleus and striatum (Grady et al., 2001) in mice,
thalamocortical terminais in prefrontal cortex (Lambe et al., 2003), striatai suces of rats
(Sandor et al., 1991 a, b) in which nicotine induces release of ACh from LA neurons in a
TTX-sensitive manner, suggesting a postsynaptic and /or presynaptic nAChR-driven
positive feedback. The increase in both ACh and glutamate release appears to be
mediated by u7 subunit-containing nAChR as it can be blocked by Œ-bungarotoxin and is
greatly dirninished in the presence of antisense oligonucleotides targeted to the a7
subunit (Picciotto et al., 199$; Pidoplichko et al., 1997).
6.4. Pre- but not post-synaptic nicotinic ACh receptors mediates the facilitation
Recording of nAChR channels and nicotine-induced Ca2 influx in intact
presynaptic terminais provides strong evidence that direct activation of presynaptic
autoreceptors and heteroreceptors, rather than being retrograde mechanisms, actually
modulates transmission at sites where nAChRs are expressed on both pre- and
postsynaptic structures (Coggan et ai., 1997; Gray et al., 1996). These studies, and others
demonstrating that nAChR-mediated synaptic facilitation is dependent on pre- but flot
postsynaptic changes in internai Ca2, indicate that the nicotinic modulation of synaptic
transmission is due to direct activation of nAChRs localized on the presynaptic terminais
per se. It is important to note that these studies do not address the role of postsynaptic
nAChRs in mediating “classical” synaptic transmission.
7. Dopaminergic modulation of neuronal excitability in the nucleus accumbens
7.1. Dopamine receptor subtypes
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DA receptors were originally differentiated into two major subtypes, Dl and D2
(Tarazi et al., 199$). Recent technical advances in molecular genetics led to the
discovery of additional DA receptor subtypes (D3, D4, D5). These proteins have
generally lower relative abundance and more restricted cerebral localization than the
classical Dl and D2 receptors, but many molecular and pharmacological similarities to
the original receptor types. Based on their similarities, DA receptors are considered to
form Di-like (Dl, D5) and D2-like (D2, D3, D4 and their variants) families. Di-like
receptors are positively coupled to AC through activating G protein (Gs/oj), and by
stimulating AC, elevating cytosolic cAMP. This second messenger, in tum, induces the
dissociation of the regulatory subunit from cAMP-dependent protein kinase A (PKA).
By phosphorylating targeted proteins, PKA alters a variety of cellular functions. There is
also evidence that Dl and D5 receptors can activate other classes of G proteins, such as
G0 and G proteins (Sidhu, 1998). D2-like receptors are thought to exert an opposite
influence on AC activity. These receptors activate G!0 proteins which inhibit AC.
7.2. Dopaminergic receptor expression in the nucleus accumbens
five subtypes of DA receptors have been detected in the nAcb. Dl and D3
receptors are more abundant in the nAcb than in the dorsal striatum and are correlated
with the expression ofSP (Lu et al., 1998; $chwartz et al., 199$; Tarazi et al., 199$). D2
receptor expression appears to 5e correlated with enkephalin expression in the nAcb. D4
and D5 receptor expression is much lower (Sibley, 1995) and the resuits from Yan and
Surmeier (1997) suggested robust D5 receptor expression by nAcb LA neurons.
7.3. Dopaminergic modulation of neuronal activities in the nucleus accumbens
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7.3.1. Modulation ofïonic conductance
Several studies have demonstrated that DA or DA receptor agonists modulate
ionic conductance in the nAcb. DA could cause three types of membrane responses
specifically. These are hyperpolarization, depolarization and hyperpolarization followed
by a depolarization in nAcb neurons of guinea-pig brain suces (Uchimura et al., 1926).
further studies revealed that the DA-induced hyperpolarization is produced by an
activation of the Dl receptor and involved an increase in K conductance, whereas DA
induced depolarization was generated by the activation of the D2 receptor accompanied
by a decrease in K conductance (Uchimura et al., 1986). Zhang et al. (2002) recently
found that Dl receptor stimulation suppresses N- and P/Q-type Ca2 cunents by
activating a cAMP/PKAlprotein phosphatase signaling system and that repeated cocaïne
treatment reduces N- and R-type, but flot P/Q- or L-type currents. In addition to
modulating K and Ca2 currents, DA probably also affect Na currents. Amphetamine,
an indirect DA agonist promoting DA release, inhibits field potentials and Na currents in
rat nAcb neurons (Huang and Lin, 1998). Also repeated cocaine injections reduced
whoÏe-ceÏÏ Na currents in nAcb suce preparations. freshÏy dissociated nAcb neurons
from cocaine-pretreated rats also exhibited diminished Na cunent density and a
depolarizing shifi in the voltage-dependence of Na channel activation (Zhang et al.,
1998). Like in the nAcb, Dl receptors modulating Na current has also been found in the
dorsal striatal cells (Schiffmann et al., 1995). Consistent with the findings in the nAcb,
either DA or SKf3 8393, a Dl receptor agonist, produced a reversible inhibition of action
potential discharge evoked by intracellular depolarizing current pulses. This inhibitory
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effect was antagonized by the Dl receptor antagonist in dorsal striatum (Calabresi et al.,
1987, 198$).
7.3.2. Modulation of synaptic transmission
Several studies have found that DA depressed excitatory synaptic transmission in
the nAcb by acting on Dl receptors (Pennartz et al., 1992; Harvey and Lacey, 1996;
Nicola et al., 1996; Nicola and Malenka, 1997, 1998). The Dl receptor-mediated
reduction of EPSPs/EPSCs observed in vitro appears to be a presynaptic effect because
the paired-pulse ratio was increased by DA (Pennartz et al., 1992; Nicola et al., 1996).
DA also reduced the frequency of spontaneous miniature EPSCs (Nicola et al., 1996).
The inhibitory effect of DA does flot appear to be dependent on elevated cAMP levels, in
spite ofa clear enhancement ofEPSC by forskolin (Harvey and Lacey, 1996; Nicola and
Malenka, 1997). In contrast, several studies in vitro in the dorsal striatum have found
that DA enhanced NMDAR-synaptic or iontophoretic responses via the activation of Dl
receptors (Cepeda et al., 1993, 1998; Levine et al., 1996a, b), whereas other groups failed
to find a facilitatory effect of Dl -like receptor activation on NMDAR-responses in the
dorsal striatum (Calabresi et al., 1995; Nicola and Malenka, 1998). Stimulation of
excitatory afferents evokes a dual component EPSP/EPSC mediated by AMPA receptors
and NMDA receptors in MS neurons (Chang and Kitai, 1985; Pennartz et al., 1991;
Kombian and Malenka, 1994). A provocative suggestion is that DA can have distinct
effects on these two components depending on the subtype of DA receptor activated.
Specifically, D2 receptor activation has been reported to reduce AMPAR-EPSPs as well
as the response to iontophoretically applied glutamate or AMPA (Cepeda et al., 1993;
Hsu et al., 1995; Levine et al., 1996b), whereas Dl receptor activation is reported to
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enhance synaptic or iontophoretic NMDAR-responses (Cepeda et al., 1993, 1998; Levine
et al., 1996a, b). On the other hand, Levine et al. (1996b) found that AMPAR-EP$P was
not be altered by Dl receptor activation.
Calabresi and colleagues (1995) have reported no effect of DA and Dl or D2
receptor agonists on the responses of dorsal striatal ceils to iontophoresed AMPA or
NMDA. Consistent with these observations, no effects of DA on excitatory synaptic
responses in field potential or whole-cell recording from dorsal striatal region was found
(Malenka and Kocsis, 1988; Nicola and Malenka, 1998), despite the discovery of robust
effects of DA on excitatory responses in nAcb region of the striatal-nAcb suce (Nicola
and Malenka, 1998).
The inhibitory effect of Dl receptor activation on excitatory transmission appears
to be mediated by presynaptic mechanism (Pennartz et al., 1992; Harvey and Lacey,
1996; Nicola et al., 1996; Nicola and Malenka, 1997, 1998) whereas a postsynaptic
mechanism is stiÏÏ the subject of some controversy. Based on the findings that adenosine
Al receptor antagonists blocked the effects of DA on EPSCs, and that postsynaptic Dl
receptor activation increased synaptic NMDAR-responses, Harvey and Lacey (1997)
concluded that the enhanced NMDA current was responsible for the release of adenosine,
which presynaptically inhibited glutamate release. This hypothesis is consistent with the
anatomical localization of Dl receptors on postsynaptic dendritic spines and shafis of
nAcb ceils (Huang et al., 1992; Yung et al., 1995; Caillé et al., 1996). However, DA
enhancement of NMDAR-EPSCs could flot be replicated (Nicola and Malenka, 1997;
Zhang and Warren, 1998). In experiments with isolated EPSCs, we found that DA (50
tM) strongly inhibits NMDAR-EPSCs and moderately inhibits AMPAR-EPSCs in the
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nAcb suces from young rats (Zhang & Warren in preparation, see chapter IV of present
thesis).
8. Aims of the present study
The present study was performed in order to examine the characteristics of nAcb
EPSCs and their modulation by ACh and DA during postnatal development in rats. The
experiments were carried out in MS neurons of the nAcb suces using whoÏe-celÏ patch
clamp recording technique in postnatal rat (PO-P71). The feature of postnatal
development of EPSCs was selected as a terminal point in these experiments. The
present thesis is composed of three articles, which have been publislied or will be
submitted to joumals for publication and presented in Chapter II, III, and IV,
respectively.
As reviewed above, glutamatergic receptors and their mediated EPSCs have been
suggested to be one of the most important excitatory drive in the nAcb, whereas ACh and
DA appear to be two important neurotransmitters in modulating nAcb function. Previous
study lias shown that the physiological properties of MS neurons during postnatal
development becorne adult-like only by the end of the third postnatal week, suggesting
that nAcb function is different during early postnatal period from that in adults (Belleau
and Warren, 2000). Presumably, there is a critical period of synapses formation and
consolidation during which the transitory deprivation of some of nAcb afferents will
produce an imbalance between the strength of different inputs and lead to a pathological
state.
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Thus, it would be important, first to determine whether there is any change in
glutamatergic receptors-mediated EPSCs during early postnatal development, and to
characterize the features of NMDAR- and AMPAR-EP$Cs during this period. The
second part of the present thesis investigated the cholinergic modulation of EPSCs during
postnatal development using different cholinergic receptor agonists and antagonists. In
the third part of this thesis, we studied the modulatory role of the doparninergic systerm
on EPSCs during early synaptic development. We found that NMDAR-EPSCs are the
largest during the second postnatal week and decline during the following weeks,
suggesting that NMDA receptor may play a critical role during synaptic maturation
during postnatal development. DA preferentially inhibited NMDAR-EPSCs compared to
AMPAR-EP$Cs. These effects were mediated by Dl type receptor mainly through both
pre and postsynaptic mechanisms. Activation of the cholinergic receptors produced a
dual modulatory function, e.g. an excitatory nicotinic action and an inhibitory muscarinic
effect on EPSCs during postnatal development. Our results reveal predominant
expressions of NMDAR-EPSCs and the contrasting effects of Ml receptor and nACbR
on EP$Cs as well as the inhibitory effect of activating Dl receptors on NMDAR-EP$Cs
during postnatal development. Presynaptic mechanism mediates the actions of ACh. Pre
and postsynaptic mechanisms may be involved in the effects of DA on excitatory
synaptic transmission. Predominant expression ofNMDA receptors and hyperfunction of
the dopaminergic system during early postnatal development might play a pivotai role in
the etiology of the schizophrenia (Joyce and Meador-Woodruff, 1997).
CHAPTER II
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ABSTRACT
We recorded excitatory postsynaptic currents (EPSCs) evoked by local electrical
stimulation in 243 nucleus accumbens (nAcb) neurons in vitro during postnatal
development from the day of birth (postnatal day O; P0) to P27 and in young aduits rats
(P59-P71). An EPSC sensitive to glutamatergic antagonists was found in ail neurons. In
the majority ofneurons (189/243), the EPSC had two distinct components: an early one
sensitive to 6-cyano-7- nitroquinoxaline -2,3-dione (CNQX) and a late one that was
sensitive to d-2-amino-5- phosphonovaleric acid (APV) showing that early and late
components of the EPSC were mediated by AMPA/KA and NMDA receptors
respectively. During the flrst few days afier birth, the amplitude of both the early and late
components ofthe EPSC were relatively small and then began to increase until the end of
the second postnatal week. Whereas the characteristics of the early component appeared
to stabilize from that point on, the late component began to decrease in amplitude and
becamevirtually absent in preparations from more than 3-week-old animals. In addition,
the ratio of the late to early component amplitudes of the EPSCs followed a
developmental pattem parallel to that of the late component showing an increase during
the flrst two postnatal weeks followed by a decrease. Together, these results show the
presence oftransiently predominant expression ofNMDA receptor-mediated EPSCs over
AMPAJKA receptor-mediated EPSCs during the first 3 postnatal weeks. The time frame
could represent a critical developmental period ofthe nAcb.
Key Words: Nucleus accumbens; development; excitatory postsynaptic currents;
NMDA receptor; AMPA/KA receptors; plasticity; schizophrenia.
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RÉSUMÉ
Nous avons enregistré les courants postsynaptiques excitateurs (CPSE5) évoqués
par une stimulation électrique locale dans 243 neurones du noyau accumbens (nAcb) in
vitro pendant le développement postnatal à compter du jour de la naissance (jour
postnatal 0; P0) jusqu’à P27 ainsi que chez de jeunes rats adultes (P59-P71). Un CP$E
sensible aux antagonistes glutamatergiques a été identifié dans tous les neurones. Dans la
majorité des neurones (189/243), le CPSE comprenaient deux composantes distinctes:
une précoce sensible au 6-cyano- 7-n itroquinoxaline-2, 3-dione (CNQX) et une tardive
sensible à la d-2-amino-5-phosphonovaleric acid (APV) démontrant qu’ils étaient
respectivement médiés par des récepteurs de type AMPA/KA et NMDA. Pendant les
premiers jours après la naissance, l’amplitude des deux composantes des CPSEs étaient
relativement petite et ont ensuite augmenté jusqu’à la fin de la deuxième semaine
postnatale. Alors que les caractéristiques de la composante précoce se sont stabilisées à
partir de cet âge, l’amplitude et la durée de la composante tardive ont commencé à
diminuer et elle est devenue difficile à évoquer dans des préparations d’animaux âgés de
plus de 3 semaines. En outre, le rapport entre l’amplitude de la composant tardive et de la
composante précoce du CPSE a suivi un modèle développemental semblable à celui de la
composante tardive montrant une augmentation pendant les deux premières semaines
postnatales suivie d’une diminution. Ensemble, ces résultats montrent la présence d’une
expression prédominante des CPSE médiés par des récepteurs NMDA pendant les 3
premières semaines postnatales. Cette période pourrait représenter une période critique
dans le développement postnatal du nAcb.
Mots-Clés : Noyau accumbens; développement; courants postsynaptiques excitateurs;
récepteur NMDA; récepteurs AMPAJKA; plasticité; schizophrénie.
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INTRODUCTION
Developmental plasticity in the central nervous system bas been well documented
in the visual and somatosensory systems where there is a critical period during which
typical development depends upon normal sensory input from the environment (Wiesel
and Hubel, 1963; Rhoades et al., 1990). The absence of appropriate peripheral input
during that period leads to irreversible alteration of perception. Presumably, sirnilar
processes operate throughout the neuraxis during postnatal development but they bave
been seldom documented outside sensory systems. Just as the lack of normal inputs in
sensory systems during the critical period leads to altered perception, the lack of normal
inputs in limbic structures could lead to mental disorders and constitute the organic basis
of some psychiatric ilinesses that may involve neurodevelopmental processes (Raedler et
al., 199$).
The nucleus accumbens (nAcb) is a part of the limbic system believed to be a
center for tbe integration of limbic and motor systems. It is a major target of the
subiculum and the prefrontal cortex, as well as other limbic structures including the
entorbinal cortex, the amygdala and midline thalamic nuclei (Kelley et aI., 1982;
Groenewegen et al., 1987; Phillipson and Griffiths, 1985; Groenewegen et al., 1982;
Krayniak et al., 1981; Groenewegen et al., 1980; Newman and Winans, 1980; Kelley and
Domesick, 1982; Jayaraman, 1985). These afferents are thought to be primarily
glutamatergic and some of them including those from prefrontal cortex, hippocampal
formation and amygdala converge on single nAcb projection neurons, the medium spiny
(MS) neurons (O’Donnell and Grace, 1995). Interactions between these different inputs,
combined with the intrinsic properties of MS neurons (Wickens and Wilson, 199$;
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Wilson and Kawaguchi, 1996) result in the expression of two stable membrane potential
states in these fleurons: a hyperpolarized state during which MS neurons are suent, and a
depolarized state during which they are active (O’Donnell and Grace, 1995). To achieve
this higb degree of functional integration, the glutamatergic innervation of the nAcb bas
to be finely tuned during development. Presumably, a transitory deprivation of some of
nAcb afferents during the critical period of synapses formation and consolidation will
produce a long lasting imbalance between different inputs and lead to pathological states.
In the present study, we have exarnined the excitatory postsynaptic currents (EPSCs)
during early postnatal development and found that the NMDA receptor-mediated EPSCs
are expressed transiently in nAcb neurons, reaching their maximum toward the end of the
second postnatal week to become virtually absent by the end of the third postnatal week.
We suggest that the time during which NMDA receptor-mediated EPSCs are present
constitute a critical period during which the disturbance of nAcb inputs could lead to
permanent loss of function. Parts of the present study have been published in abstract
form (Zhang et al., 1998; Zhang and Warren, 1999).
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METHODS
Suce preparation. Detailed procedures appear elsewhere (Belleau and Warren, 2000).
Briefly, 400itm parasagittal suces containing the nAcb were obtained from the day of
birth (P0) up to P71 rats. Suces were incubated for at least one hour before recording
was started in a submerged type chamber superfused with room temperature artificial
cerebrospinal fluid (ACSf) containing (in mM) 126 NaCÏ, 26 NaHCO3, 10 dextrose, 3
KC1, 1.3 MgSO4. 2.5 CaCI2, 1.25 NaH2PO4 with a pH of 7.4 when bubbled with a gas
mixture of 95% 02 and 5% C02. The nAcb was visualized with a stereo microscope
using the anterior commissure, the neostriatum, the septum and the ventricles as
landmarks based on Paxinos and Watson (1986).
Recording aitd etectrical stimulation. Whole-cell recording was achieved using the
blind patch-clamp technique (Blanton et al., 1989) with an Axoclamp-2B amplifier
(Axon Instruments) in single electrode voltage clamp mode. Recording pipettes had a
resistance between 3 and 6 MQ when fihled with a solution containing (in mM) 135 CsF1,
2 MgC12, 1 CaC12, 11 EGTA, 10 HEPES and 2 K2-ATP with a pH of 7.3 ±0.05. QX314
(5 mM; Alomone Laboratories) and 0.3% neurobiotin were routinely added to the
recording solution to block voltage-dependent Na channels and to label recorded
fleurons. The potential reference on the Axoclamp-2B was adjusted to zero prior to
achieving whole-cell configuration. Data acquisition was realized using pClamp 6.0
software (Axon Instruments). Local electrical stimulation was accomplished by using a
monopolar tungsten microelectrode placed at least 2mm away from the recording
eÏectrode either within nAcb or just outside its border. In order to adjust the stimulus
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strength, the voltage was gradually increased until the postsynaptic response at a holding
membrane potential of -70mV reached its maximum. The stimulus was then decreased to
get a stable response that was around 90% of the maximum. With the membrane
potential holding at -7OmV, the synaptic response was recorded at membrane potentials
between -100 to +4OrnV in 2OmV increments using 350ms voltage steps that were
administered every 8-20s depending on the age of the preparation. A single anodal
electrical stimulus (0.lms, 3-7V) was superimposed at l5Oms into the voltage step. Four
to eight traces were recorded at each membrane potential (Vm) and averaged offline.
Pharmacological agents used to isolate EPSCs including bicuculline methiodine (BMI),
d-2-arnino-5 -phosphonovaleric acid (APV) and 6-cyano-7- nitroquinoxaline-2,3 -dione
(CNQX) (all obtained from Tocris) were added to the superfusing medium to final
concentrations of 10, 50 and 2OiiM, respectively.
Analysis. Data analysis was done utilizing Cambridge Electronic Design software. The
amplitude of the evoked synaptic current (IR) was pÏotted as a function of Vm at two
different time points: one at an early point corresponding to the peak of the inward
current recorded at -1 OOmV, and a later one at a point when the fast inward current
recorded at -lOOmV had decayed into a slow depolarizing plateau almost parallel to the
baseline (e.g. Fig. 1). At the time the later component of the response was measured, the
early component had decayed by an average of 89%. The offset potential, measured
upon electrode withdrawal from the cell, was accounted for by assuming that it drifted in
a linear fashion with time from the start of the recording session. Ah membrane potential
values have been corrected for hiquid junction potentials of -1 4mV (Barry, 1994).
Throughout the text, membrane potentials are reported to the closest 1 OmV whereas exact
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membrane potentials have been used for calculations. Statistical analysis was performed
using SigmaStat (SPSS Inc.) and, when necessary, raw data were logarithmically
transformed to fulfihi the requirements of parametric statistical tests. Non-parametric
statistical tests were used only if this procedure failed (Sokal and Rohif, 1995). Results
are presented as mean ± standard error.
liorpltotogy. Following electrophysiological experiments, suces were placed in a
fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 24 hours.
Some suces were cryoprotected in a 30% glucose solution and re-sectioned 60tm thick
on a freezing microtome whereas most slices were whole processed for neurobiotin using
standard procedures. Sections and suces containing labeled celis were imaged using a
CCD camera (Dage model DC330) mounted on a microscope (Nikon model Optiphot 2)
using 4x, 1 Ox and 40x objectives and the images were stored on a computer using Image
Pro Express software (Media Cybemetics). Cell body measurements were made using
Image Pro Express software. Final images montages were assembled using Corel Photo
Paint software using images taken with a lOx objective and printed using a dye
sublimation printer (Sony model UP-5600MD). Neurons filled during other series of
experiments on the development of the nAcb (Zhang and Warren, 1999, 2002) have been
included in the present analysis.
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RESULTS
Postsynaptic currents evoked by local electrical stimuli of nAcb were recorded in
over 243 nAcb fleurons in suces from animais between P0 and P71. In a subset of 41
neurons recorded in preparations from comparable ages (between Pi and P71) in normal
ACSf, the addition of BMI (lOj.tM) produced a 46 + 3mV positive shifi in the reversai
potential of evoked postsynaptic currents from -38 ± 4mV to 8.4 ±3.7mV, suggesting that
a significant GABAA-mediated component was present eariy afier birth and throughout
the postnatal period examined. With BMI present in the bathing solution, postsynaptic
currents were completely abolished when the glutamatergic receptor antagonists CNQX
(20tM) and APV (50iM) were added to the superfusing medium (e.g. Fig.1B)
suggesting that under these conditions postsynaptic currents consisted of isolated
ionotropic glutamatergic EPSCs. Following these initial experiments, BMI (10j.iM) was
routinely added to the ACSf in order to isolate and record glutamatergic excitatory
postsynaptic currents (EPSCs). IRVm relationships of EP$Cs were obtained from
recording 243 nAcb neurons in 84 experiments using nAcb suces obtained from P0-P27
(231 cells) and P59-P71 (12 celis) animais.
(‘haracteristics and nature oftlte EPSCs
EPSCs could be readily evoked in preparations ofthe nAcb from P0 animals and
they were found in ail recorded neurons, aithough their characteristics changed
substantially during the postnatal period. The most commonly encountered type of
response consisted of an early, fast, inward current having a linear relationship with the
membrane potential, foiiowed by a late and extended inward current having a non-linear
relationship with membrane potentiai. An example of postsynaptic cunents recorded
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between holding membrane potentials of -100 and +4OmV with corresponding IRVm
curves from a representative neuron is shown in figure lA, lefi and right panels
respectively. In this case, an inward current with a peak occurs 13 ms afier the stimulus
rapidly developed at membrane potentials -4OmV and below (fig. lA, Early labeled
vertical dotted line). This early, inward current decayed with a similar time course at
membrane potentials between -100 and -6OmV (3 lower traces) whereas at -4OmV the
decay of the response was altered by a second inward current having a much siower time
course (f ig. lA, Late labeled dotted une). The IRVm curves (fig. lA, lower panel)
showed that the early current had a close to linear relationship with the membrane
potential (r = 0.986 in this case), whereas the late current was virtually absent at negative
membrane potentials and became apparent only at membrane potentials -4OmV and
above. The early postsynaptic current had a constant peak latency and appeared to decay
at the same rate at membrane potentials below -4OmV, suggesting that late inward current
contamination was minimal at these membrane potentials (e.g. fig. 1).
Figure 1.
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figure 1. A. Postsynaptic currents recorded in a nAcb neuron from a P15 suce preparation
(left) and corresponding IRVm curves measured l3ms (early) and lO6ms (late) after the stimulus
(right). The early inward current at -1 OOmV peaked 1 3ms after the stimulation, whereas the late
response was measured 93ms later, when the early inward current had almost completely
decayed. The IRVm relationship of the early inward current was linear (r = 0.986, a= 11.429, b =
30.56), whereas the late component was voltage-dependent with a peak around -4OmV in the
negative membrane potential range. B. Effects of ionotropic glutamatergic antagonists on the
EPSCs recorded in a neuron from a Pli preparation. The upper row shows the response traces
recorded between -1 2OmV and +2OmV in incremental steps of 2OmV before (Control), during
the bath application of CNQX (20p.M; CNQX) and CNQX and APV (50tM; CNQX + APV).
The lower row shows the IRVm relationships measured at the time point labeled Early (8ms after
stimulus onset) and Late (4Oms after stimulus onset) in the first panel of the upper row before
and during the application ofglutamatergic antagonists.
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The characteristics of the early component of the EPSCs were measured at the
membrane potential of -1 OOmV in order to minimize possible contamination by the late
component as the latter appeared virtually absent at this membrane potential. At —100
mV, the early postsynaptic current peaked 4-2lms (9.5 ± 0.2ms, n243) afier electrical
stimulus onset and decayed to a small steady state plateau in 13-126ms (40 ±lms,
n=243). The late component of the response was measured after the early component of
the EPSCs had decayed, 20-13$ms (49 ±lms, n=243) afier stimulus onset in order to
reduce contamination by the early component of the EPSC as rnuch as possible. Under
these conditions, a late EPSC with a non-linear V-shaped current-voltage relationship,
typical of currents mediated by NMDA receptors, was found in 189 neurons. In the
remaining 54 cells, no non-linear current-voltage relationship could be found at these or
longer latencies. No statistically significant difference was found between neurons
displaying a late EPSC and neurons lacking one for the peak latency ofthe early response
(9.3 ± 0.2ms vs 10.2 + 0.4ms respectively; T = 7280.5, p = 0.129), its decay time (39 ±
ims vs 41 ±3ms respectively; t 0.0697, df= 241, p 0.944) and its amplitude (269 ±
l4pA vs 221 ± l8pA respectively; t = 2.013, df= 241, p 0.052), suggesting that the
early response was similar in neurons with and without a late response.
The peak amplitude of the early component of the EPSC was measured at a
membrane potential of -1 OOmV and that of the late current at the membrane potential at
which it appeared to be in the negative range of membrane potentials (usually —4OmV or
-2OmV, e.g. f ig. lA) and afier the early response had decayed. With these measuring
parameters, the early component of the response was on average larger than the late
component, being -265 ±l4pA (n= 243) vs -125 ±$pA (n1$9) respectively (t 12.077,
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df= 430, p <0.00 1).
Overail, the characteristics of the EPSCs strongly suggested that early and late
components of the EPSC represented glutamatergic AMPA/KA and NMDA receptors
mediated responses respectively. These assumptions were tested by adding the specific
glutamatergic antagonists CNQX and APV to the superfusing medium. A representative
example recorded in a neuron from a Pli preparation substantiating this hypothesis is
shown in figure 1. During the control period preceding the administration of an
antagonist (f ig. 1 B, Coittro! labeled panel), the EPSC characteristically comprised an
early and a late component. The addition of the AMPA!KA receptor antagonist CNQX
to the superfusing medium completely abolished the early component of the response at
ail membrane potentials, while producing only marginal effects on the late component
(Fig. lB, CNQX labeled panel). further addition of APV, abolished the late response
leaving no detectable postsynaptic current (Fig. 13, CNQX + APV labeled panel). The
IR-V11 relationships of the early and laie component before and during antagonists
superfusion are shown in the bottom lefi and right panels of Figure 1 B respectively.
CNQX was tested in 33 neurons and produced a decrease of the early component
of the response averaging 91 ± 2% (ranging from 46 to 100%) whereas APV produced an
average decrease of the late component of $5 ± 5% (ranging from 44 to 100%) when
tested in 14 neurons displaying a late component. From these results we concluded that
the early EPSC was mainly mediated through activation of AMPA/KA receptors,
whereas the late component was mediated by the activation ofNMDA receptors.
Aithough the largest effects of CNQX and APV were on the early and late
components of response respectively, there were some significant exceptions to the
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pattern described above, especially in preparations from very young animais. In some
celis, CNQX and APV non-selectively antagonized both the early and late components of
the response. figure 2A illustrates such a case in which APV reversibly decreased both
the late and early components of the EP$C in a neuron recorded from a P2 animal
preparation. During the control period (fig. 2A, Control labeled panel) both an early and
late component of the EPSC was apparent in the current traces, as well as in the
corresponding ‘R Vm curves. When APV was added to the superfusing medium, both
the early and late components of the EPSC were completely abolished (fig. 2A, APV
labeied panel) and these effects were reversible (fig. 2A, Wash labeled panel). APV
produced similar effects, within the range of those produced by CNQX on the early
component of the EPSC (74 ± 7%; ranging from 45 to 98%) in 9 of 21 neurons with an
early component that were tested; 7 of these neurons were recorded in preparations from
animais less than a week old. These results suggest that in some neurons, the EPSC was
mediated only by NMDA receptors.
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In some neurons, CNQX appeared to abolish both the early and late components
of the EPSCs. It produced a significant reduction (69 ± 7%; ranging from 54 to 97%) of
the late response in 5 of 17 neurons tested. An example is shown in figure 2B. During
the control period, the EPSC comprised an early and a late component, which were both
abolished when CNQX was added to the superfusing medium. Following wash out of
CNQX, the addition of APV antagonized only the late component whereas the early
component appeared unaffected. These resuits show that in some cases CNQX could
reduce significantly the late NMDA receptor-mediated component ofthe EPSCs.
Deve!opmeuta! characteristics ofpostsynaptic ctcrrents
In neurons in which the EPSC consisted of both early and late components, the
ratio between the two components appear to vary significantly and this was related to the
age of the preparation. To illustrate that point, we have characterized the EPSCs
according to the relative apparent magnitude ofthe late component ofthe response.
Type I response
In a subset of 25 neurons (10% of the sample), the peak inward current was flot
observed when the membrane potential was held at -1 OOmV but was seen at a more
depoÏarized membrane potential of -60 or -4OmV. Concurrently with the increase in peak
cunent, the response became broader, and the latency to peak often increased by several
milliseconds between - I OOmV and more depolarized membrane potentials. This kind of
response was named Type I.
f igure 3A shows a representative Type I response recorded from a P3 neuron. In
the current traces of the response (fig. 3A upper panel), only an early fast inward current
was evoked by local electrical stimulation at a holding membrane potential of -1 OOmV.
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At -6OmV, this response reached its maximum, increasing by more than 40% as
compared to the response obtained at -lO0mV. There was no change in peak latency of
the early response between -100 and -6OmV although the response appeared broader
because of a siower decay rate. In contrast, at -4OmV, the peak of the response was
delayed by several milliseconds as compared to more negative membrane potentials
because of a much siower rise time. The decay rate of the response was also much
siower at -4OmV and overali. The response was much broader due to the full
developrnent of the late component. The lower panel of Figure 3A shows a plot of the ‘R
Vm relationship of the responses shown in the upper panel. It is apparent that there was a
marginal late component in the response below -4OmV, whereas between -40 and +4OmV
the IRVm of the late response was linear and reversed around OmV. The early response
IVm curve was linear and parallel to that of the late one between -60 and +4OmV where
it appeared to saturate and reach a plateau at more hyperpolarized potentials. $imilar
observations were made in 25 neurons and the increase in the peak EPSC between -
lOOmV and more depolarized membrane potentials ranged from 9 to 322pA with an
average of $2 + l6pA (n = 24). In addition, as the membrane was depolarized, the
response peak was delayed in 23 neurons by an average of 19 + 6ms.
In terms of amplitude and time course, Type I responses had on average the
smallest early component with the longest time to peak and decay time of ail 4 types of
responses (Table I). In contrast, they displayed the largest late component amplitude and
this even if it was measured l0-lSms later than in Type II and III responses on average
(see below). Consequently, the ratio between late and early components was the highest
at 0.85 in Type I responses.
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from a deveiopmentai point of view, Type I responses were under represented
until P3 and were most ofien encountered between P3 and P13. They were rarely
encountered in preparations from more than 2- week-oid animais (fig. 4A).
Figure 4.
Ij
I
I
4
2
o
—I
2
o
-2
-4
A-Typel
Postnatal age (days)
I
I
Cl)
I
6
4
2
o
-2
-4
9
6
3
0
-3
B- Type2
Postnatal age (days)
Postnatal age (days)
Figure 4. Distribution of Type I (A), Type 11(B), Type III (C) and no late response (D)
neurons as a function of postnatal age. Each graph represents the difference between the
number of neurons of each type sampled on a given postnatal day and the number of
neurons expected if it was identical to the daily distribution of the whole sampÏe.
Upward and downward bins indicate that respectively more and less neurons ofthis type
were sampled than expected on this specific postnatal day. The curves are polynomial
regressions to underscore trends in the data. The last two bins of each graph (marked by
an asterisk) represent fleurons sampled on P21-27 and P59-71 respectively. Note that no
neurons were sampled on P18. Number ofneurons were 25, 7$, $6 and 54 for A, B, C
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and D, respectively.
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Type II response
In a second group of neurons (n = 78; 32% of sample), the largest inward current
was recorded at the most hyperpolarized membrane potential. However, as the
membrane was depolarized, the rise time of the EP$C noticeably increased, delaying the
peak of the response by several milliseconds when the late component of the response
reached its maximum around -4OmV (fig. 35, upper panel). The average shift in peak
response between holding membrane potentials of -100 and -4OmV was 20 ± ims (n =
7$) and appeared to be independent of the age of the animal used for suce preparation.
The IRVm relationships of Type II responses resembled that of Type I responses. As
with Type I responses, the IR-V1 curve of the early component apparently saturated at
hyperpolarized membrane potentials, whereas at depolarized membrane potentials, it was
parallel to the non-voltage dependent portion ofthe late component IRVm curve (Fig. 3B,
lower panel).
Type II responses were characterized by an early component 37% larger on
average than Type I responses, whereas the late component of the EP$Cs was not
significantly smaller than that of Type I resulting in an average late to early ratio of 0.53
(Table I). In terms of postnatal ages, Type II responses appeared to be under represented
between P0 and P6 but were the most cornmonly found in preparations from animals
between P7 and P14 (Fig. 4B).
Type III response
In 86 neurons (35% ofthe sample), the late response was relatively small and was
apparent only as a continuation of the early response at membrane potentials above -
6OmV (Fig. 3C, upper panel). In contrast with Type I and II responses, the rise time of
71
the early peak response was constant at ail membrane potentials. Consequentiy, no delay
in the peak response was observed between hyperpolarized and depolarized membrane
potentials. Despite the small size of the late response, its IRVm curve was ciearly V
shaped with a peak usually around -4OmV (fig. 3C, Iower panel). The early component
IRVm curve was close to a single straight une passing through the origin.
The amplitude of the late component of Type III responses was about haif that of
Type I and II responses, while the amplitude of the early component was comparable to
that of Type II neurons (Table I), resuiting in a comparatively small late to early
component ratio of 0.3 2. This response type was also characterized by the shortest early
response tirne to peak and decay time.
Type III responses were most ofien recorded during the first and third postnatal
week, whereas they were comparatively less common during the second postnatal week.
As with all neurons with a late EPSC, they were rarely recorded in preparations from
animals older than 3 weeks (Fig. 4C).
No tate response
In 54 neurons (22% of the sample) no late EPSC could be positively identified
(not shown). In these neurons, no apparent late response was present, and the IRVm
curve measured after the decay of the response at -1 OOmV was close to parallel to the
abscissa. The AMPA/KA receptor antagonist CNQX was tested in 11 neurons of this
type (P1-P71) and produced a large reduction of the EPSC at all membrane potentials
with an average of 95 ±1% ($5 to 100%), suggesting that in these neurons, the EPSCs
were exclusively mediated by non-NMDA type ofreceptors.
The amplitude of the responses lacking a late component was smaller than the
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early component of Types II and III responses but slightly larger than that of Type I
(Table I). The range of response amplitudes of neurons lacking a late component largely
overlapped with that of the early response of neurons expressing a late response. This
indicates that the absence of a late response was flot likely the resuit of deficient afferent
fibers activation.
Neurons lacking a late response were most commonly encountered before P5
(16/45; 36%) or afler P16 (24/33; 73%), whereas they were only seldom encountered
between P5 and P15 (14/165; 8%; Fig. 4D). After P 20, the EPSC comprised only an
early component in 17 out of 19 responses recorded, showing that under the present
conditions, very few neurons expressed NMDA receptor-mediated EPSC afier the third
postnatal week.
When the ratio between the late and early components ofthe EPSC was plotted as
a function of postnatal age a clear developmental pattem emerged: the late to early
response ratio increased up to around P12 and decreased afterwards to become virtually
equal to zero during the 4th postnatal week and adulthood (Fig. 5). These results indicate
that the ratio between NMDA and AMPA/KA receptor-mediated current was largest
during the second postnatal week whereas AMPA/KA receptor-mediated currents largely
dominated the responses later during development and adulthood.
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Figure 5. Ratio between the late and early components of the EPSCs as a
function of postnatal age. A statistically significant 2’ degree polynomial
correlation was found between response amplitude and postnatal age (r2 =
0.784, F = 32.660, p<O.00I).
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In addition to the ratio between the late and early components of the EP$C, other
characteristics of EPSCs changed significantly over the first three to four postnatal
weeks. The latency to peak of the early component of the EPSC substantially increased
during the first four postnatal weeks and was even longer in aduits (Fig. 6A). It averaged
8.8 + 0.2ms (n = 105) during the flrst postnatal week and reached 13.8 ± 0.$ms (n12) in
aduits, the increase being statistically significant (T = 1239, p<O.00l). These data have
to be carefully interpreted for two reasons: the regression coefficient between postnatal
age and response delay was small even though it was significant (F ig. 4A legend), and
developmental factors explain only 4.6% of the variation in the delay. The increase in
the decay tirne of the early response was slightly more robust, the regression explaining
about 10% ofthe variation (Fig. 6B). This measure averaged 33 ± lms during the first
postnatal week and increased steadily to reach 55 ± 6ms in the aduit, a 22ms increase that
was statistically significant (t = 4.578, df= 115, p<O.001). In addition, the decay time of
the early response was positively correlated with the amplitude of the response recorded
at -lOOmV (r = 0.21$, F = 11.442, p < 0.00 1), suggesting that part of the increase in
duration of the response was due to an increase in its amplitude (see below), i.e., larger
responses tended to have longer decay tirne. As a consequence of the increase in both
early response peak latency and early response decay, the latency at which the late
component of the EPSC was measured was significantly delayed with age (Fig. 6C) but
yet sufficient enough to have a substantial incidence on the measurements of the late
component because of its comparatively slow decay.
Figure 6.
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Figure 6. Characteristics of the
early and late responses as a
function of postnatal age. A.
lime to peak of the early
response from the electrical
stimulus onset. A statistically
significant linear correlation was
found between time to peak and
postnatal age (r = 0.20$, F =
10.315, p0.OOl5). B. Decay
time from peak to a steady state
plateau of the early response at
an online membrane potential of
-lOOmV. A statistically
significant linear correlation was
found between decay time and
postnatal age (r 0.308, F =
23.962, p<O.001). C. Delay
between electrical stimulus
onset and the steady state of the
early response at which time the
late response was measured. A
statistically significant 2’
degree polynomial correlation
was found between time delay
and postnatal age (r = 0.24, F =
13.99$, p<O.001). Each filled
circle and bar represents the
average ± SEM for neurons
recorded on the corresponding
postnatal day on the abscissa.
Number of cells per postnatal
day ranged from 2 to 26 with an
average of 11.0 ± 1.5. No
sampled on P18
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In most celis, we could not detect the presence of a NMDA receptor-mediated
component in the compound EPSCs in preparation from animais more than three weeks
old. This is in contrast to several studies (e.g. Martin et al., 1999; Martin et al., 1997b;
Martin et al., 1997a; Pennartz et al., 1991a) that reported the presence of NMDA
receptor-mediated EPSCs in mature nAcb. To verify for the presence of NMDA
receptor-mediated EPSCs in older animai, we have recorded EPSCs in preparations from
animais during their fourth postnatal week with CNQX in the bathing medium. In ail
neurons tested using adequate stimulus pararneter, we coutd record NMDA receptor
mediated EPSCs of amplitude comparable with those recorded in younger (Fig. 7A).
Whereas EPSCs were comparable in amplitude, those recorded during the fourth
postnatal week were found to be much shorter than those recorded during the second
postnatal week (Fig. 7A right panel and 73). Despite the fact that a substantial NMDA
receptor-mediated EPSC could be evoked in the presence of CNQX, the presence of an
NMDA component could not be cieariy identified in the compound EPSC (fig. 7C).
Morphotogy
A total of 310 neurobiotin fi lied MS neurons were recovered from the present and
other series of similar experiments (Zhang and Warren, 1999, 2002). In neonatal rats,
MS neurons appeared quite different from those described in aduit animais. During the
first 10 postnatal days, the dendrites appeared reiatively thin, varicose ami aÏmost
completeiy aspiny (Figs. $A and 83). The slendemess ofthe dendrites was particularly
marked during the first few postnatal days during which the dendrites were so thin that
they could be barely detected between the small varicosities (fig. 8A). By the end of the
first postnatal week, dendrites stiii had a varicose appearance but both the varicosities and
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Figure 7. A. NMDA receptor-mediated EPSCs recorded at a holding membrane potential of
-2OmV in preparations from P12 (left panel) and P25 (middle panel) animais with CNQX (2OjiM)
and BMI (10tM) present in the bathing medium. The right panel shows the overlay of the
responses scaled on the amplitude of the P25 response. B. Average decay time constant of
isolated NMDA receptor-mediated EPSCs recorded during the second (n8) and fourth postnatal
week (n=9). The time constant was measured by fitting a single exponential on the decay phase of
the EPSCs. C. Compound response from the same P25 neuron shown in A at holding membrane
potentials of -100 and -2OmV in the absence of CNQX. Note the absence of an obvious NMDA
receptor-mediated component at -2OmV.
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dendritic shafis appeared larger (Fig. $B). During the second postnatal week, the
dendrites gradually lost their varicose appearance and by P14, the dendrites of the
rnajority of neurons unbroken continuous appearance (Fig. $C) and celi displaying an
immature appearance were rarely encountered during the third postnatal week and neyer
afterwards (Fig. $D). In addition, dendrites of more mature ceils (e.g. Fig. $C and 8D)
were more convoluted than at earÏier stages (e.g. Fig. 8A and $13) and the dendritic fleld
appeared to growth slightly during the first three postnatal weeks although we did not
measure it.
We did not observed dendritic spines on highly varicosed dendrites but they were
consistently present on dendrites from P12 and older neurons. Their density was very
low at the beginning but appeared to increase until the end of period studied (P31)
without apparently reaching a density comparable to the one found in adult MS neurons.
The axon was also labeled in several neurons and it could oflen be followed for several
hundreds iim (Fig. 8C and $D, arrows). In these cases, it aiways branched within the
nAcb before a single brandi was seen leaving the nucleus and this even at the younger
ages.
The cdl body ofMS neurons increased in size during the postnatal period covered
by the present study as shown by the positive correlation between ceil body perimeter and
area and postnatal age (Fig. 9A and 9B). The somatic area increased by 24% between the
first and third postnatal week from an average of 126 ± 5jim2 to 156 ± l3jim2 (t 2.656,
dfz= 174, p = 0.009). In contrast, there was no change in the number ofprimary dendrites
during the same period (Fig. 9C).
figure 8.
A-P2
B-P7
C- P14
4-
79
•44 —
s
Figure 8. Image montages of neurobiotin fihled neurons from P2 (A), P7 (B), P14 (C) and P22 (D)
preparations. Anows in panels C and D indicate the axons. The scale bar in panel A represents
5Otm and applies to ail panels.
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Figure 9. Graphs
showing the ceil body
perimeter (A) and area
(B) and the number of
primary dendrites (C)
of neurobiotin fihled
neurons as a function
of postnatal age. Each
dot represents one
fihled neuron and the
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regression. There was
a significant correlation
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DISCUSSION
We recorded electricaily evoked EPSCs in nAcb neurons using suce preparations
from rat pups (between P0 to P27) and young aduit animais (P59 to P7 1). An EPSC was
found in ail recorded neurons (n = 243) demonstrating that functionai excitatory synapses
are aiready present in the nAcb at the time of birth. At ail ages, the EPSCs were sensitive
to giutamatergic antagonists. confirming that they were mediated by excitatory amino
acids. Additionally, in a majority of neurons (189/243), the EPSC consisted of two
distinct components: an eariy one with a peak between 3.6 and 21 ms afier stimulus
onset, and a iate one that became apparent oniy at depolarized membrane potentiais. The
early and iate components of the EPSC had IRVm relationships characteristic of
AMPA/KÀ and NMDA receptor-mediated currents respectively, and were generally
sensitive to specific receptor antagonists. However, in some ceiis from young
preparations, both components could be abolished by oniy one type of antagonist.
During the first few days afier birth, the amplitude of both AMPA/KA and
NMDA receptor-mediated EPSCs was relativeiy smali and then started to increase until
the end of the second postnatal week. Whereas the amplitude of the AMPAJKA receptor
mediated response appeared to stabilize from that point on, the NMDA receptor-mediated
response decreased rapidiy during the foiiowing days and becarne virtualiy absent afler
the end of the third postnatal week. In addition, the ratio between the NMDA and
AMPA!KA receptor-mediated responses foliowed a deveiopmental pattem parailei to that
of the NMDA receptor-mediated response, showing an increase during the first two
postnatal weeks foÏÏowed by a decrease. This was also reflected in the distribution of
response types with age. Responses with comparativeiy large NMDA receptor-mediated
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components were found mainly in preparations from P7 to P14 animais, whereas those
showing small or no NMDA receptor-rnediated components were more commonly found
in preparations younger than P7 and older than P14. Together, these resuits show that
there is a preeminent expression of NMDA receptor-mediated EPSC during the second
postnatal week in the nAcb. NMDA receptor-mediated currents have been shown to play
an important rote during the activity-dependent developmental phase in severai regions of
the neuraxis (Murphy, 2003; Yoshimura et al., 2003; Savicc et al., 2003; $hibata et al.,
2003; Schramm et al., 2002; Stegenga and Kalb, 2001; Luthi et al., 2001). The relative
importance of NMDA receptor-mediated currents during the second postnatal week
suggests that it could play a similar role in the nAcb during that time. The end of the
second postnatal week corresponded aiso with the morphological maturation of MS
neurons and the appearance of spines on their dendrites suggestive of intense synapse
formation. This period also overlaps with the period of active maturation of membrane
and firing properties of nAcb projection MS neurons (Belleau and Warren, 2000)
implying a synchronization in the maturation of the inputloutput organization of the
nAcb.
Validiry of tite observations. Glutamatergic EPSCs could be evoked from the day of
birth, showing that functional glutamatergic innervation of the nAcb is already underway
before parturition. During the first two postnatal weeks, the amplitude of the EPSC
increased suggesting an active maturation of nAcb gtutamatergic innervation during that
period. The fact that NMDA receptor-mediated currents decreased afler the second
postnatal week to be rarely observed afier the third postnatal week, suggest that most of
postsynaptic ionotropic glutamatergic neurotransmission in mature nAcb is mediated by
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AMPA!KA type of receptors. The observation that the peak amplitude and duration of
AMPA!KA-mediated currents during the 3’ and 4th postnatal weeks did flot statistically
differ from that recorded in adults does flot necessarily imply that glutamatergic
innervation of the nAcb is mature at this time. Further maturation and consolidation of
the innervation may occur without significant changes in the amplitude of the response
by a process involving an equilibrium between synapse formation and pruning.
In some neurons, both the early and late components of the response were
abolished by APV, suggesting that the EPSC was mediated only by NMDA receptors. In
addition, these results suggest that part of the NMDA receptor-mediated response
recorded at hyperpolarized membrane potentials was less sensitive to Mg2 block. This is
in agreement with the finding that the subunit composition of NMDA receptors is
developmentally regulated and that NR2D subunits relatively resistant to Mg2 block are
predominantly expressed during early postnatal stages (Ben An et al., 198$; Dunah et al.,
1996; Kirson et al, 1999; Kleckner and Dingledine, 1991; Kuner and Shoepfer, 1996;
Laurie et al., 1997; Monyer et al., 1994; Morrisett et al., 1990; Pollard et al., 1993;
Wenzel et al., 1996). In some neurons, CNQX aboÏished both the early and late
component of the response. These effects may have been mediated by an action of
CNQX on the glycine binding site ofthe NMDA receptor (Lester et al., 1989; Pellegrini
Giampietro et al., 1989).
We did not pharmacologically isolate each ofthe two components ofthe EPSC in
ail neurons to measure isolated AMPA/KA and NMDA receptor-mediated currents. Our
resuits suggest that there was a significant contribution by NMDA receptor-mediated
currents to the early component ofthe response at depolarized membrane potentials. This
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problem was circumvented by measuring the AMPA/KA receptor-mediated current at a
hyperpolarized potential when the NMDA receptor-mediated current was minimal.
Sirnilarly, we measured the late component only afier the early response had decayed in
order that our data exclusively represented NMDA receptor-mediated responses, although
with this method it was flot possible to measure the peak of the NMDA receptor
mediated current. But the decay time of the late component of the response was very
long and the NMDA response was very close to its peak at the time measurements were
made (e.g. fig. 2). We can conclude that our measurements represent fair representation
of the amplitude of AMPAJKA and NMDA receptor-mediated postsynaptic currents in
the nAcb.
Glutamatergic neurotransmission in the nAcb originates exclusively from extemal
structures including the media! prefrontal cortex, the subiculum and the amygdala (Kelley
et al., 1982; Groenewegen et al., 1987; Phillipson and Griffiths, 1985; Groenewegen et
al., 1982; Krayniak et al., 1981; Groenewegen et al., 1980; Newman and Winans, 1980;
Kelley and Domesick, 1982; Jayaraman, 1985). We have used local electrical
stimulation to evoke glutamatergic EPSCs in the nAcb and presumabÏy, we have
indiscriminately activated afferents of various origins. Consequently, it is impossible to
know if the innervation from different sources follows different deveÏopmental pattems
and/or time courses. Alternatively, it is possible (although unlikely) that our results
represent the postnatal development of one specific group of afferents. Nevertheless, the
present resuits clearÏy show that at least one source of glutamatergic afferents involve
transient expression of NMDA receptor-mediated EPSCs in developing nAcb. future
experiments should examine the development of individual afferents.
$5
It is likely that the pattern of change in NMDA receptor-mediated currents that we
found reftect an actual weakening in NMDA receptor-mediated current occurring in
maturing nAcb. This is supported by the fact that while the NMDA receptor-mediated
component of the EPSC decreased, the AMPA!KA receptor-mediated response remained
constant, ruling out the possibility that the change was due to improper stimulation of
afferents or a decrease in the density of the innervation. In addition, the fact that there
was a strong correlation between the amplitude of the early and late components,
combined with the stabiiity of the early response, also suggest a weakening of the NMDA
receptor-mediated current with aging. This is in agreement with other studies reporting
that NMDA receptor-mediated responses were weak in preparations of the nAcb from
young aduits in vitro under normal conditions (Pennartz et al., 1991b; Martin et ai.,
1 997b; Martin et ai., 1 997a). Substantiai NMDA receptor-mediated responses could oniy
be recorded by using high stimulus intensity and paired-puise stimulation in conditions
where inhibition was reduced (Martin et al., 1997a; Rajadhyaksha et al., 199$) underlying
the weakness of NMDA receptor-mediated postsynaptic currents in aduit nAcb. The
difference between developing and mature animais suggest that NMDA receptors play
different roles in young and aduit animais, participating activeiy in fast glutamatergic
neurotransmission at early deveiopmental stages and being confined to a
neuromodulatory role at later stages. Furthermore, there is rnuch evidence that a
substantial proportion of NMDA receptors are located on giutamatergic terminais rather
than on nAcb postsynaptic neurons in mature nAcb (Grace, 1991).
The most striking change in M$ neurons morphology was observed in individuai
dendrites which were essentiaily aspiny and highly varicose during the first 10-12
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postnatal days. In addition, the soma of MS neurons slightly increased in size over the
period studied. These finding are in close agreement with those observed in the dorsal
striatum in the same specie (Tepper and Trent, 1993; Tepper et al., 199$). In the dorsal
striatum, the third postnatal week corresponds with the period during which there is the
greatest increase in axospinous asymmetric synapses (Hattori and McGeer, 1973; Tepper
et al., 1998), a period corresponding with the relative decline in NMDA receptor
mediated EPSC in the present study.
functionat sigiijjïcance
The gross development of the brain is genetically guided. In contrast, the fine
tuning of synaptic organization is ofien activity-dependent, allowing the individual to
adapt to the prevailing environment. It is now well accepted that some fine tuning of
neuronal connectivity also occurs in mature organisms but for the most part, it occurs
during postnatal developmental stages and ofien irreversible.
The glutamatergic innervation of the nAcb lias its origin in several preponderant
limbic structures although the exact timing of arrivai of the fibers from those locations is
not known. We can assume that there will be some competitionlcooperation among these
different inputs that will presumably follow Hebbian rules (Hebb, 1949). The
involvement of NMDA receptor-mediated currents in such mechanisms lias been
recognized for a number of years (Collingridge and Singer, 1990) and they could play a
similar role during nAcb development.
The different sources of glutamatergic innervation of the nAcb are known to each
have specific functions and to be active under specific behavioral circurnstances related
to environment. Presurnably, depending upon the environmental context during synapse
$7
formation, some of these inputs miglit be over active during a critical period and produce
an imbalance between the different inputs, eventually resulting in a pathological state at
later stages. Recent studies in which an imbalance between the different glutamatergic
inputs to the nAcb have been produced by lesioning specific pathways at P7 have resulted
in behavioral changes in the aduit that were accompanied by biochemical changes in the
nAcb during adulthood (Flores et al., 1996a; flores et al., 1996b; Lipska et al., 1993;
Weinberger and Lipska, 1995; Lipska et al., 199$). This suggests that such processes
might be involved in pathological states.
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RÉSUMÉ
Nous avons étudié les effets modulateurs des agonistes cholinergiques sur les courants
postsynaptiques excitateurs (CPSEs) dans des neurones du noyau accumbens (nAcb)
pendant le développement postnatal. Les enregistrements ont été obtenus dans des
tranches provenant des rats âgés de un jour (jour postnatal Î, Pi) à P27 en utilisant la
technique whole-celÏ patch-cÏamp. Les CPSEs ont été produits par une stimulation
électrique locale, et toutes les expériences ont été réalisées en présence du bicuculline
methchÏoride dans le milieu extracellulaire et avec du QX-3 14 dans la pipette
d’enregistrement. Dans ces conditions, les courants postsynaptiques étaient composés de
CPSEs glutarnatergiques comprenant deux composantes médiés par des récepteurs
AMPAIKA et de NMDA. L’addition d’acétylcholine (ACh) ou de carbachol (CCh)
produisait une diminution de 30-60% des deux composantes des CPSEs. Par contre,
l’ACh produisait une augmentation (35%) des CPSEs lorsqu’administrée en présence
d’atropine; un antagoniste des récepteurs muscariniques. Les effets excitateurs de l’ACh
en présence d’atropine ont pu être reproduits par un agoniste des récepteurs nicotiniques,
l’iodure 1,1 -diméthyl-4-phényÏ-piperazinium (DMPP), et pouvaient être bloqués par la
mécamylamine, un antagoniste des récepteurs nicotiniques. Les effets antagonistes de
l’atropine pouvaient être reproduits par le pirenzepine, suggérant que la dépression
muscarinique des CPSEs implique des récepteurs muscariniques de type Ml/M4. En
outre, les effets inhibiteurs de I’ACh sur les CPSEs médiés par le récepteur NMDA ont
augmenté significativement pendant les deux premières semaines postnatales alors que
les effets sur les CP$Es AMPA!KA sont demeurés stables. Nous avons constaté que,
dans les présentes conditions expérimentales, les agonistes cholinergiques ne produisaient
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aucun changement dans la conductance membranaire, la constante de temps des CPSEs
AMPA!KA ni sur les réponses évoquées par application de glutamate exogène en
présence de tétrodotoxine. Par contre ils ont produit des changements sur le rapport des
réponses à des stimuli pairés, suggérant que leur action était médiée principalement par
des mécanismes présynaptiques. Lorsque le QX-3 14 a été omis de la solution interne de
l’électrode d’enregistrement, le CCh a produit des changements dans le potentiel de repos
des neurones et à augmenté le nombre de potentiels d’action produit par une injection
intracellulaire de courant, suggérant que le QX-3 14 bloquait les effets cholinergiques
postsynaptiques. Ensemble, ces résultats suggèrent que l’ACh peut diminuer ou
augmenter la neurotransmission glutamatergique dans le nAcb en agissant respectivement
sur les récepteurs muscariniques et nicotiniques situés sur les terminaisons
glutamatergiques. La modulation cholinergique de la neurotransmission médiée par les
récepteurs AMPA!KA et NMDA dans le nAcb pendant le développement postnatal
pourrait jouer un rôle important dans les processus développementaux dépendant de
l’activité.
Mots-Clés : Acétylcholine; récepteur muscarinique, récepteur nicotinique, courant
excitateur postsynaptique, mécanisme présynaptique
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Zhang, Liming, and Richard A. Warren. Muscarinic and nicotinic
presynaptic modulation of EPSCs in the nucleus accumbens during
postnatal development. J Neurophysiol 88: 3315—3330, 2002;
10.1152/jn.01025.2001. We have studied the modulatory effects of
cholinergic agonists on excitatory postsynaptic currents (EPSCs) in
nucleus accumbens (nAcb) fleurons during postnatal development.
Recordings were obtained in suces from postnatal day 1 (P1) to P27
rats using the whole celi patch-clamp technique. EPSCs were evoked
by local electrical stimulation, and alt experiments were conducted in
the presence of bicuculline methchloride in the bathing medium and
with QX-314 in the recording pipette. Under these conditions,
postsynaptic currents consisted of glutamatergic EPSCs typically con
sisting of two components mediated by AMPAlkainate (KA) and
N-methyl-D-aspartate (NMDA) receptors. The addition of acetylcho
line (ACh) or carbachol (CCh) to the superfusing medium resulted in
a decrease of 30—60% of both AMPAIKA- and NMDA-mediated
EPSCs. In contrast, ACh produced an increase (35%) in both
AMPAJKA and NMDA receptor-mediated EPSCs when administered
in the presence of the muscarinic antagonist atropine. These excitatory
effects were mimicked by the nicotinic receptor agonist 1,1 -dimethyl
4-phenyl-piperazinium iodide (DMPP) and blocked by the nicotinic
receptor antagonist mecamylamine, showing the presence of a cho
linergic modulation mediated by nicotinic receptors in the nAcb. The
antagonistic effects of atropine were mimicked by pirenzepine, sug
gesting that the muscarinic depression of the EPSCs was mediated by
M11M4 receptors. In addition, the inhibitory effects of ACh on NMDA
but flot on AMPAIKA receptor-mediated EPSC significantly in
creased during the first two postnatal weeks. We found that, under our
experimental conditions, cholinergic agonists produced no changes on
membrane holding currents, on the decay time of the AMPAIKA
EPSC, or on responses evoked by exogenous application of glutamate
in the presence of tetrodotoxin, but they produced significant changes
in paired pulse ratio, suggesting that their action was mediated by
presynaptic mechanisms. In contrast, CCh produced consistent
changes in the membrane and firing properties of medium spiny (MS)
neurons when QX-3 14 was omitted from the recording pipette solution,
suggesting that this substance actually blocked postsynaptic cholinergic
modulation. Together, these results suggest that ACh can decrease or
increase glutamatergic neurotransmission in the nAcb by, respectively,
acting on muscarinic and nicotinic receptors located on excitatoiy termi
nals. The cholinergic modulation of AIVPAJKA and NMDA receptor
mediated neurotransmission in the nAcb during postnatal development
could play an important role in activity-dependent developmental pro-
cesses in refining the excitatoly drive on MS neurons by gating specific
inputs.
INTRODUCTION
The nucleus accumbens (nAcb) constitutes the major portion
of the ventral striatum and is an important point of convergence
of information originating in several limbic structures, includ
ing the prefrontal cortex (PfC), the amygdala, the hippocam
pus, and the midiine thalamic nuclei (Groenewegen et al. 1980,
1982, 1987; Jayaraman 1985; Kelley and Domesick 1982;
Kelley and Stinus 1984; Kelley et al. 1982; Krayniak et al.
1981; Newman and Winans 1980; Phullipson and Griffiths
1985). These projections, believed to be mainly glutamatergic,
are tbought to mediate their excitatory drive by acting on
N-methyl-D-aspartate (NMDA) and AMPAlkainate (KA) glu
tamatergic receptors (DeFrance et al. 1985; finch 1996;
Kombian and Malenka 1994; Nicola et al. 1996; ;Yim and
Mogenson 1982 Zhang and Warren 1999). The primary output
of the nAcb is to the ventral pallidum (Hakan et al. 1992; Yang
and Mogenson 1985), which is involved in the activation of
voluntary movements (Heimer et al. 1994; Swerdlow and
Koob 1987). This inputloutput organization suggests that the
nAcb is an important interface between motivational and motor
systems driven by the ventral pallidum (Beninger et al. 1983;
Lopes da Silva et al. 1984; Mogenson et al. 1980). The nAcb
is known to be involved in reinforcement aspects of behavior
(Cador et al. 1991; Joseph and Hodges 1990; Wise and Bozarth
1987) and could be implicated in a number of psychiatric
diseases, such as schizophrenia (Csernansky et al. 1991; Grace
1992; Matthysse 1983; Snyder 1973) and Tourette’s syndrome
(Braun et al. 1993; Comings 1987).
The only class of neurons that project outside the nAcb are
the medium spiny (MS) fleurons, which are GABAergic and
account for about 95% of the neuronal population. In addition,
the nAcb contains small populations of interneurons including
the large aspiny (LA) neuron, which is the only known source
ofacetylcholine (ACh) in the nAcb (Meredith and Chang 1994;
Meredith and Wouterlood 1990; Meredith et al. 1989; Phelps et
al. 1985). Cholinergic systems have been implicated in funda
mental aspects of human behavior including memory, motiva
tion, and motor behavior (File et al. 1998; Gotti et al. 1997).
Interest in understanding cholinergic mechanisms involved in
the control and regulation of motor and higher brain functions
bas been growing ever since the neostriatal cholinergic system
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was postulated to play a role in the pathophysiology of several
diseases. Alterations in the leveis of ACh and cholinergic
receptors have been linked to neumiogical and neuropsycho
logical diseases including schizophrenia and Parkinson’s dis
ease (Gotti et aI. 1997; Lena and Changeux 1997; MacDermott
et al. 1999). Selective loss of cholinergic neurons in the nAcb
in schizophrenia and Alzheimer’s disease has also been dem
onstrated (Hok et al. 1999; Lehéricy et al. 1989).
In the nAcb, LA neurons establish synaptic contacts with
MS neurons (Contant et al. 1996) as well as with glutamatergic
terminais (Meredith and Wouterlood 1990). The action ofACli
is mediated by nicotinic and muscarinic receptors, which are
both present in substantial amounts in the nAcb and dorsal
striatum (Bernard et al. 1992; Clarke et al. 1984; Court and
Perry 1995; Hersch and Levey 1995; Hersch et al. 1994; Levey
et al. 1991; Schuiebs and Robner 1995). Consistent with the
cellular location of cholinergic muscannic receptors (Wei et al.
1994), ACh has been found to modulate glutamatergic neuro
transmission in MS neurons by acting on presynaptic musca
rinic receptors (Pennartz and Lopes da Silva 1994; Sugita et al.
1991) and to increase the excitability of MS neurons by acting
on muscarinic postsynaptic receptors (Sugita et al. 1991;
Uchimura and North 1990). The role of nicotinic receptors in
modulating the activity of MS neurons lias flot been investi
gated.
It has been proposed that the major role of nicotinic cholin
ergic receptors in the CNS, including the nAcb, is to modulate
synaptic transmission by controlling neurotransmitter release
rather than by exerting direct postsynaptic actions (Gray et aï.
1996; MacDermott et al. 1999; McGehee et al. 1995; Wonna
cott 1997). Nicotine has been found to facilitate the release of
diverse neurotransmitters, including GABA (Guo et al. 1998;
Léna et al. 1993), glutamate (Fisher and Dani 2000; Girod et al.
2000; Guo et al. 1998; McGehee et al. 1995; Radcliffe and
Dani 1998; Toth et al. 1993), ACh (McGehee et al. 1995),
dopamine (Auta et al. 2000; Puttfarcken et al. 2000; Rapier et
al. 1988, 1990; Sharpies et aI. 2000), and 5-HT (Reuben and
Clarke 2000). Whereas nicotine can enhance glutamatergic
neurotransmission, it has also been found to differentially
modulate AMPAIKA and NMDA receptor-mediated synaptic
transmission (Aramalds and Metherate 1998). In the striatum,
including the nAcb, nicotine has been found to increase neu
ronal glutamate release (Kaiser and Wonnacott 2000; Reid et
al. 2000; Toth et al. 1992, 1993). The presence of nicotinic
receptors on glutamatergic terminais in the nAcb is also sup
ported by the fact that glutamatergic neuronal populations
known to project to the nAcb express high levels of several
nicotinic receptor subunit mRNAs, whereas a comparatively
low expression of these subunits is found in the nAcb itself
(Quik et al. 2000; Wada et al. 1989, 1990).
The goal of the present study was to understand how ACh,
through an action on both muscarinic and nicotinic receptors,
modulates glutamatergic neurotransmission in the nAcb. Our
findings suggest that ACh acts on both muscarinic and nico
tinic presynaptic receptors to moduïate glutamatergic neuro
transmission, but whereas muscarinic receptor activation de-
presses excitation, nicotinic receptor activation enhances
glutamatergic neurotransmission. Parts of the present study
have appeared in abstract form (Zhang and Warren 2000).
M E T H O D S
Suce preparation
The procedures used to obtain nAcb suce preparation have been
described elsewhere (Bel]eau and Warren 2000). Briefly, 400-im
parasagittal suces containing the nAcb were obtained from rat pups on
the day following birth (Pi) up to P27. Slices were incubated for at
least Ï h before recording was undertaken in a submerged-type cham
ber superfused with room temperature (22—25°C) artificial cerebro
spinal fluid (ACSf) containing (in mM) 126 NaCI, 26 NaHCO3, 10
dextrose, 3 KC1, 1.3 MgSO4, 2.5 CaCI2, and 1.25 NaH2PO4 with a pH
of 7.4 when bubbled with a gas mixture of 95% 02-5% C02. The
nAcb was visualized with a stereo microscope using the anterior
commissure, the neostriatum, the septum, and the ventricles as land-
marks based on Paxinos and Watson (1986).
Recordiitg
Whoie ceil recording was achieved using the blind patch-clamp
technique (Blanton et al. 1989). Pipettes were pulled from thin wall
borosilicate capillary glass with a P-$7 micropipette puller (Sutter
Instrument). The pipettes had a resistance of 3—5 Mfi when fihled with
a solution containing (in mM) 140 potassium gluconate, 2 MgCI2, 0.1
CaCl2, 1.1 EGTA, 10 HEPES, 2 K2-ATP (ATP), and 0.5 guanosine
trisphosphate (GTP). Biocytin (0.3%) and QX-314 (2 mM; Alomone
Labs) were routinety added to the recording solution to label recorded
neurons and to minimize voltage-sensitive Na channels generating
action potential, respectively. The pH of the recording solution was
adjusted to 7.3 with $N KOH solution, and its final osmolarity was
adjusted to 285—290 mosmollkg. Neurons were recorded in continu
ous single-etectrode vottage-clamp mode with an Axoclamp 2B am
plifier (Axon Instruments). The output of the amplifier was fed to a
LPF 200A DC amplifier/filter (Warner Instruments) and digitized at
0.5—10 kHz with a real-time acquisition system Digidata 1200 (Axon
Instruments). Data acquisition was achieved using the pClamp 6.0
software (Axon Instruments), and off-une analysis was performed
with pClamp 6.0 and Cambndge Electronic Design softwares. The
resting membrane potential (RMP) was measured as soon as the
whole cdl configuration was achieved, and the offset potential, mea
sured on withdrawal of etectrode from the celi, was accounted for
assuming that it drifted in a linear fashion with time from the start of
the recording session. A — 10-mV correction for liquid junction po
tential was routinely added to membrane potential measurements
(Spigelman et al. 1992).
Synapric stimulation
Excitatory postsynaptic currents (EPSCs) were evoked by means of
a monopolar tungsten microelectrode placed close to the border of the
nAcb, 0.5—1.0 mm away from the recording electrode. The stimuli
consisted of single 0.l-ms, 3- w 6-V cathodal pulses delivered at 15-s
intervals. Paired-pulse stimulation with the same parameters and
separated by 50 ms were used in some experiments to distinguish
between pre- and postsynaptic mechanisms. Ail experiments were
performed with bicuculline methochloride (BMI) 10 M present in
the superfusing medium solution to block GABAA receptor-mediated
synaptic currents aiid to isolate glutamatergic-mediated EPSCs
(Zhang and Warren 1999). Under these conditions, the addition of
glutamatergic antagonists completely abolished synaptic responses
(e.g., Fig. 1), and in no cases did we observed evidence that the
stimulus directly activated the neuron under study. In ail experiments,
the membrane potential was clamped on-line at —70 mV, and the
EPSCs were recorded at potentials between —100 and +40 mV using
incremental steps of 20 mV.
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FIG. I. Nature of the excitatory postsynaptic current (EPSC) evoked by
local electrical stimulus in the presence of bicuculline methochlodde (BMI, 10
M). A: current traces of the response evoked by single local electrical
stimulus and recorded at holding membrane potentials of —40 and —100 mV
before glutamatergic antagonists application (1) and during superfusion with
6-cyano-7-nitroquinoxalene-2,3-dione (CNQX; 20 jiM; 2) and CNQX and
2-amino-5-phosphonovaleric acid (APV; 50 jiM; 3). Recordings were obtained
in a medium spiny (MS) neuron from a P3 animal. Current traces represent the
average of $ sweeps. B: current-voltage relationship of Oie response f’R”m)
between
— 120 and 20 mV. The early component was measured 9 rus after Oie
stimulus as indicated in A, left vertical dotted line. The late component was
measured 43 ms after the stimulus as indicated in A, right vertical dotted line.
Phannacological agents
The following phannacological agents were used: 6 cyano-7-nitro-
quinoxaline-2,3-dione (CNQX; 20 iM), (+)-2-amino-5-phosphono-
pentanoic acid (APV; 50 j.tM), carbachol (CCh; 50 jiM); ACh (100
jtM); atropine sulfate (10 M); pirenzepine HC1 (10 M); 1,1-
dimethyl-4-phenyl-pïperazinium iodide (DMPP; 10 MM); mec
amylamine HC1 (MMA; 10 LM). CNQX and APV were obtained
from Tocris Cookson; Ccli, atropine, pirenzepine, DMPP, and
mecamylamine were from Research Biochemicals International; and
ACh was from Sigma. Drngs, with the exception of CNQX, which
was dissolved in dimethlysulfoxide (DMSO), were made up as 10 mlvi
stock solutions in dîstilled water (ACh on the day of use) and diluted
with external solution to final concentration just before their addition
to the perfusion medium. The final concentration of DMSO during
CNQX administration was 0.1%. Under our expenmentai conditions,
the fui] effect of choiinergic agonists on the response occurred 5—7
min following their addition to Oie bathing medium and no recording
was made before a drug had been perfused for at least 15 min.
Antagonists were added to Oie superfiising medium at least 15 min.
and then a baseline was recorded before the addition of agonista. In
several cases atropine was present in Oi ACSf throughout Oie ex
periment. The suce was superfused with control ACSF for at least 30
min to allow washout of a drug before a new baseline was recorded.
In some experiments, suces were incubated for 2 h in Oie presence of
Oie antagonist (mecamylamine) prior to experimentation to enable full
penetration of the dmg into Oie slice. Synaptic currents were stored as
Oie on-une average of four to eight events at each membrane potential
before, during, and after drug administration.
Statistics
Statistical analysis was performed with SigmaStat software (SPSS)
using paired Student’s t-test to compare Oie response before and
during the application of agonists and antagonists. Probability values
of <0.05 were considered statistically significant. Ail numerical data
are expressed as means ± SE. Neurons that could flot be unambigu
ously classified as MS based on their physiological characteristics(Belleau and Warren 2000) and morphological appearance were ex
cluded from statistical analysis.
RESULTS
Whole celi voltage-clamp recording was obtained from 127
MS neurons in suces from rats between Pi and P27. Most ceils
(n = $6) were recofded in preparations from P5 to P15 ani
° mais, a time frame dunng which relatively large NMDA
mediated responses can be more readily evoked (Zhang and
Warren 1999). The membrane and firing characteristics of MS
-50 neurons were similar to those previously reported for animais
of comparable age (Belleau and Warren 2000). In addition, 79
-100 neurons fiiled with biocytin were examined under light micros
pA copy and displayed features that have been previously attrib
-150 uted to MS neurons from animais of similar age (Tepper et al.
199$).
Characteristics of gtutamatergic EPSCs
Typicaily, postsynaptic currents evoked by local electrical
stimulation in the presence of Oie GABAA receptor antagonist
BMI consisted of a compound glutamatergic EPSC comprising
an early and a late component mediated, respectiveiy, by Oie
activation of AMPAIKA and NMDA receptors (Fig. 1). We
characterized postsynaptic EPSCs in 91 neurons; the EPSC in
79 displayed an early and a late component, whereas only an
early component was found in the remaining 12.
The eariy EPSC peaked bctween 3.6 and 21 ms. after stim
ulus onset at a holding membrane potential of —100 mV, had
a linear relationship with Oie membrane potential and reversed
around O mV (n = 91). In contrast, Oie maximal amplitude of
Oie late EPSC occurred much later, was usually observed at
holding membrane potentiais of —20 or —40 mV, displayed a
nonlinear relationship with voltage, and aiso reversed around O
mV (n = 79).
Figure 1 shows a representative example of an EPSC re
corded in a preparation from n P3 animal on which specific
glutamatergic antagonists were tested. During the control pe
riod (Fig. lAi), the early EPSC peaked 9 ms. after the stimulus
onset at a holding membrane potential of —100 mV, and Oie
response decayed to baseline within 35 ms. The current voltage
relationship (IVm) of Oie early EPSC was linear at membrane
potentiaus between
—80 and 20 mV, but Oie response appeared
to saturate at membrane potentials below —80 mV (Fig. lB]).
Bath application of Oie AMPA/KA receptor antagonist CNQX
completely abolished Oie early component of Oie FPSC, and
there was virtua]ly no residual postsynaptic current at ail mem
brane potentials at Oie latency the early response was measured
(Fig. 1, A2 and Bi).
The late component, measured after Oie early component
had decayed, increased at membrane potentiais between —100
and —40 mV and reached its maximum usualiy at —40 or —20
mV. At more depolarized membrane potentials, it decreased
and reversed pouarity around O mV (Fig. 1, A and B, 2), a
current-voltage relationship typical of NMDA receptor-medi
ated current. The further addition of the NMDA receptor
antagonist APV to the superfusing medium compuetely abo]
1. Control
A
B
2.CNQX 3.CNQX÷APV
1. Early 2. Late
50
mV
-120 -100 -80 -60 -40
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ished the late EPSC (Fig. 1A3), demonstrating that it was
mediated by NMDA-type receptors. In the presence of CNQX
alone, the NMDA receptor-mediated EPSC was recorded in
isolation showing that measurements of the Ïate component of
the EPSC made on the compound EPSC were close to the peak
of the NMDA-mediated EPSC and represented mostly NMDA
receptor-mediated current (Fig. 1A2). Also, note there was no
residual postsynaptic current in the presence of CNQX and
APV, showing that glutamatergic EPSCs were effectively iso
lated by the addition of BMI to the superfusing medium.
CNQX and APV were tested together in four other fleurons
producing similar resuits. In addition, CNQX and APV were
tested individually in 17 and 14 neurons, respectively, produc
ing an inhibition of the early and late components of the
response of 91 ± 2 and 85 ± 5%.
In most neurons, the effects of cholinergic agonists and
antagonists were assessed at holding membrane potentials usu
ally between —100 and 40 mV in steps of 20 mV. The
AMPAIKA-mediated EPSC was measured at the peak of the
early component of the EPSC at a holding membrane potential
of —100 mV, when the amplitude of the late component was
minimal (Fig. lA, left vertical dotted unes), whereas the effects
on NMDA receptor-mediated currents were measured at a
latency at which the early component recorded at a holding
A Effects of CCh
membrane potential of —100 mV had decayed (Fig. lA, right
vertical dotted unes).
Effects of chotinergic agonists
The addition of the general cholinergic agonists ACh or CCh
to the superfusing medium in the presence of BMI typically
produced a decrease of both the early and late components of
the EPSC. A representative example of this effect is shown in
Fig. 2A. In this case, the amplitude of the early and late
component of the EPSC recorded at —100 and —20 mV,
respectively, was reversibly reduced by 38 and 40% dunng the
application of CCh. Similar results were observed in 15 other
neurons, while CCh produced no effects on the EPSC in one
case. The effects of CCh on the early and late components of
the EPSC as a function of holding membrane potential are
summarized in Fig. 28. The amplitude of the early component
of the EPSC was significantly reduced at holding membrane
potentials between —100 and —20 mV by an average of
39—46% (n = 16). The magnitude of the effect of CCh on the
early component of the EPSC did flot vary significantly with
holding membrane potential (F = 0.220, P 0.926, df = 4,).
No significant changes were observed at more positive mem
brane potentials because the EPSCs were small and the ampli
tudes were more variable. CCh also produced a reduction of
99
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no. 2. Effect of cholinergic agonists on the EPSC. A: current
traces of the tesponse evoked by single local electrical stimulus
tecorded at holding membrane potentials of —20 and — 100 mV
before (1), during (2), and after (3) superfusion with carbachol
(CCh, 50 jcM). 4: the overlay of the responses before and during
CCh application. Current traces represent the average of 8
sweeps. BMI (10 rM) was present in the superfusing medium
throughout recording. Recordings were obtained from a MS
fleuron in a preparation from a P8 animal. Left and right vertical
100 arrows in I indicate where the early and late responses were
respectively measured. B: average IRV,,, of the early (n = 16; 1)
50 and late (n 14; 2) recorded before and during superfusion with
CCh. C: average IRVm of the early (n = 28; 1) and tate (n = 26;
2) components of the EPSC recorded before and during super-
fusion with acetylchoiine (ACh). In 2 neurons tested with CCh
and 2 tested with ACh, the EPSC consisted only of an early
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the late component of the EPSC, which generally appeared to
be of larger magnitude than that observed on the early com
ponent, averaging 45—72% (n = 14) at holding membrane
potentials at which a statistically significant effect was ob
served. Indeed, the effect of CCh was statistically smaller on
early responses recorded at —100 mV than on late responses
measured at their maximal amplitude (inhibition of 45 ± 5 and
66 ± 6%, respectively; t 3.40$, P 0.002, df = 2$).
ACh (100 JLM) was tested in 33 neurons; it produced a
reduction of the EPSC in 28 celis and no change in the
remaining 5. The inhibitory effects of ACh appeared smaller
than those produced by CCh on the early component of the
EPSC (Fig. 2C1), ranging from 29 to 38% (n 28), although
the difference was flot statistically significant at any membrane
potential (0.418 t .667, 0.1 P 0.678, df = 42). As
observed for CCh, the magnitude of the effects of ACh did flot
vary significantly with holding membrane potenfial (F
0.700, P 0.594, df = 4). The effects of ACh on the late
component of the EPSC ranged from 26 to 44% at membrane
potentials at which a significant inhibition was observed (Fig.
2C2). No significant difference was found between the effect
of ACh on the late component at the membrane potential at
which the responses were largest and on the early component
recorded at —100 mV of the EPSC (inhibition of 44 ± 4 and
38 ± 5%, respectively; t = 0.866, P 0.396, df 52),
although the effect of ACh on the late component of the
response was significantly smaller than that produced by CCh
(t = 2.779, df = 38, P 0.008; 44 vs. 68%, respectively) at
the membrane potential at which the late EPSC was largest.
b validate our experimental assumption that the effects of
cholinergic agonists on the early and late components of the
EPSC accurately represented the effects on AMPA/KA and
NMDA receptor-mediated EPSCs, we studied the effects of
ACh on pharmacologically isolated AMPAIKA and NMDA
mediated EPSC using APV (50 tM) and CNQX (20 p.M),
respectively. In these experiments, ACh produced an inhibition
on AMPAJKA and NMDA receptor-mediated EPSCs of a
magnitude comparable to the effects observed on the early and
tate components of the compound EPSC. The AMPAIKA
receptor-mediated EPSC peak was reduced by 40—45% at
membrane potentials between —100 and —20 mV (n = 7; Fig.
3A) and the NMDA receptor-mediated current by 61% at the
membrane potential at which the response was the largest (n
4; Fig. 35), thus confirming the observations made on com
pound EPSCs. In general, the effects of CCh and ACh were
fully reversible after 10—30 min of washing with control
ACSF.
Together, these results indicate that the activation of cholin
ergic receptors results in a net depression of both AMPAJKA
and NMDA receptor-mediated EPSCs in nAcb MS neurons,
whereas in some cases, the inhibition appeared larger on the
NMDA than on the AMPAIKA mediated response.
Effects of muscarinic receptor antagonists
To identify the type of receptors mediating the inhibitory
action of cholinergic agonists, ACh was administered along
with specific cholinergic receptor antagonists. We first tested
the effects of the general muscarinic receptor antagonist atro
pine (10 M). When administered alone, atropine produced an
increase in both tise early and late components of the EPSC in
—e— Control (APV)
—O-- ACh
—e-— Control (CNQX)
—O— ACh
FIG. 3. A: average IR•Vm of the AMPA/KA receptor-mediated EPSC re
corded in the presence of APV (50 M) and BMI (10 jcM) before (control) and
during (ACh) the addition of ACh (100 M) to the superfusing medium (n
7). B: average peak response of the N-methyl-D-aspanate (NMDA) receptor
mediated EPSC in the presence of CNQX (20 jM) and BMI (10 iM) before
(control) and during (ACh) the addition of ACh (100 jcM) to the superfusing
medium (n = 4). , a statistically significant difference between control and
agonisÉ treatment at this holding membrane potential (Student’s t-test, P <
0.05).
five cells tested (Fig. 4A), suggesting that endogenous ACh
produced a significant inhibition of the EPSC in our prepara
tion. Interestingly, when concomitantly applied with atropine,
ACh produced a further enhancement of the EPSC in most
neurons tested instead of a decrease, as observed when general
cholinergic agonists were administered alone.
figure 43 shows an example of the effects produced by ACh
administered in the presence and absence of atropine. In this
case, atropine was first added to the superfusing medium for 15
min (Fig. 43]) and, when ACh was added, a significant en
hancement of both the early and late components of the EPSC
was obsen’ed (Fig. 432). Following the washout of atropine,
the same dose of ACh produced a significant decrease of the
EPSC (Fig. 453) as compared with the atropine period and
following the washout of ACh (Fig. 434).
The effects of ACh in the presence of atropine were tested in
18 neurons; a significant enhancement of the early component
of the EPSC averaging 33% was observed in 13 (72%) neu
A
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rons, -whereas ACh in the presence of atropine produced no
significant change in the remaining 5 (fig. 4C). Similarly, the
late component of the response was increased by an average
36% (at the membrane potential at which the response was
largest) in eight of fine neurons tested, with no significant
change observed in the remaining celi. Because ACh alone
reduced the amplitude of evoked EPSCs whule producing an
increase when given in combination with atropine, we con
cluded that muscarinic receptor activation mediated inhibitory
effects that masked an excitation possibly mediated by nico
tinic receptors.
To identify the pharmacologicai type of muscarinic recep
tors mediating the inhibitory effects of cholinergic agonists, we
tested the effect of CCh in the presence of the M1/M4 receptor
antagonist pirenzepine. In three of four cases, CCh applied in
the presence of pirenzepine (10 M) produced no effect on the
early component of the EPSC (110 ± 10%) whiie it produced
an increase of the early response of 70% in the remaining case.
following washout of pirenzepine (103 ± 12% of control),
CCh alone produced n significant decrease in ail four celis
relative to controi (—33 ± 5%). CCh in the presence of
pirenzepine produced similar effects on the late response: an
increase was observed in two ceils (24 and 31%, respectively),
but no significant change in a third one. Following washout of
pirenzepine (iii ± 14% of controi), CCh alone produced a
decrease in the late response of 36—53% in the three neurons
tested. In conclusion, pirenzepine appeared to mimic the an-
FIG. 4. Effects of the muscarinic receptor antagonist atro
pine on ACh inhibition of the EPSC. A: average IRVm of the
early (n = 5; 1) and late (n = 5; 2) components of the EPSC
recorded before and during superfusion with atropine (10
.rM). Asterisk, statistically significant difference between con-
trot and atropine treatment at Éhis holding membrane potential
(Student’s t-test, P < 0.05). The increases produced by atro
pine ranged from 35 to 46% on the early response and were of
54% on the late response. B: current traces of the response
evoked by single local electrical stimulus recorded at holding
membrane potentials of —20 and —100 mV during superfu
sion with atropine (10 sM; 1), with atropine and ACh (100
j.rM; 2), with ACh following washout of atropine (3) and
following washout of ACh (4). Current traces represent Ihe
average of 8 sweeps and BMI (10 M) was present in the
superfusing medium throughout recording. Recordings were
obtained from a MS neuron in a preparation from a P5 animal.
Left and right vertical arrows in BI indicate where the early
and late responses tvere measured, respectively. C: average
IRV of the early (n = 13; 1) and late (n = 8; 2) components
of the EPSC recorded during superfusion with atropine and
atropine with ACh. In 5 neurons, the EPSC consisted only of
an early component and these were included in the average of
the early component. The IgVr,, of the late response was
aligned on the holding membrane potential at which the re
sponse was maximum before averaging (usually at —20 or
—40 mV). Asterisk, a statistically significant difference be
tween atropine and atropine with ACh treatment at this holding
membrane potential (Student’s t-test, P < 0.05).
tagonistic effects of atropine, suggesting that the M11M4 recep
tor mediated much of the inhibitory effects of cholinergic
agonists.
Effects of the nicotinic receptor agonist
b corroborate the existence of nicotinic receptor-mediated
modulation of excitatory neurotransmission in the nAcb, we
tested the specific nicotinic agonist DMPP (10 jiM) with
atropine (10 jM) present in the bathing medium throughout
the expenments. DMPP was tested on both the composite
EPSC (n = 9) and pharmacoiogically isolated AMPAJKA (n
7) and NMDA (n = 4) receptor-mediated responses. Data from
the two types of experiments were combined because simiiar
results were obtained. As shown in a characteristic example in
Fig. SA, DMPP produced an enhancement of the EPSC that
was simiiar to the one observed with ACh and CCh adminis
tered in the presence of atropine. DMPP increased the ampli
tude of the eariy AMPA/KA component of the EPSC in 13 of
the 16 neurons (8 1%) tested and that of the late component in
12 of 13 neurons (92%) by an average of 37 ± 4% (19—80%)
and 59 ± 8% (1$—107%), respectively. Resuits are summa
rized in fig. 53. Statistically significant effects were observed
at membrane potentials below —40 mV for the eariy response
and only at the membrane potentiai at which the late response
was maximal for the iate responses. The effect of DMPP was
statisticaily iarger on the maximum of the late component of
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the EPSC than on the eariy one recorded at a holding mem
brane potenfial of —100 mV (t5 = 2.423, df = 23, P = 0.024).
DMPP was aiways administered in the presence of atrophie,
showing that the enhancements were independent of musca
rinic mechanisms. In addition, DMPP produced no changes in
either the early or late components of the EPSC in four neurons
when administered in the presence of the nicotinic receptor
antagonist mecamylamine (Fig. 5C).
Effects of ACh as function ofpostnatal age
We have recorded neurons from Pi to P27 animais, but most
celis were recorded in preparations from P5 to P15 animais,
and only with ACh we recorded a significant number of neu
rons over a range of postnatal ages sufficient to perform a
developmentai analysis (P3—P15, n = 33). The magnitude of
the inhibition produced by ACh as a function of postnatal age
is presented in Fig. 6 for both the early and late responses. The
effects of ACh on the early component of the EPSC did flot
change with postnatal age, but those on the iate component
increased significantly during the first two postnatal weeks. In
the same group of neurons, we found no statisticaily significant
changes in the amplitude of either the early (r = 0.135, df
26, P 0.492) or late (r 0.073, df = 24, P = 0.72 1)
component of the EPSC.
Locus of the cholinergic modulations of evoked EPSCs
To identify the iocus (pre- or postsynaptic) of action of
choiinergic agonists, we compared several features of our
recordings in the presence and absence of cholinergic agonists.
Dur evidence suggests that the effects produced by both mus
carinic and nicotinic agonists were exciusiveiy mediated by
presynaptic mechanisms in the present study. First, we ob
served that ACh, DMPP, or ACh in the presence of atropine
did not consistently produced changes in the holding mem
brane current at holding membrane potential between —100
and +40 mV (Fig. 7), suggesting that cholinergic agonists
produced no change in input conductance. Similar results were
obtained using steady-state current-vokage curves generated
by slow voltage ramps between —100 and +40 mV (not
shown). Second, ACh produced no change in the decay time
0mV1
5Oms
*
Ï
20 40 60
=12
Atropine
*
2. Mecamylamine 3. DMPP Wash 4. 1 + 2
+ DMPP .1- atropine
102
FIG. 5. Effects of nicotinic agonist and antagonist on tise
early and laie EPSCs in tise presence of atropine. A: current
traces of tise response evoked by single local electrical Stim
ulus recorded at holding membrane potentials of —40 and
—100 mV before (1), during (2), and after (3) superfusion
with the nicotinic receptor agonist 1,1-dimethyl4-phenyl-
piperazinium iodide (DMPP; 10 1iM). 4: tise overlay of tise
responses before and during DMPP application. Current
traces represent the average of $ sweeps and BMT (10 M)
and atropine (10 M) were present in tise superfusing me
dïum throughout recording. Recordings were obtained from a
MS fleuron in a preparation from a P14 animal. Left and right
vertical arrows in I indicate where tIse early and late te
sponses were measured, respecfively. B: average IRVm of tise
early (n = 13; 1) and late (n = 12; 2) components of tise
EPSC in which DMPP produced an increase of tise response
and fecorded before and during superfusion with DMPP. Tise
‘R4”m of the late response was aligned on the holding mem
brane potential ai which tise response was maximum (usually
at —20 or —40 mV) before averaging. In 1 fleuron, tise EPSC
consisted only of an early component and it was included in
tise average of tise early componenc Tise IRVm of tise late
response was aligned on the holding membrane potential at
wisich tise response was maximum before averaging (usually
ai —20 or —40 mV). Astensk, s statistically significant
difference between atropine and DMPP + atropine treatment
at this holding membrane potential (Student’s t-test, P <
0.05). C: current traces of tise response evoked by single local
electrical stimulus recorded at holding membrane potenfials
of —40 and —100 mV during superfiision with
mecamylamine (1), mecamylamine and DMPP (2), and after
washout of DMPP (3). 4: tise overlay of the responses dudng
mecamylamine and mecamylamine with DMPP application.
Recordings were obtained from a MS neuron in a preparation
from a P6 animal. Other conventions are the same as in A.
Tise scale bars in A also apply to C.
C
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+ atropine
-4OmV
-lOOmV
Ï—
V....
J Neurophysiol . VOL 88 • DECEMBER 2002• www.jn.org
L. ZHANG AND R. A. WARREN
(T) of the evoked EPSC measured by fitting a single exponen
tial to the isolated AMPA response (i.e., recorded in the pres
ence of APV) at holding membrane potential of —100 mV
(12.2 ± 1.4 and 13.2 ± 1.9 ms during control and during ACh
administration, respectively, n = 7, P > 0.4) or —40 mV
(12.6 ± 1.3 and 13.3 ± 1.6 ms during control and during ACh
administration, respectively, n = 7, P> 0.7). Third, we used
a paired-pulse protocol with a 50-ms interval between stimuli
to discriminate between pre- and postsynaptic mechanisms
(d’Alcatara et al. 2001; Hoffman and Lupica 2001; Mulder et
aI. 1996, 1997; Pennartz et al. 1991; Robbe et al. 2001; Zucker
1989). We found that the ratio (PPR; 2nd EPSC amplitude/lst
EPSC amplitude) significantly changed during administration
of agonists, thus suggesting presynaptic mechanisms. In the
presence of ACh (n = 7), the amplitude of the first and second
evoked EPSCs both decreased, but the second response de
creased b a larger extent, resulting in a decrease in the PPR
(Fig. sA). In contrast, during the application of DMPP (n = 6),
the amplitude of evoked EPSCs increased but the second
response increased more, resulting in an increase in the PPR
(Fig. SB). Fourth, we found that ACh produced no effects on
the response evoked by pressure ejection of glutamate in the
vicinity of neurons in the presence of tetrodotoxin (TFX; fig.
$C). Together, these results suggest that under the present
experimental conditions muscarinic and nicotinic receptors
agonists produced no detectable postsynaptic effects in the
nAcb and that the present resuits reflect an action on presyn
aptic receptors.
Several studies in the nAcb and dorsal striatum have de
scribed direct postsynaptic effects on the passive and/or active
membrane properties of MS neurons mediated by muscarinic
receptors (Gabel and Nisenbaum 1999; Galarraga et al. 1999;
Hsu et al. 1996, 1997; Pineda et al. 1995; Sugita et al. 1991;
Uchimura and North 1990; see also Pennartz and Lopes da
Silva 1994) consistent with the distribution of muscarinic re
ceptor (Bemard et al. 1992; Weiner et al. 1990; Yan and
Surmeier 1996). Several factors could explain the discrepan
cies between these studies and the present resuits, including the
fact that we used whole celi patch clamp recording and that
experiments were performed at room temperature. We found
that under the present expenmental conditions, cholinergic
agonists produced a direct effect on the membrane andJor finng
properties of MS neurons when QX-314 was omitted from the
pipette solution, figure 8D shows an example of the effects
produced by CCh (50 M) under these conditions. In this case,
CCh produced a membrane depolarization of 21 mV. Intracel
lular depolarizing current pulse that was subthreshold during
control readily evoked spiking when CCh was added to the
bath, and the number of action potentials increased in response
to suprathreshold current injection. These resuits suggest the
that the presence of QX-314 into the recording pipette oc
cluded the postsynaptic effects mediated by muscarinic recep
tors.
DISCUSSiON
We have studied the effects of cholinergic agonists on iso
lated EPSCs in nAcb MS neurons. Broad-spectmm cholinergic
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ito. 6. Effects of ACh as a function of postnatal age. A: magnitude of the
inhibitory effects of ACh on the early component of the EPSC recorded at a
holding membrane potential of —100 mV as a function of postnatal age (n =
28). No statistically significant correlation was found between the magnitude
of the effects of ACh and postnatal age (r = 0.265, df = 26, P = 0.172; “
B: magnitude of the inhibitory effects of ACh on the late component of the
EPSC at tise holding membrane potential at which the response was maximal
as a function of postnatal age (n = 26). A statistïcally significant correlation
was found between the magnitude of the effects of ACh and postnatal age (r =
0.556, df =24, P 0.003; —). ., the effect observed for individual neuron in
A and B.
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no. 7. Effects of cholinergic agonists on holding membrane currents. A:
average IboIdVm before and during superfusion with ACh (100 jtM). B: same
as A but during superfusion of atropine and during superfusion with DMPP or
ACh in the presence of atropine. No statistically significant differences were
found at any holding membrane potentials.
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FIG. 8. Locus of the effects of cholinergic agonist on EPSCs.
A: effects of ACh on PPR. Current traces of the responses
evoked by a pair of single local electrical stimuli 50 ms apart at
holding membrane potentials of —100 mV before (1) and during
(2) superfusion with ACh (100 jiM). 3: tIse overlay of the
responses before and during ACh application; tIse amplitude of
the 1 st response in the presence of ACh was scaled tu match tise
amplitude of die lst response during control. Note that tIse 2nd
response proportionalty decreased more than the isi response in
die presence of ACh and diat there is no apparent changes in die
time course of die EPSCs. Current traces represent die average
of 8 sweeps and BMI (10 .rM) was present in the supeffusing
medium throughout recording. 4: die average amplitude of die
PPR from 7 neurons before and during superfusion widi ACh.
PPR was statistically larger in die presence of ACh dian during
control condition (t = 3.045, df 6, P = 0.023). B: effects of
DMPP on PPR. Conventions are die same as in A. Note that die
2nd response proportionatly increased more than the lst re
sponse in die presence 0f DMPP and diat there is no apparent
changes in die time course of die EPSCs. PPR vas statistically
larger in tise presence of DMPP than during control condition
(t = 3.660, df = 5, P = 0.015). C: current traces of tise response
evoked by local pressure ejection of glutamate (1 mlvi) from a
patch pipette before (1) and during (2) superfusion with ACh
(100 M) at a holding membrane potential of —100 mV in die
presence of tetrodotoxin (1 jrM) and BMI (10 jM). 3: die
overlay of die responses recorded in] and 2. 4: the amplitude of
die peak response recorded at a holding membrane potential of
—100 mV for 3 neurons before and during supcrfusion widi
ACh. D: effect of die cholinergic agonist carbachol on die
membrane and firing properties of MS fleurons. Voltage Te
sponses evoked with intracellular current pulses of 15 (top) and
75 pA (bottom) from resting membrane potential before (]),
during (2), and afier (3) tise addition of carbachol (50 rM) to die
superfusing medium. In dis case, die addition of carbachol
produced a 21-mV depolarization of the membrane potential.
Recordings were obtained under die same experimental condi
tions as die other neurons in die present study widi tise exception
that QX-3 14 was omitted from the pipette solution.
agonists ACh and CCh produced a reduction of both
AMPA/KA and NMDA receptor-mediated components of the
EPSC. In contrast, in the presence of the muscarinic receptor
antagonist atropine, cholinergic agonists produced an increase
of the EPSC, suggesting that the inhibition of the EPSC was
mediated by muscarinic cholinergic receptors and that, under
the present expenmentaÏ conditions, an excitatory effect me
diated by nicotinic cholinergic receptors was masked by mus
carinic-mediated inhibition. The effects of atropine were gen
erally mimicked by the antagonist pirenzepine, suggesting that
the inhibitory effects of cholinergic agonists were mediated in
part by M11M4 type of muscarinic receptor. DMPP, a specific
nicotinic receptor agonist, produced an enhancement of the
EPSC. However, this effect was blocked by mecamylamine,
demonstrating the presence of a modulation of the EPSC
mediated by nicotinic receptors. Cholinergic agonists appar
ently produced no postsynaptic effects, but produced consistent
changes in the paired-pulse ratio. Conversely, they produced
no effects on responses evoked by brief glutamate ejection in
the vicinity of the recorded neurons in the presence of TfX,
showing that the cholinergic agonists were acting on presyn
aptîc receptors, probably located on glutamatergic terminals.
Because cholinergic agonists produced direct effects on the
membrane and firing properties of MS neurons when QX-3 14
was omitted from the pipette recording solution, intracellular
QX-314 could constitute an interesting pharmacological tools
for studying presynaptic mechanisms. Together, these resuits
suggest that ACh modulates glutamatergic neurotransmission
by decreasing glutamate release via an action on pfesynaptic
muscarinic receptors or by increasing glutamate release via
nicotinic receptors. These contrasting effects of ACh on single
neurons emphasizes the complexity of cholinergic modulation
of glutamatergic neurotransmission in the nAcb. In addition to
its presynaptic effects on glutamatergic neurotransmission,
ACh produces a direct modulation of the membrane and firing
properties of MS neurons and is also known to modulate the
release of other neurotransmitters in the nAcb. We suggest that
ACh may play an important role in the nAcb by gating gluta
matergic excitation. This function may be important for syn
apse formation and consolidation during postnatal develop
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ment as weIl as in controlling MS neurons membrane
bistability in mature nAcb.
Locus of cholinergic receptors
Our resuits suggest that both muscannic depression and
nicotinic potentiation of EPSCs were mediated by an action on
cholinergic receptors located on giutamatergic terminais. We
found that neither CCh and ACh or DMPP altered the input
conductance nor changed the time course (the hse or decay
phase) of EPSCs. Cholinergic agonists also produced consis
tent changes in the paired-pulse ratio in agreement with an
action mediated by presynaptic mechanisms (d’Alcatara et al.
2001; Hoffman and Lupica 2001; Mulder et al. 1996, 1997;
Pennartz et al. 1991; Robbe et al. 2001; Zucker 1989). fur
thermore, ACh produced no effects on the response evoked by
exogenous glutamate dunng blockade of synaptic transmission
with TTX. In contrast, CCh produced marked effects on the
membrane and firing properties of MS neurons when QX-314
was omitted from the pipette recording solution. We conclude
that the modulation of EPSCs by cholinergic agonists was
mediated by presynaptic mechanisms. Our findings are in
general agreement with studies on the effects of muscarinic
agonists on glutamatergic neurotransmission in both the nAcb
(Pennartz and Lopes da Silva 1994; Sugita et al. 1991) and the
dorsal striatum (Akaike et aI. 1988; Barrai et al. 1999; Her
nandez-Echeagaray et al. 1998; Hsu et aI. 1995; Malenka and
Kocsis 1988), whereas, to our knowledge, there have been no
reports on the modulation of glutamatergic neurotransmission
by nicotinic receptor in either structure.
In agreement with Pennartz and Lopes da Silva (1994), we
observed no changes in the passive membrane properties of
MS neurons in the presence of cholinergic agonists, whereas
several studies on the nAcb and dorsal striatum have described
direct postsynaptic effects on the passive andlor active mem
brane properties of MS neurons mediated by muscarinic recep
tors. These observations suggest that postsynaptic activation of
muscarinic receptors enhanced the excitability of MS neurons
by producing membrane depolarization (Hsu et al. 1996; Su
gita et al. 1991; Uchimura and North 1990) and an increase in
input resistance (Galarraga et al. 1999; Hsu et al. 1996; Pineda
et al. 1995; Uchimura and North 1990) likely by reducing K
conductances including inward rectifying (I) and persistent
(t) (Gabel and Nisenbaum 1999; Galarraga et al. 1999; Hsu
et al. 1996, 1997; Pineda et al. 1995). These resuits are con
sistent with the membrane potential depolarization we ob
served when QX-314 was omitted from the pipette solution
that likely resulted from the suppression of these K conduc
tances. Postsynaptic effects mediated by muscarinic receptors
were typically blocked by pirenzepine and attributed to the
activation of M1 receptors. These observations are consistent
with the distribution of muscarinic receptors in the nAcb and
striatum where M1 receptors are primarily found postsynapti
cally on MS neurons (Bemard et al. 1992; Weiner et al. 1990;
Yan and Surmeier 1996).
Because muscarinic receptors are coupled to G protein
(Caulfield and Birdsall 1998), one possibility is that by using a
whole ceil recording technique, we washed out some elements
of the second-messenger system necessaiy for the expression
of postsynaptic effects even though ATP and GTP were always
included in the pipette solution. Altematively, we routinely
added QX-314 to the recording pipette solution to block action
potential generation. We found that by omitting QX-314 from
the pipette recording solution, cholinergic agonists modulated
the membrane and firing properties of MS fleurons, suggesting
that QX-314 occluded the postsynaptic effects of cholinergic
agonists. In addition to blocking voltage-gated Na channels,
QX-3l4 is also known to inhibit G-protein-gated K conduc
tances (Aireja and Aghajanian 1994; Andrade 1991; Lambert
and Wilson 1993; Nathan et al. 1990; Otis et al. 1993;
Slesinger 2001) and may have occluded muscarinic postsyn
aptic effects on K conductances (Gabel and Nisenbaum 1999;
Galarraga et al. 1999; Hsu et al. 1996, 1997; Pineda et al.
1995). This hypothesis is consistent with recent findings show
ing that intracellular QX-314 blocks muscannic M1 and M3
receptor signaling pathways expressed in Xenopus oocytes
(Hollmann et al. 2000, 2001). The present resuits suggest that
internal QX-314 may aiso block the signaling pathway of
native muscarinic receptors and that it could be a useful phar
macologicai tool to isolate presynaptic mechanisms in the
study of the muscarinic cholinergic system or other neurotrans
mitter systems modulating G-protein-gated K conductances.
further studies would be needed to test these hypothesis.
To our knowledge, this is the first study reporting a
modulation of glutamatergic neurotransmission mediated by
nicotinic receptors in the nAcb or other neostriatal struc
tures. Some of the previous studies on the nAcb and dorsal
striatum have limited their scope to muscarinic receptor
mediated modulation of excitatory neurotransmission (B ar
ral et al. 1999; Calabresi et al. 1998; Hernandez-Echeagaray
et al. 1998; Sugita et al. 1991). In studies in which general
cholinergic agonists were used, none reported an increase in
excitatory neurotransmission in the presence of muscarinic
antagonists (Hsu et ai. 1995; Pennartz and Lopes da Siiva
1994), whereas Akaike et al. (1988) found that nicotine
produced no effect on excitatory postsynaptic potentials
(EPSPs) in the caudate nucieus of aduit rats.
The presence of functional presynaptic nicotinic receptors
in the nAcb and dorsal striatum has been documented (see
Lendvai and Vizi 1999; MacDermott et ai. 1999). Recent
studies in other regions of the CNS have found that nicotinic
agonists potentiated glutamatergic neurotransmission pre
sumabiy by acting on presynaptic receptors located on glu
tamatergic terminais (Aramakis and Metherate 1998; Gil et
al. 1997; Girod et al. 2000; Gray et al. 1996; Radcliffe and
Dani 1998; McGehee et al. 1995; Vidai and Changeux 1993)
in agreement with the present findings. Nicotine has also
been found to exert direct postsynaptic excitation on some
specific neuronal populations, including interneurons in the
cerebral cortex (McCormick and Prince 1986; Porter et al.
1999; Roerig et ai. 1997) and hippocampus (frazier et al.
1998; Jones and Yakel 1997; McQuiston and Madison
1999), dopaminergic neurons in the ventral tegmental area
(Calabresi et al. 1989; Pidoplichko et al. 1997), retinal
ganglion celis (Feller et ai. 1996), and in brain stem nucleus
ambiguus (Zhang et al. 1993), but we found no evidence for
a similar action in nAcb MS neurons. Nicotinic receptors are
ligand-gated channels independent of second-messenger
system and would flot be occluded by QX-3l4 in the same
way as muscarinic receptors.
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Muscarinic depression of EPSCs
Few studies have examined the modulatory role of ACh on
glutamatergic neurotransmission in the nAcb. Pennartz and
Lopes da Silva (1994) reported that in ventral striatal slices
muscarine and CCh reversibiy attenuated the EPSP through
presynaptic mechanisms and that this action was completely
antagonized by atropine or pirenzepine in agreement with our
findings. They aiso found that increasing endogenous levels of
ACh with acetylcholinesterase inhibitors resuited in a decrease
in the EPSP in accordance with our finding that endogenous
ACh exerted a tonic depression of EPSC, as suggested by the
increase in the EPSC produced by atropine alone in our prep
aration. Sugita et al. (1991) also reported that cholinergic
muscarinic receptor activation depressed glutamatergic neuro
transmission in the nAcb through presynaptic mechanisms.
Comparable results have been obtained in the dorsal stria
tum, a structure that shares several anatomical and physiolog
icai characteristics with the nAcb and in which cholinergic and
muscarinic agonists have been found to decrease the respon
siveness of MS neurons to excitatoiy inputs, presumably by
acting on presynaptic muscarinic receptors (Akaike et al. 1988;
Barrai et al. 1999; Hernandez-Echeagaray et al. 1998; Hsu et
ai. 1995; Maienka and Kocsis 1988). Therefore our findings
that muscarinic receptors depressed giutamatergic EPSCs by
acting on presynaptic receptors are in general agreement with
previous studies.
Previous studies on the nAcb and dorsal striatum made no
attempt to examine the possibility that cholinergic agonists
exerted differentiai modulation of AMPAJKA and NMDA
receptor-mediated excitation. We found that the activation of
muscarinic receptors depressed both AMPAJKA- and NMDA
mediated EPSCs and that with CCh the depression was larger
on the NMDA than on the AMPAJKA receptor-mediated com
ponent. The larger depression of the NMDA-mediated re
sponse couid be the result of rundown of the NMDA response
in vitro, but the fact that we observed a larger increase in the
NMDA receptor-mediated component than on the AMPA/KA
mediated response with nicotinic receptor agonists suggests
that this was not the case. Altematively, it is possible that the
effects are mediated by different types of muscarinic receptors
for which ACli and CCh have different binding characteristics.
There are no highiy selective antagonists for muscarinic
receptor subtypes (Caulfield and Birdsall 1998), and we did not
perform extensive pharmacological studies to identify the sub
type of muscarinic receptor involved in the inhibition of the
EPSC. We found that pirenzepine, which acts predominantly
on M1 and M4 receptors, mimicked mucli of the effects of
atropine. These resuits are in agreement with those of Pennartz
and Lopes da Silva (1994). Others have suggested that mus
carinic receptor-mediated inhibition in the nAcb and dorsal
striatum were mediated by M3 (Hsu et al. 1995; Sugita et al.
1991) or M2-M3 (Hemandez-Echeagaray et al. 199$) receptors.
A subset of M1, M3, and M4 muscarinic receptors are found on
axon terminais forming asymmetrical synapses (Hersch and
Levey 1995; Hersch et al. 1994) and provide an anatomical
basis for the presynaptic modulation of giutamatergic neuro
transmission by ACh. In contrast, the M2 receptor appears to be
located on axon terminals making symmetricai synapses, sug
gesting that they do flot participate in the modulation of exci
tatory input. M1 and M3 receptors mRNA are found in cortical
and hippocampal pyramidal fleurons as well as in the amygdala
and thalamus (Bucldey et al. 198$; Wei et al. 1994), and these
structures could be the source of presynaptic muscarinic recep
tors located on glutamatergic terminais in the nAcb.
Nicotinic potentiation of EPSCs
ACh and CCh not only act on muscarinic receptors but also
activate nicotinic receptors. Under the present experimental
conditions, nicotinic receptor-mediated excitation became ap
parent only when appropriate muscarinic receptor antagonists
were added to the superfusing medium, suggesting that nico
tinic receptor-mediated excitation was masked by a predomi
nant muscarinic inhibition. furthermore, the application of
DMPP mimicked the enhancing effects produced by general
cholinergic agonists in the presence of atropine or pirenzepine,
and this effect was blocked by mecamylamine, a specific
nicotinic receptor antagonist, showing that the potentiation of
the EPSC was mediated by the activation of nicotinic recep
tors. To our knowledge, this is the first demonstration that
glutamatergic neurotransmission is modulated by nicotinic pre
synaptic receptors in the nAcb.
The presence of presynaptic nicotinic cholinergic receptors
bas been documented in both the nAcb and dorsal striatum (see
Lendvai and Vizi 1999; MacDermott et aI. 1999). Our findings
are in agreement with several recent studies showing that the
activation of presynaptic nicotinic cholinergic receptors facil
itates glutamatergic neurotransmission in different regions of
the CNS (e.g., Aramakis and Metherate 1998; Girod et al.
2000; Gray et al. 1996; Guo et al. 1998; McGehee et al. 1995).
These studies suggested that facilitation of glutamatergic neu
rotransmission was mediated by nicotinic receptors containing
the a subunit. Our results suggest that another type of nicotinic
receptor is involved in the nucleus accumbens because recep
tors containing the a subunit are insensitive to mecamylamine
(e.g., MacDermott et al. 1999). Our results are supported by
recent findings showing that nicotine increases glutamate re
lease in the nAcb via n mecamylamine-sensitive nicotinic
receptor (Reid et al. 2000).
Several studies have demonstrated that local nicotinic recep
tor activation increased dopamine release in the nAcb (Fu et al.
2000; Hildebrand and Svensson 2000; NiseIl et al. 1994a,b)
raising the possibility that some of the effects we observed
were indirectly mediated through the dopaminergic system.
This appears unlikely because nicotinic-evoked dopamine re
lease in the nAcb has been found to be insensitive to
mecamylamine but is sensitive to subunit antagonists (Fu et
al. 2000), suggesting that a different type of nicotinic receptors
control glutamate and dopamine release in the nAcb.
We have found that nicotinic agonist enhanced both
APMA/KA and NMDA receptor-mediated EPSCs but that the
effect was statisticaily larger on NMDA- than on AMPA/KA
mediated response. This is in partial agreement with Aramairis
and Metherate (1998), who found that in rat auditory cortex
during postnatal development nicotine selectively enhanced
NMDA receptor-mediated EPSP while producing no change in
AMPAIKA receptor-mediated EPSP. The authors concluded
that nicotinic receptors were located on glutamatergic termi
nals at synapses containing only NMDA receptors, whereas the
present resuits suggest that nicotinic receptors are located on
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terminais containing both AMPAJKA and NMDA receptors,
whereas a subclass contains only NMDA receptors.
Aramalds and Metherate (1998) reported that nicotinic mod
ulation of NMDA receptor-mediated EPSC was only observed
in preparations from animais less than 19 days old. In the
present study, we used animais of an age comparable to those
used by these authors, whereas previous studies on the nAcb
and dorsal striatum used aduit animais. This raises the possi
bility that nicotinic modulation of glutamatergic transmission
is also developmentally regulated in the nAcb. Indeed, the
expression of different nicotinic receptor subunit mRNA ap
pears to be developmentally regulated in the nAcb as well as in
brain regions providing glutamatergic innervation to the nAcb
(Aubert et al. 1996; Cimino et al. 1995; Fiedier et al. 1990;
Hellstrom-Lindahl et al. 1998; Shacka and Robinson 199$;
Zhang et al. 1998), suggesting that nicotinic modulation may
vary with the stage of development. We found that the inhib
itory effects of ACh increased during the first two postnatal
weeks. This developmental change could result from an in
crease in the number of muscarinic receptors on glutamatergic
terminais or, altematively, in a decrease in nicotinic receptors.
Further experiments are needed to explore these possibilities.
Functional considerations
The nAcb constitutes an important point of convergence of
information from several limbic structures, including the pre
frontal cortex (PFC), the amygdala, the hippocampus and mid
line thalamic nuclei (Groenewegen et al. 1980, 1982, 1987;
Jayaraman 1985; Kelley and Domesick 1982; Kelley and Sti
nus 1984; Kelley et al. 1982; Krayniak et al. 1981; Newman
and Winans 1980). These afferent systems, which are believed
to be glutamatergic, are thought to mediate their excitatory
drive mainly through AMPAJKA and NMDA glutamatergic
receptors (Defrance et al. 1985; Finch 1996; Kombian and
Malenka 1994; Nicola et al. 1996; Yim and Mogenson 1982;
Zhang and Warren 1999). Because we used local electrical
stimulation, the EPSCs recorded in the present study were
probably evoked by the activation of these pathways. Our
results as well as these of others show that ACh exerts complex
control over the excitability of nAcb MS neurons by acting at
both pre- and postsynaptic levels. At presynaptic level, we
found that ACh can increase or decrease the efficacy of incom
ing glutamatergic input possibly by controlling glutamate re
lease through an action on nicotinic and muscarmnic receptors,
respectively. Postsynaptically, ACh increases the excitability
and responsiveness of MS neurons by acting on postsynaptic
muscarinic receptors located on MS neurons.
We studied the effects of cholinergic agonists during post
natal development between Pi and P27. During that period, the
intrinsic and firing properties of nAcb MS neurons mature and
appear to become aduit-like only by the end of the third
postnatal week (Belleau and Warren 2000). In addition, during
the first 10 postnatal days, nAcb MS neurons are essentially
aspiny and possess varicose dendrites, whereas they assume an
adult spiny appearance only toward the end of the third post
natal week (unpublished observation). Similar developmental
changes were found in MS neurons in the developing dorsal
stnatum and were accompanied by a large increase in the
density of excitatory synapses, particularly on spines (Sharpe
and Tepper 1998; Tepper and Trent 1993; Tepper et al. 199$).
Presumably, excitatory synapse formation and consolidation is
also taldng place in the nAcb during the postnatal period.
During postnatal development, behavioral experience is
thought to shape and refine neural circuits tbrough activity
dependent mechanisms (Aamodt and Constantine-Paton 1999;
Collingridge and Singer 1990; Fox et al. 1999), and the dis
ruption of both glutamatergic and cholinergic functions bas
been shown to reduce developmental plasticity in some regions
of the neuraxis (Aramakis et al. 2000; Bear and Singer 1986;
Bear et al. 1988, 1990; Brooks et al. 1997; Cantallops and
Routtenberg 1999; Iwasato et al. 2000). In adult animais, the
normal function of MS neurons involves the interactions be
tween their intrinsic properties and their glutamatergic inputs,
whereas different glutamatergic inputs from different sources
appear to have different functions in initiating MS neuron
activation (O’Donnell and Grace 1995). Part of this organiza
tion could be triggered by activity-dependent mechanisms in
volving glutamatergic neurotransmission, especially when me
diated by NMDA-type receptors (Craig and Lichtman 2000).
Indeed, functional glutamatergic innervation of MS neurons is
already present on the day of birth and NMDA receptor
mediated EPSCs are preponderant dunng the first two postnatal
weeks, whereas AMPAJKA receptor-mediated EPSCs predom
mate in juvenile and adult animais (Zhang and Warren 1999).
The cholinergic modulation of glutamatergic neurotransmis
sion during the postnatal period possibly contributes to the
maturation and refinement of the glutamatergic innervation of
the nAcb. In addition, glutamatergic innervation of the nAcb is
topographically organized and ACh could participate in the
refinement of this organization by turning on and off specific
inputs in the nAcb.
Dismption of some of the glutamatergic inputs to the nAcb
during early postnatal development (P7) bas been found to
produce enduring behavioral changes (Al Amin et al. 2001;
Flores et al. 1996a,b; Lipska et ai. 1993; Sams-Dodd et al.
1997; Weinberger and Lipska 1995; Wood et al. 1997; see also
Lipska et al. 1998) as well as changes in dopaminergic recep
tors (Baca et ai. 1998; Flores et al. l996a,b) and dopamine
release (Lilkank et al. 1999) in the nAcb. Typically, these
changes are expressed only after puberty, and, interestingly,
the same lesions at P14 or in aduit animais produced no
comparable changes (Wood et ai. 1997), suggesting that there
is a critical penod during which developmental plasticity can
be expressed in the nAcb.
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ABSTRACT
We studied the effects of dopamine (DA) on glutamatergic excitatory
postsynaptic currents (EPSCs) of medium spiny (MS) neurons in nucleus accumbens
(nAcb) during postnatal development using whole-cell patch-clamp technique in vitro.
The EPSCs evoked in MS neurons by local nAcb stimuli displayed both early and late
ionotropic glutamate receptor-mediated components that could be respectively abolished
with specific AMPA/KA and NMDA receptors antagonists. The addition of DA to the
supefusing medium produced a marked decrease of the evoked EPSCs. The AMPA!KA
receptor-mediated response was on average abolished by 40% whereas the NMDA
receptor-mediated component of the response was decreased by 91%, an effect
comparable to the effect produced by specific NMDA receptor antagonist. The effects of
DA on evoked EPSCs were mimicked by the D1-like receptor agonist, SKF 38393 and
were antagonized by the D1-like receptor antagonist SCH 23390 but flot by the D2-like
receptor antagonist sulpiride or by clozapine. DA did flot change either the membrane
input conductance nor the characteristics of PSCs evoked by the local administration of
glutamate in the presence of tetrodotoxin. In contrast, DA altered the paired-pulse ratio
of evoked EPSCs at a holding membrane potential of -lOOmV but flot at -4OmV. The
action of DA was resistant to protein kinase inhibitors H89 and Ro-32-0432, suggesting
that DA-induced EPSCs depression did not involve protein kinase A nor C. These resuits
suggest that the inhibitory effects of DA on EPSCs are mediated by both pre and
postsynaptic mechanisms in the nAcb. The present resuits show that the activation D1-
like dopaminergic receptors modulates glutamatergic neurotransmission by preferentially
115
abolishing NMDA receptor-mediated EPSCs by acting independently of PKA and PKC
through both pre- and postsynaptic mechanisms.
Key Words: Nucleus accumbens; excitatory postsynaptic currents; DA
modulation; NMDA and AMPA receptors; postnatal developrnent.
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RÉSUMÉ
Les effets de la dopamine (DA) sur la transmission glutamatergique dans les
neurones épineux moyens GABAergiques du noyau accumbens (nAcb) ont été examinés
dans des tranches de rat en utilisant la technique whoÏe-cell patch-clamp pendant le
développement postnatal. Les CPSEs évoqués par une stimulation locale dans le nAcb
comprenaient généralement deux composantes: une précoce médiée par des récepteurs
AMPA!KA et une tardive médiée par des récepteurs NMDA. L’ajout de DA a produit
une inhibition beaucoup plus importante de la réponse médiée par les récepteurs NMDA
(-92%) que de celle médiée par les récepteurs AMPA!KA (-40%). Les effets de la DA
sur les réponses NMDA étaient comparables à ceux produits par l’APV, un antagoniste
spécifique des récepteurs NMDA. Les effets de la DA sur les CPSEs pouvaient être
reproduits par un agoniste (SKF 38393 ) des récepteurs Dl-semblables et bloqué par un
antagoniste (SCH 23390) des mêmes récepteurs alors que les substances agissant sur des
récepteurs D2-semblables ne produisaient aucun effet. La DA a changé le rapport des
réponses à des stimuli pairés, mais n’avait aucun effet sur les propriétés membranaires
des neurones étudiés ou sur les réponses évoquées par l’injection de glutamate en
présence de tétrodotoxine. Ces résultats suggèrent que les effets de la DA étaient
principalement médiés par des mécanismes présynaptiques pendant le développement
postnatal. La dépression des CPSEs induite par la DA ne semble pas impliquer la
protéine kinase A ni la protéine kinase C car elle était résistante aux inhibiteurs de
protéines kinases H89 et Ro-32-0432. Ces résultats démontrent que l’activation des
récepteurs dopaminergiques Dl-semblables dans le nAcb diminue la libération de
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glutamate et suppriment de préférence les CPSEs médiés par les récepteurs NMDA
pendant une étape cruciale du développement postnatal.
Mots-Clés noyau accumbens, courants postsynaptiques excitateurs, modulation DA,
récepteur NMDA, développement postnatal
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INTRODUCTION
Nucleus accumbens (nAcb) which forms the ventral part of the striatum has been
proposed to serve as an interface between the limbic system and the motor system
(Mogenson et al., 19$0; Groenewegen et al., 1996). While the nAcb receives a dense
glutarnatergic innervation from the prelimbic cortex and different limbic structures,
including the hippocampus and amygdala (for review, see Zahm and Brog, 1992; Finch,
1996; Groenewegen et al., 1996; Heimer et al.. 1997), it also receives a massive
doparnine (DA) input from ventral tegmental area (VTA) of midbrain. An important
feature of these glutamatergic and dopaminergic afferents to the nAcb is that they
converge on the same dendritic spines of medium spiny (MS) GABAergic projecting
neurons (Bouyer et al., 1984; Totterdell and Smith, 1989; Seaack and pickie, 1990;
Johnson et aI., 1994; Meredith, 1999). This closed spatial relationship suggests a
possible interaction between the glutamatergic and dopaminergic systems at the pre
and/or postsynaptic levels. Behavioral studies have shown that interactions between DA
and glutamatergic synaptic transmission, particularly those rnediated by NMDA
receptors, play a key role in animal behaviors associated with the nAcb (see
Vanderschuren and Kalivas, 2000; Baldo et al., 2002). Recent finding of D1/NMDA
receptor complexes in striatal and hippocampal tissue indicates possible direct protein
protein interactions between D1 and NMDA receptors (Lee et al., 2002).
In the nAcb, expression of the NMDA receptor-dependent form of long-term
potentiation has been demonstrated (Pennartz et al., 1993; Kombian and Malenka, 1994;
Schramm et al., 2002) and plasticity withïn nAcb is thought to mediate instrumental
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leaming processes and many aspects of drug addiction in which coincident activation of
NMDA and dopamine D1 receptors is required (Kelley et al., 1997; Smith-Roe and
Kelley, 2000; Baldwin et al., 2000; Hemandez et al., 2002). The nAcb may thus
constitute a locus where NMDA receptors promote drug reinforcement (Maldve et al.,
2002). In addition to aspects of instrumental learning and drug addiction, the nAcb
appears to be involved in a number of functions such as motivation, attention and reward
(Mogenson et al., 1980; Kalivas and Nakmura, 1999) under the control of the mesolimbic
dopaminergic system (Willner et al., 1991).
Despite the well-known role of nAcb DA in the modulation of motivated
behaviors, and despite recent advances in the understanding of cellular and molecular
aspects of dopaminergic and glutamatergic receptor interaction (Lee et aÏ., 2002), the
precise mechanisms underlying DA and NMDA receptors interaction to be reflected on
EPSCs in the nAcb rernain unclear. Some studies reported that the activation of D1
receptors enhanced NMDA receptor-mediated EPSCs (NMDAR-EPSCs) in dorsal striatal
suces (Cepeda et al., 1993; Cepeda and Levine, 1998; Levine et al., 1996a, b), while
others reported that D1 receptor agonists attenuated NMDAR-EPSCs in MS striatal
neurons in culture (Lee et cl., 2002; Lin et al., 2003). Additionally, certain investigators
reported that DA or D1 receptor agonists potentiate NMDAR-EPSCs in the nAcb suces
(Harvey and Lacey, 1997; Chergui and Lacey, 1999), while others reported no significant
rnoduÏatory effects of DA on NMDAR-EPSCs (Nicola and Malenka, 199$; Beurrier and
Malenka, 2002). Although electrophysiological studies in brain suces have shown that
activation of D1 receptors inhibit glutamatergic synaptic transmission in the nAcb by a
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presynaptic action (Higashi et al., 1989; Pennartz et al., 1992; Harvey and Lacey, 1996;
Nicola et al., 1996; Nicola and Matenka, 1997, 1998; Beurrier and Malenka, 2002), the
inhibitory effect of DA on EPSCs by presynaptic locus via the D1 receptor was only
determined on the compound current levels, in particular, on AMPAJKA receptor
mediated EPSCs (AMPAJKAR-EPSCs) in the nAcb. A substantive effect of DA on
pharmacologically isolated NMDAR- and AMPA!KAR-EPSCs remains unknown.
In a previous study, we showed that ACh presynapticaLly modulated
AMPA/KAR- and NMDAR-EPSCs in a parallel fashion in the nAcb (Zhang and Warren,
2002). In an effort to clarify how the NMDAR- and AMPA!KAR-EPSCs rnight be
affected in the nAcb by dopaminergic innervation, we investigated the effect of DA on
NMDAR and AMPA!KAR-excitatory synaptic transmission in this region. Our resuits
demonstrate that DA depresses the excitatory input onto MS neurons probably by
activation of pre- and postsynaptic D1-like receptors. While DA depressed the elicited
AMPA!KAR-EPSCs in MS neurons by 40% of control, evoked NMDAR-EPSCs were
almost cornpletely abolished.
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MATERIALS AND METHODS
Suce preparation The procedure used for preparing suces has been previously described
(Belleau and Warren, 2000; Zhang and Wanen, 2002). One to 20-day-oid (P1-P20)
Sprague Dawley rat pups of either sex were used in the present experiments. P5 and
younger pups were anaesthetized by hypothermia whereas P6 and older animais were
anesthetized by inhalation of methoxyfluran vapor in a closed environment. Once deeply
anesthetized, animais were decapitated and their brains were quickiy removed and
transferred to chilled, oxygenated artificiai cerebrospinal fluid (ACSF) in which NaCY
had been replaced by equivaient osmoiarity of sucrose and containing (in mM) sucrose
252 (NaC1 126 in standard ACSF); KC1, 3; NaH2PO4, 1.25; MgSO4 7 H20, 1.3; CaC12,
2.5; NaHCO3, 26; and glucose, 10, and saturated with a gas mixture of 95% 02 and 5%
CO2. four hundred jim thick suces comprising the nAcb were cut in the parasagittai
plane using a vibrating microtome (Campden Instruments). Suces were transferred to a
submerged type of recording chamber ami continuousiy superfused with standard ACSF
at room temperature (20-22°C) at a rate of 1 .Smi/min. The nAcb was visualized under a
stereomicroscope (Leica Inc.) using the anterior commissure, the neostriatum, the septum
and the ventricles as iandmarks based on Paxinos and Watson (1986). The suces were
incubated at ieast one hour before recording.
Recording Whoie-cell recording was achieved using the ‘biind’ patch-clamp technique
(Bianton et ai., 1989). Pipettes were puiied from thin waii borosiiicate capillary giass on
a P-$7 micropipette pulier (Sutter Instrument). The pipettes had a resistance of 3-5MQ
when fiuied with a solution containing (in mM) potassium gluconate, 140; MgCI2, 2;
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CaC12, 0.1; EGTA, 1.1; HEPES, 10; K2-adenosine trisphosphate (ATP), 2; guanosine
trisphosphate (GTP), 0.5 and 0.3% neurobiotin. The pH was adjusted to 7.3 with KOR
solution, and final osmolarity was 290-300 rnosmol/kg. QX314 (5mM; Alomone
Laboratories) was routinely added to the recording pipette solution to prevent voltage-
sensitive Na channels from generating action potentials.
Whole-cell recordings were made with an Axoclamp 2B amplifier (Axon
Instruments) in continuous single-electrode voltage-clamp mode. The output of the
amplifier was fed into a LPf 200A DC amplifier/filter (Warner Instruments Corp.) and
digitized at 0.5 to 10 kHz with a real-time acquisition system Digidata 1200 (Axon
Instruments). Data acquisition was achieved using the pClamp 6.0 software (Axon
Instruments). Pipettes capacitance was optimally adjusted before whole-cell
configuration was achieved. The resting membrane potential was measured just after
rupturing the cell membrane and the offset potential, measured upon withdrawal of the
electrode from the celi, was accounted for assuming that it drifted in a linear fashion with
time from the start of the recording session. We did flot correct for liquid junction
potential, which for a pipette containing 140 mM potassium gluconate amounts for an
additional potential shifi ofaround —lOmV (Spigelman et al., 1992).
Synaptic stirntdatioît and drugs application Excitatory postsynaptic currents (EPSCs)
were evoked by 0.lms, 3 to 6V cathodal pulses deÏivered at 15 sec intervals to the
cortical tissue towards the rostral pole of the nAcb, using a monopolar tungsten
stimulating microelectrode placed on the slice superficial layer, 0.5-1.0 mm from the
recording electrode. In some experiments, the paired-pulse stimulation with the same
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parameters and separated by 50 msec were used to distinguish between pre- and
postsynaptic mechanisms. In order to isolate glutamate receptor-mediated EPSCs, ail
experiments were performed in the presence of (-) bicuculline methiodide (BMI, 10 iM)
in bath solution to block GABAA receptor-mediated synaptic currents. BMI was applied
30 min before obtaining whole-cell configuration to insure a complete diffusion in the
slice tissue. In ail experiments the EPSCs were recorded from online voltage-clamped
potentials between -100 to +4OmV in 2OmV increment from a holding membrane
potential of -7OmV. Local application of glutamate (10 mM) onto nAcb was conducted
using a patch pipette connected to a Picospritzer (General Valve Corporation) under
differential interference contrast and infrared optics using pressure pulses of 1 5psi lasting
5-10 msec.
The following pharmacological agents were applied through the superfiising
AC Sf: 6 cyano-7-nitroquinoxaline-2,3-dione (CNQX); (+)-2-amino-5-
phosphonopentanoic acid (APV) and (-) bicuculline methiodide all obtained from Tocris
(Bristol, UK); dopamine HC1, S-(-)-5 -amino-sulfonyl-N- [(1 -ethyl-2-pyrrolidinyl)-
methyl] -2-methoxybenzamide (sulpiride), (4aR-trans)-4,4a,5 ,6, 7,8,$a,9-octahydro-5-
propyl- 1 H-pyrazolo [3,4-g] quinoline [(-)-quinpirole hydrochloride]; (±)- 1 -phenyl-2,3 ,4,5-
tetrahydro-( 1 H)-3 -benzazepine-7,8-diol (SKF-3 $393); R(+)-7-chloro-8-hydroxy-3-
methyl- 1 -phenyl-2,3 ,4,5 -tetrahydro- 1h-3 -benzazepine hydrochloride [(+)-SCH-23 390];
9-(tetrahydro-2furyl) adenine (SQ 22536) which have been obtained from RBI (Natick,
MA); clozapine from Sigma; Ro-32-0432; H89 and forskolin from Calbiochem (La Joua,
CA). Most drugs were made up as 10 mM stock solutions in distilied water (dopamine
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on the day of use) and diluted with AC$f solution to final concentration just before
addition to the perfusion medium. The same procedure was used for CNQX except that it
was initially dissolved in dimethysulfoxide (DMSO, final concentration 0.1%).
Antagonists were applied for at least 15 min before application of agonists. In the cases,
of H89 and Ro-32-0432, slices were incubated for 2-4 hours with the antagonists prior to
experimentation to allow enough time for the drug to equilibrate within the suce tissue.
Current measurernents Data analysis was done using Signal 2.1 software (Cambridge
Electronic Design). The amplitude of the evoked synaptic current was plotted as a
function of voltage at two points: one at the peak of inward current recorded at -lOOmV,
and another later one at a point when the fast inward current at —100 mV had just decay
to base line. This point was usually close to the maximal amplitude of the late component
as recorded in the presence of the AMPAJKA receptor antagonist CNQX and no
postsynaptic current was observed at this point at holding membrane potential -100 mV
under these conditions (Mayer et al., 1984; Mayer and Westbrook, 1987).
Statistics Statistical analysis was performed using Sigmastat 2.0 software (SPSS) and the
effects of dopaminergic compounds on evoked EPSCs were tested using paired t-test
unless otherwise stated (P values of less than 0.05 were considered as statistically
significant). All numerical data are expressed as mean ± standard error of the mean
(S.E.M). Neurons that could flot be unambiguously classified as MS cells using
physiological and morphological parameters were excluded from statistical analysis.
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RESULTS
Whole-cell voltage-clamp recording was obtained from 154 physioiogicaliy
identified M$ neurons (ODonneli and Grace, 1993; Beileau and Warren, 2000; Zhang
and Warren, 2002) in suces from rat pups between Pi and P20. The membrane and firing
characteristics of MS neurons were similar to those previously reported for animais of
comparable age (Belleau and Warren, 2000). In addition, 58 neurons fihled with
neurobiotin were examined under light microscopy and displayed features that have been
previously attributed to MS neurons from animais of similar age (Tepper et al., 1998).
Ail labelled neurons appeared to be located in the core region ofthe nAcb.
Characteristics ofgtutamatergic EPSCs
As previously described (Zhang and Warren, 2002), local electrical stimulation in
the presence of the GABAA receptor antagonist BMI evoked an EPSC in ail recorded
neurons. Typically, the EP$C consisted of a compound glutamatergic EPSC comprising
an early and a late component mediated respectively by the activation of AMPA!KA and
NMDA receptors.
Figure 1 shows a representative example of an EPSC recorded in a preparation
from a P20 animai on which specific glutamatergic antagonists were tested. During the
control period (Fig. lA panel 1), the early EPSC peaked 9 msec after the stimulus onset
at a holding membrane potential of—i00 mV and the response decayed to baseline within
45 msec. The current-voltage relationship (IRVm) of the early EPSC was close to linear
and reversed at a membrane potential around OmV (Fig. I B panel 1). Bath application of
the AMPA/KA receptor àntagonist CNQX completely abolished the early component of
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the EPSC and there was virtually no residual postsynaptic current at ail membrane
potentials at the latency in which the early response was measured (Fig. lA panel 2 and
Fig. lB panel 1).
The late component, measured afier the eariy component had decayed, increased
at membrane potentials between —100 and —40 mV and reached its maximum usually at —
40 mV or —20 mV. At more depolarized membrane potentials, it decreased and reversed
polarity around O mV (Fig. lA and Fig. lB panel 2), a current-voitage relationship typicai
of NMDA receptor-rnediated current. The addition of the NMDA receptor antagonist
APV to the superfusing medium completely abolished the late EPSCs (Fig. 1 panel 3),
demonstrating that it was mediated by NMDA-type receptors. In the presence of CNQX
alone, the NMDAR-EPSC was recorded in isolation showing that measurements of the
late component of the EPSC made on the compound EPSC were close to the peak of the
NMDAR-EPSC and represented mostly NMDA receptor-mediated current (Fig. lA panel
2). Also, note there was no residual postsynaptic current in the presence of CNQX and
APV, showing that glutamatergic EPSCs were effectively isolated by the addition ofBMI
to the superfusing medium (Fig lA panel 4 and Fig. 13). CNQX and APV were tested
together in 4 other neurons producing similar resuits. In addition, CNQX and APV were
tested individually in 17 and 14 neurons respectively producing an inhibition of the early
and late components ofthe response by 91± 2% and 85 ± 5%.
[Figure 1]
In most neurons, the effects of dopaminergic agonists and antagonists
were assessed at holding membrane potentials usually between -100 and +4OmV in steps
100mV
-4OmV
Figure 1. Pharmacologically isolated excitatory postsynaptic currents (EPSCs). A. Two distinct
components of the EPSCs were evoked by local electrical stimulation in the presence of 10 tM of
the GABAergic antagonist BMI in MS neurons depending on the holding membrane potentials.
Before an application of glutamatergic receptor antagonists (1); during the presence of CNQX (20
tM) (2); during the application ofAPV (50 jiM) (3) during the presence of CNQX and APV (4).
Recordings were obtained in a P20 animal. Current traces represent the average of 6 sweeps. B.
The 1Rm reÏationship of the response between —100 and +40 mV. The early component was
measured 9ms afier the stimulus as indicated by the lefi dotted line in A. The late component was
measured 50 ms after stimulus as indicated by right dotted line in A.
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of 2OmV. The AMPA/KAR-EPSC was measured at the peak of the early component of
the EPSC at a holding membrane potential of —100 mV, when the amplitude of the late
component was minimal (lefi vertical dotted unes in Fig. lA) whereas the effects on
NMDA receptor-mediated currents were measured at a latency at which the early
component recorded at a holding membrane potential of —100 mV had decayed (right
vertical dotted unes in Fig. lA).
Effects of dopaminergic agonists
Exposure of suces to 50 tM of dopamine for s-10 min resulted in a perceptible
decrease in the amplitude of both CNQX- and APV-sensitive current components of
evoked EPSCs. This decrease in EPSC amplitude significantly occurred in holding
membrane potentials between —lOOmV and —2OmV and was completely reversible and
repeatable once dopamine was washout and reapplied. A representative example of this
effect is shown in Figure 2A. In this case, the early and late components of the EPSCs
recorded at —lOOmV and —2OmV, respectively, were reversibly reduced by 41% and 72%
during the application of DA. Similar results were obtained in 78 other fleurons, and DA
produced no effects on the EPSC injust one case. The effects of DA on the early and late
components of the EPSC as a function of holding membrane potential are summarized in
Figure 213. The amplitude of the early component of the EPSC was significantly reduced
at holding membrane potentials between —lOOmV and —2OmV by an average of 5 1-45%
as weÏl as at positive membrane potentials. DA also produced a reduction of the late
component of the EPSC, which were generally of larger magnitude than that observed on
the early component, averaging 66-57% between —4OmV and O mV. [Figure 2J
2. Dopamine
—•— Control
—o— Dopamine
4. 1+2
Figure 2. Effect of dopaminergic agonist on the EPSCs. A. Current traces of the response
evoked by single electrical stimulus recorded at holding membrane potentials of — OOmV and -
2OmV. Before (1), during (2), and afier (3) superfusion with dopamine (DA 50 iM). The
overlay (4) shows the responses before and during DA application. Current traces represent the
average of 6 sweeps. Recordings were obtained in a suce from a P7 animal. The arrows in (1)
indicate where the early and late responses were measured. B. Average IR-Vfl relationship of
the early (n=z 80; 1) and late (n=80; 2) recorded before and during superfusion with DA.
Asterisks indicate a statistically significant difference between control and agonist treatment at
this holding membrane potential (Student’s t-test, *p<o.os).
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Doparnine reduced tite ratio ofNMDAR-EP$Cs to AMPA/KAR-EPSCs
In the study on compound EPSCs, we found that both early and late components
ofEPSCs were significantly inhibited by 50 tM ofDA. To investigate the efficacy of
DA on AMPA/KAR-EP$Cs and NMDAR-EPSCs, we also examined the ratio ofthe late
component to the early component ofthe EPSCs.
In 67 fleurons, we found that application of 50 iM DA significantly reduced the
late to early component ofEPSC ratio by an average of 50% from 28 ± 2% during control
to 14 ± 3% with DA (paired t-test, P< 0.01, n = 67, Fig. 3B). This effect was present
throughout the developmental period studied (Fig. 3). Our data demonstrates that DA
decreased the late to early component of EP$Cs ratio in all of ages and that DA more
effectively reduces NMDAR-EPSCs than AMPA/KAR-EP$Cs rather than decreasing
them both equally.
jFigure 31
To further test the inhibitory effect of DA on NMDAR-EPSCs, we compared its
inhibitory effect with a specific NMDA receptor antagonist, APV on the late component
ofthe EPSCs in 4 cells. We found that DA was as potent as APV in reducing the late
component ofthe EPSCs (144 ± 54 pA in control, 26 ± 13 pA in DA, average inhibition
82%: 117 ± 43 pA in control and 15 ± $ pA in APV, average inhibition 87% (Fig. 4C).
Figure 4A show a representative example of the effects produced by DA and APV in the
same late component of the EPSCs.
[Figure 41
Figure 3.
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Figure 3. DA (50 iM) decreased ratio of late to early component of the EPSCs. A.
Representative traces taken from holding membrane potentials of —1 OOmV and -4OmV
in a MS neuron from a P15 animal suce in the presence or absence of DA (50 jiM)
respectively. B. Averaged late to early component ratio from 67 neurons during
control and DA application (Student’s t-test; F<0.01, n =67). C. Late to early
component ratio as a function of postnatal age (Student’s t-test; n = 65; ** p< or =
0.01; * p< or = 0.05). The number of celi at each age is indicated in the brackets. DA
is specifically preferential to attenuate NMDAR-EPSCs. Dotted lines in A indicate the
sites where EPSCs were measured.
B
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Figure 4. The inhibitory effects of DA and APV on late component of compound EPSCs.
A. Inhibito;y efficacy of DA (50 p.M) and APV (50 1iM) is shown in a representative
neuron in which evoked EPSC was mainÏy mediated by NMDA receptors. Before (1),
during (2), and after (3) DA perfusion, 4 during APV; overlay (1+2, 5) and overlay (3+4,
6). B. The IR-Vfl relationship for the representative neuron. Dotted unes in A indicate
sites where current amplitudes were measured and displayed in B. C. % inhibitions
produced by DA and APV on late EPSCs were compared in 4 neurons at a holding
membrane potential of —40 mV between the effect of DA and APV (Student’s t-test, P
>0.05, n= 4).
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DA inltibited both isotatedNliDAR-EPSCs andAMPA/K4R-EPSCs
Because it was reported that DA exerted opposite rather than a parallel
modulatory effects on AMPA/KAR-EPSCs and NMDAR-EPSCs i.e. DA potentiated
NMDAR-EPSCs and depressed AMPAIKAR-EPSCs in the nAcb (Harvey and Lacey,
1997; Chergui. and Lacey, 1999) whereas others reported that DA produced no effect on
NMDAR-EPSCs (Nicola and Malenka, 1998; Beurrier and Malenka, 2002). We tested
the effect of DA on pharmacologically isolated AMPA!KAR-EPSCs and NMDAR
EPSCs using CNQX (20 iM) and APV (50 tM) in the presence of the GABAA receptor
antagonist BMI (10 tM). The studies on isolated EPSCs further confirmed that DA (50
iM) had a profound inhibitory effect on NMDAR-EPSCs. In the presence of AMPAJKA
receptor antagonist, CNQX, DA potently inhibited NMDAR-EPSCs in ail 5 isolated
neurons. In control recordings, the NMDAR-EPSCs amplitude averaged —77 ± $ pA.
During bath application of 50 iM DA for $ mm, the amplitude of the NMDAR-EPSCs
was significantly reduced to 7 ± 5 pA (the peak amplitude of NMDAR-EPSC was
decreased by 91%, paired t-test. F< 0.01, n = 5, fig. 5C). figure SA shows a
representative ccli in which the isolated NMDAR-EPSC was strikingly inhibited.
jFigure 5]
DA (50 tM) atso significantly reduced the amplitude of stimulus-evoked
AMPAIKAR-EPSCs, but only by 40% of control. In control recordings (holding
membrane potential —1 OOmV), the EPSC amplitude averaged -241± 45 pA. During bath
application of 50 jiM DA for 8 mi the amplitude ofAMPA/KAR-EPSCs was
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Figure 5. DA inhibited both NMDAR-EPSCs and AMPA!KAR-EP$Cs. A. DA (50 1iM)
potently inhibited NMDAR-EPSCs in the presence of CNQX. Original traces evoked by
electrical stimulus were taken from holding membrane potentiai —20 mV and represent the
average of 6 sweeps. BMI (10 jiM) and CNQX (20 j.iM) were present in the superfusing
medium throughout recording. Before (1), during (2), and afler (3) DA. 4 is an overÏay of 1
and 2. B. DA (50 tM) also significantiy inhibited AMPA/KAR-EPSCs isoiated with APV (50
1iM) and BMI (10 1iM). Before (1), during (2) after (3) DA (50 tM), and 4 is an overlay from 1
and 2. C. The IR-VIl reiationship at membrane potential from —1 OOrnV to 4OrnV was measured
in the absence and presence of DA on isolated NMDA currents. DA (50 iM) used in bath for
10 min attenuated most ofNMDAR-EPSCs at ail holding membrane potentiais (Student’s t-test,
n = 5, ** F<0.01). The dotted unes in panels A and B label the sites for the measurement of ‘R
Vm relationship. D. Tirne course of DA inhibition of AMPA/KAR-EPSCs from panel B. E.
Sumrnary of the effect of DA (50 tM) on AMPA!KAR-EPSCs at holding membrane potential
—100 mV (Student’s t-test, n = 7, ** indicatesp< 0.0 1).
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significantly reduced to -144 + 25pA (fig. 5E, paired t-test, P<0.05; n = 7). figure 5B
shows a typical example of the inhibitory effect of DA on AMPA!KAR-EPSCs at a
holding membrane potential of —1 OOmV traces and figure 5D shows time course of the
effect.
Inhibition ofDA on EPSCs is inediated by a Dj-!ike receptor
To identify the DA receptor subtype responsible for the inhibition ofEPSCs, we
examined the effects of D1- and D2-like receptor agonists and antagonist on stimulus
evoked EP$Cs. Like DA, SKf 38393 (10 tM), an agonist of D1-like DA receptors,
decreased the early EPSC peak amplitude by 43% of control at holding membrane
potential —lOOmV (-304 ± 131 pA in control and —173 ± 76 pA, in SKf 38393, n = 5)
and the late EP$C amplitude by 53% at holding membrane potential —4OmV (-5 1± 23 pA
in control and 24 +15 pA in SKf 38393, see table I). Figure 6A shows a representative
example of the inhibitory effect of SKf 38393 on the early and late components of the
EPSCs. In contrast, the D2-like receptor agonist quinpirole failed to suppress EPSCs in
the same concentration (n=4; data flot shown). Concomitantly, the D2-like receptor
antagonist sulpiride (10 1iM) failed to prevent the 40% depression-induced by DA (n =
4), which is not different from the observed decline in the absence ofthe antagonist (-224
± 22 pA in control, and —112 + 14 pA in DA at —100 mV, n = 4). In addition, clozapine
(10 1aM), an antagonist of D2-like dopamine receptors and certain 5-HT receptors, failed
to block the inhibitory effect of DA (Student’s t-test, P> 0.05, n = 9, see table I), further
excluding the possibility that D2-like receptor may be involved. However, the D1-like
receptor antagonist SCH 23390 (10 jiM) antagonized the depressant action of DA (50
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tM) to 87% ofcontrol (-205 ± 44 pA in control and —179 ± 33 pA in DA in the presence
ofSCH 23390) at holding membrane potential —100 mV, and to 91% of control (-65 ± 15
pA in control and —59 + 15 pA in DA) at —20 mV (Student’s t-test, P> 0.05, n = 9),
respectively. Figure 6C shows a representative ceil in which D1 receptor antagonist $CH
23390 (10 tM) blocked the inhibitory effect of DA on compound EPSCs, whereas DA
alone suppressed much of the EPSC. Figure 6D summarizes the effect of DA in the
presence or absence of D1 receptor antagonist SCH 23390 at holding membrane potential
—100 mV and —20 mV in 9 neurons We also found that low concentrations of $CH
23390 (1 or 5 iM) only decreased partially the inhibitory effect ofDA (n = 20, data flot
shown).
[Figure 61
We attempted to characterize the signal transduction pathways mediating the
effects ofDA (Snyder et al., 199$). H89 (20 tM), a ceil-permeable, selective and potent
inhibitor of protein kinase A (PKA) in both pipette and bath failed to block the inhibitory
effect ofDA on both early and late components ofthe EPSCs in the presence ofH$9 (n
7, see table I). Ro-32-0432 (10 iiM), a selective celi-permeable inhibitor of protein
kinase C (PKC) could not abolish the inhibitory effect ofDA (n = 3, see table I). We also
examined the role of the cAMP pathway by activating adenylate cyclase tAC) with
forskolin. Forskolin (10 1iM) increased AMPA!KÀR-EPSCs and NMDAR-EPSCs, and
also appeared to partialÏy antagonize the inhibitory effect of DA (n 5, see table I), but,
Q$22536 (100 tM), an antagonist ofAC, had no effect on the inhibitory effect ofDA (n
= 3, see table I). We also tested the effect of DPCPX (500 nM), an A1 receptor
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Figure 6. The inhibitory effect of DA on the EPSCs was mediated by D1-like receptor. A.
Representative celi in which D1-like receptor agonist SKf 38393 (10 jiM) mirnicked the inhibitoiy
effect of DA on both the early (-lOOmV) and late (-4OmV) components of the EPSCs. Before (1),
during (2), afier (3) $Kf 38393. 4 is an overlay of 1 and 2. B. The effect of DA was blocked by D1-
like receptor antagonist. In the presence ofD1-like receptor antagonist, SCH23390 (10 jiM, 1); adding
DA (50 iM for 10 min in the presence of SCH23390, 2); reapplying DA after washout of SCH23390
and DA, 3); 4 is an overlay of 1+2 where the inhibitory effect of DA was blocked by SCH23 390. C.
Summary ofthe inhibitoiy effect ofDA in the presence or absence ofSCH2339O at holding membrane
potential —100 and —4OmV for 9 ceÏls. The dotted unes in A and B indicates the sites where the
amplitudes ofthe EPSCs were measured (Student’ t-test, **< 0.01).
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Table I
The effects of DA on EPSCs in the presence of different antagonists and forskolin
Early EP$Cs (pA) Late EPSCs (pA)
(-1 OOmV) (-2OmV)
Antagonists n Control DA(5OtM) Control DA(5O.iM)
SuÏpfride lOjiM 4 -150 ± 26 -92 ± 30 -59 ± 6 -37 ± 6
Clozapine lOjiM 9 -228±34 -91±20 -87±24 -21±14
QS22536 100jM 3 -165±8 -14±7 -50±9 -8±0
H89 20.iM 7 -331±124 -152±67 -141±58 -39±25
Ro320432 1OiM 3 -158±29 -92±20 -51±20 -13±4
Forskolin 1OiM 4 -266±38 22O±12* -153±21 1O2±12*
* indicates P>0.05 (student’ t-test)
Ii
antagonist (see Harvey and Lacey, 1997) in a few celis and no significant effect was
found (data flot shown).
Pre andpostsynaptic rnechanisms are in volved in tite attenuation ofEPSCs by DA
The mechanism underlying DA inhibitory effect on EPSCs may involve a
decrease in glutamate release (presynaptic) and/or change in membrane conductance
(postsynaptic). To identify the site of action of DA, we compared different
characteristics ofthe EPSCs before and during DA administration.
An alteration in the paired-pulse ratio (PPR) is thought to imply presynaptic
mechanisrn of action (Zucker, 1989; Regehr and Stevens, 2001). To determine if the
locus of dopamine-dependent inhibition of the EPSC amplitude in MS neurons is pre- or
postsynaptic, we examined the effects of DA on the paired-pulse stimulation-evoked
EPSCs (stimuli with 50 ms interpulse interval) comparing the change of PPR i.e. the 2nd
response to the 1st response (EPSC2/EPSC1) at a holding membrane potential —lOOmV.
We found that in the presence of DA both the first and second evoked EPSCs were
decreased but a relatively greater reduction in the amplitude of the first EPSC was
observed resulting in an increase in the PPR (in control recordings, PPR was 1.3 ± 0.05;
during bath application ofDA, it was 1.6 ± 0.14, paired t-test, P< 0.05, n = 12, Fig. 7A
and A’). However, the PPR of the late component recorded at a holding membrane
potential of—4OmV was not altered during application ofDA. The PPR was 2.2 ± 0.14 in
control recordings condition, while during bath application of DA, PPR was 2.3 ± 0.14
(Fig. 73 and B’, paired t-test, P> 0.05, n = 12). EPSCs induced at a holding membrane
potential of —4OmV are largely mediated by NMDA receptors. The fact that the PPR of
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the laie response does flot change suggests that the inhibition of NMDAR-EPSCs by DA
is mainly mediated by postsynaptic mechanisms. This implies that the major locus of
inhibition by DA may be different for AMPA/KAR and NMDAR-EPSCs.
Change in membrane current conductance is considered to be one of criteria for a
postsynaptic effect. We measured the membrane conductance before and during the
application ofDA (50 iM) at eight holding membrane potentials in 50 neurons and found
no statistically significant change in membrane conductance during the application of DA
at any membrane potential tested (fig. 7C, in control recordings, membrane conductance
was 33 ± 4 pA, during bath application of DA, membrane conductance was 34 ± 4 pA at
holding membrane potential —1 OOmV; in holding membrane potential —4OmV, control
membrane conductance was 16 + 2 pA, while bath application of DA, membrane
conductance was 23 + 4 pA. paired t-test, P> 0.05, n = 50). This suggests that no
intrinsic property of the membrane altered during the application of DA.
Change in the time course of synaptic response may be an indicator for detecting
a presynaptic or postsynaptic effect. We rneasured the tirne course of synaptic responses
for AMPA!KAR-EPSCs in 9 cells before and during application of DA. The results
indicate that DA did not produce significant changes in the decay time (t) of the evoked
EPSCs (in controt: 10.94 ± 1.2 ms, in DA 12.64 ± 3.1 ms at holding membrane potential
—100 mV, paired t-test, n = 9, F> 0.05). The decay of the EPSC in the presence of DA
could be perfectly fitted with the controls (data flot shown).
Steady-state current-voltage curves generated by changing membrane potentials
showed that DA did not change the I-V relationship configuration over the voltage range
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tested in early compound EPSCs (from —100 to +40 mV) although EP$Cs were depressed
to some extent (fig. 2, n 80).
Finally, effects of DA (50 jiM) on postsynaptic response evoked by pressure
application of glutamate (10 mM) were studied at a holding membrane potential of —
1 OOmV. DA (50 iM) neither reduce the mean peak amplitude of glutamate-evoked
response nor changed the kinetic curve of the currents, indicating the depression of
EPSCs produced by DA was flot mediated by postsynaptic mechanisms on glutamate
receptor (fig. 7 D and D’. 120 ± 10 pA in control; 121± 10 pA in DA, Student’s t-test,
F>0.05, n 5).
In sumrnary, DA decreased the NMDAR-EPSCs to AMPA/KAR-EPSCs ratio in
all age groups but did flot change the PPR of NMDAR-EPSCs at a holding membrane
potential of —4OmV, suggesting that the inhibition of NMDAR-EPSCs by DA might be
mediated predominantly by postsynaptic mechanisms. DA significantly altered the PPR
of the AMPA/KAR-EPSC at a holding membrane potential of —100 mV. In addition,
there was no change in membrane conductance at any holding membrane potential levels
and no effect of DA was observed on glutamate-induced EPSC at holding membrane
potential of —1 OOrnV, suggesting that the inhibition of DA on AMPA!KAR-EPSC
occurred at presynaptic sites.
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Figure 7. DA inhibited paired-pulse-induced EPSCs and increased PPR at holding membrane
potential of—lOOmV, but flot at —40mV. A. Before (1); during (2) DA (50 1iM). 3 is an overlay of 1
and 2. A’: Summary for 12 celis at holding membrane potential of —lOOmV. B. DA had no
significant effect on PPR at holding membrane potential —40mV. B’: Summary for 12 cells at
—40mV. C: The effect of DA (50 tM) on membrane current conductance measured in 50 cells at
eight holding membrane potentials between —1 OOmV and +4OmV. D. The effect of DA (50 jiM) on
glutamate injection-induced EPSCs in the presence of TTX (1 1.iM) in perfusing medium. D’:
Summary of 5 ceils for D (Student’ t-test, * P< 0.05). Dotted line indicates the sites where the
amplitude ofthe cuirents was measured.
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DISCUSSION
Our resuits support the notion that the EPSC evoked by local stimulus in the nAcb
is composed of both early and late components. 50 1iM of DA strongly inhibited
NMDAR-EPSCs, whereas only slightly but signiflcantly, reduced the amplitude of
AMPA/KAR-EPSCs by acting on D1-like receptors. Previous studies have shown that
depression of EPSCs or EPSPs produced by DA was mediated by AMPAJKA receptor
and our findings are consistent with these resuits (Higashi et al., 1989; Pennartz, et al.,
1992; Harvey and Lacey, 1996, 1997; Nicola and Maïenka, 1997, 1998). Our finding
that DA produced a much stronger inhibition of NMDAR-EPSCs is, to our knowledge,
the first report to demonstrate a preferential depression of NMDAR-EPSCs by DA in the
nAcb. In contrast with previous studies, we did not find that the inhibitory effect of DA
involved PKA or PKC pathways under our experimental conditions.
DA inhibited bot!, NMDAR-EPSCs andAMPA/KAR-EPSCs in the nAcb
Intra-nAcb infusion of amphetamine reduces levels of extracellular glutamate,
suggesting that the dopaminergic system may inhibit glutamate release (Kalivas and
Duffy, 1997). Although no axo-axonal synaptic contacts between dopaminergic
terminals and limbic cortical afferents exist, there is considerable evidence to indicate
that their inputs terminate on the same spines of MS neurons and ofien in close
apposition (Smith and Bolam, 1990; Bouyer et aÏ., 1984; $esack and Pickel, 1990). This
indicates that they interact on a common target-MS neurons to modulate the function of
MS projecting neurons and that dendritic spines of MS neurons is a potential site for
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physiological interactions between DA and glutamate in the nAcb (Antonopoulos et al.,
2002).
DA receptors expression changed during postnatal development in the nÂcb
(Teicher et al., 1991; Lu et al., 1998; Schwartz et al., 1998; Tarazi et al., 1999;
Antonopoulos et al., 2002). The density tevels of D1-like receptor increases from P7 to
P28, then declines by 20-40% afier P35 to remain unchanged until P60. Excessive D1-
like receptors are eliminated during maturation of the nAcb (Tarazi et al, 1999). The
major finding of the present study is that the activation of DA receptors (Di-like)
preferentially inhibited NMDAR-EPSCs in the nAcb in vitro during postnatal
development. Our conclusion is based on several findings: (1) the ratio of NMDAR
EPSCs to AMPA/KAR-EPSCs amplitude was significantly decreased by DA; (2) the
effect of DA on NMDAR-EP$Cs was as pronounced as that of the NMDA receptor
antagonist, APV, and (3) the inhibitory efficacy of DA on isolated NMDAR-EPSC
amplitudes in the presence of CNQX and BMI was over 90% of the control. However,
the present finding contradicts the results obtained by Harvey and Lacey (1997) who
reported that DA, via the activation of D1-like receptor, enhanced NMDAR-EPSCs in the
nAcb slices. Stili, others have not observed this effect (Nicola and Malenka, 1998;
Beurrier and Malenka, 2002). The conclusion for potentiation of NMDAR-EPSCs by
DA (Harvey and Lacey, 1997) was based on the presence of A1 receptor antagonist,
DPCPX, but we could flot replicate these finding. However, the actual effect of DA on
NMDAR-EPSCs was inhibitory in the absence of DPCPX (Harvey and Lacey, 1997).
Chergui and Lacey (1999) again reported that D1 agonist increased NMDA inward
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current in 50% of the celis and this enhancement was blocked by Ro-32-0432, a PKC
inhibitor. This is in contrast with our present resuits. The discrepancy in the effect of
DA on NMDAR-EPSCs in our study and others are perhaps due to the methods used in
different studies or to the fact that our study was concluded during early postnatal
developrnent. Chergui and Lacey (1999) elicited NMDA cunents by inj ecting NMDA
while membrane potentials was heid at —90 mV. However, in our experimental protocol
we found neither NMDAR-EPSCs at comparable holding membrane potential could be
evoked nor the NMDA current was pharmacologically isolated. However, inhibition by
DA of both AMPA!KAR- and NMDAR-EPSCs is compÏetely consistent with the
findings in the subicular nucleus (Behr et al., 2000) and in striatal MS neurons (Lin et al.,
2003). Inhibitory effect of DA on NMDA currents has also been demonstrated in striatal
and hippocampal neurons (Lee et al., 2002).
Botit pre- andpostsynaptic mechanism were involved in inhibition ofEPScs by DA
DA receptors are distributed on both the presynaptic glutamatergic terminais and
postsynaptic membrane of MS neurons in the nAcb (Lu et al., 199$; Schwartz et al.,
1998; Tarazi et al., 199$; Antonopoulos et ai., 2002). Therefore, DA may exert its
inhibitory action on stimulus-evoked EPSCs by either an alteration of the postsynaptic
glutamate receptors or a decrease in presynaptic glutamate release, or a combination of
both pre- and postsynaptic mechanisms.
Our flndings suggest that the synaptic mechanisrns by which DA depresses
NMDAR-EP$Cs and AMPA/KAR-EPSCs are complex and may be somewhat different.
We examined the changes in the PPR during DA application as an indication of pre- or
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postsynaptic mechanisrn. In the paired-pulse paradigm of DA inhibition, if DA acts
presynaptically to reduce the probability of glutamate release from presynaptic terminals,
then the ratio of the second EPSC to the first EPSC (EPSC2/EPSC1) amplitude should be
altered. In contrast, if DA acts postsynaptically, the amplitude of EPSC1 and EPSC2
should be reduced to the same degree, and therefore the ratio would remain unchanged
(Kline et al., 2002). Bath application of DA greatly reduced EPSC, but had less effect on
EP$C2 at a holding membrane potential of —1 OOmV, suggesting that DA promotes a
decrease in presynaptic quantal release, rather than a decrease in postsynaptic glutamate
sensitivity of AMPA!KA receptor. DA significantly altered the paired-pulse depression
ratio, but neither changed membrane conductance nor effected the extrinsic glutamate
induced currents at holding membrane potential of —1 OOmV, suggesting that DA inhibits
AMPA!KAR-mediated current through presynaptic mechanisms. Our resuits are
consistent with those of previous investigators studying DA inhibition on EPSCs in the
nAcb (Nicola and Malenka, 1997, 1998; Harvey and Lacey, 1996, 1997; Pennartz et aï.,
1992; Higashi et al., 1989). In addition, PPR changes attributed to DA application in
relatively hyperpolarized membrane potentials have also been observed in the nucleus of
the solitary tract (Kline et al., 2002), in subicular neurons (Behr et al., 2000), in
supraoptic nucleus (Price and Pittman, 2001) and in parabrachial nucleus (Chen et al.,
1999). Paired-pulse facilitation is due to residual free Ca2 in the presynaptic terminal
left unbuffered from the first pulse and summates with Ca2 influx from the second
stimulus, enhancing the probability of transmitter release with the second pulse.
Therefore, the magnitude of the second response is typically larger (Santschi and Stanton,
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2003). A change in the ratio of these amplitudes by DA, in the absence of changes in
postsynaptic input resistance, is thought to reflect a presynaptic mechanism (Debanne et
al., 1996; Zucker, 1989; Zucker and Regehr, 2002; Kiine et al., 2002). However, in
testing PPR at a holding potential of —4OmV we found that DA neither increased nor
decreased PPR at —4OmV, i.e. the amplitude of EPSC1 and EPSC2 were reduced to the
same degree. No significant PPR alteration at this holding membrane potential suggests
that the inhibition of NMDAR-EPSCs by DA may flot be mediated by a presynaptic
mechanism and could also involve postsynaptic mechanisms.
The larger effect of DA on NMDAR-EPSC may be due to either a specific
postsynaptic inhibitory action of DA on NMDA receptors or may be related to a higher
affinity of glutamate for AMPA!KA receptors than for NMDA receptor. In the latter
case, a low concentration of glutamate would activate more AMPA than NMDA
receptors so that the ratio of NMDAR-EP$Cs to AMPA/KAR-EPSCs can be decreased
only by decreasing glutamate release via presynaptic mechanisms. However, in fact,
NMDA receptors have a much higher affinity for glutamate than do AMPA receptors and
the concentration of glutamate achieved in the synaptic clefi may often be sufficient to
activate NMDA, but not AMPA receptors (Kullmaim and Asztely, 199$; Isaacson, 1999).
We proposed that DA-induced depression of EPSCs is probably due to a decrease in
presynaptic glutamate release and a simultaneous attenuation of the function of
postsynaptic NMDA receptors. This proposal is consistent with recent findings in
cultured striatal and hippocampal fleurons (Lee et al., 2002; Lin et al., 2003). Lee et al.
(2002) found that D1 receptor agonist treatment significantly reduced the number of
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NMDA receptors on the ceil surface. When D1 receptors are activated, NMDAR-EPSCs
are inhibited by direct protein-protein interaction (Lee et al., 2002).
Tite inhibitory effect ofDA on EPSCs did flot ht volve PK4 and PKCpathways
In our study, we observed that activation of AC by forskolin potentiated both
NMDA and AMPA!KA receptor-mediated responses. This finding is consistent with
observations from other investigating in the nAcb (Harvey and Lacey, 1996; Brundege
and Williams, 2001). A study in the striatum also showed that NMDA responses were
potentiated afier stimulation of PKA (Blank et al., 1997; Colwell and Levine, 1995).
However, we found that the inhibitory effect of DA on the EPSCs was flot antagonized
by the AC inhibitor, SQ 22536. In the presence of forskolin (10 jiM), the ability of
dopamine to depress synaptic transmission was flot significantly altered (Harvey and
Lacey, 1996). Although some studies report that PKA and PKC mediate the effect of DA
(by D1 receptor) on NMDA-evoked currents (Chergui and Lacey, 1999; Snyder et al.,
1998), these flndings on involvement of PKA or PKC are always related D1 receptors
enhancement of the currents evoked by NMDA agonists in the nAcb. We did flot observe
the enhancement action of DA on stimulus evoked NMDA currents nor found any
involvement of PKA or PKC signal transduction pathway in the inhibitory effect of DA.
In addition, the lack of change in EPSC decay time constants and no change in membrane
cunent conductance of the postsynaptic cell while membrane potential was clamped
between —100 and 4OmV may indicate the effect of DA on EPSCs is independent of any
effect on intrinsic properties ofthese neurons (Lee et al., 2002). Blocking the PKA signal
transduction pathway by incubating suces in bath for 2-4 hours and in pipette with H89
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(2OjiM) could flot prevent the depression of EPSCs by DA, indicating the inhibitory
effect of DA on EPSCs was flot rnediated via PKA route (Friedman et al., 1997; Deveney
and Waddington, 1995; Wang et al., 1995). Also, Ro-32-0432, a PKC inhibitor failed to
antagonize the inhibitory action of DA, exciuding the possibility that PKC was involved
in DA inhibitory process under our experimental conditions (Friedman et al., 1997; Lee
et al., 2002). Consistent with our observations, D1 and NMDA receptors exhibited an
inhibition of NMDA receptor-mediated currents upon D1 receptor activation by a D1
receptor agonist in whole-cell patch-clamp recordings from hippocampal, striatal
fleurons, and HEK-239 ceils coexpressing D1 and NMDA receptors, has been
demonstrated (Lee et al., 2002; Lin et al., 2003). The effect of D1 receptor agonist could
flot be attributed to either PKC or PKA activation, and was independent of G-protein
mediated D1 receptor signaling (Lee et al., 2002). This result suggests that D1 receptors
modulate NMDAR-EPSCs independent of PKA and/or PKC activation although
numerous studies have demonstrated that NMDA receptor function may be regulated by
G protein-coupled receptors, including D1 receptors, through the activation of PKA/PKC
dependent pathways (reviewed in Greengard, 2001).
Other possibilities could also explain why we found no involvernent of PKA and PKC in
the effects produced by DA. First, PKA and PKC may only be involved in the
enhancement of the response induced by DA. Second, it is possible that some enzyme
systems involved in the PKA and PKC pathways were washout by the whole-cell
recording protocol. Third, in order to prevent voltage-sensitive sodium channels from
generating action potentials, we applied QX314 in the recording pipette solution.
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Blockade of sodium and potassium channels by QX3 14 may partially affect postsynaptic
response. This appeared to be the case in cholinergic modulation of EPSCs (Zhang and
Warren, 2002). fourth, the inhibitory effect of DA on NMDAR-EPSC is possibly
independent of the PKA and/or PKA system. We consider this the most probable
mechanism for the inhibition of DA on NMDAR-EPSCs. More importantly, recent
evidence provided by Lee and colleages (2002) shows that the modulation of NMDA
receptors may be mediated through the regulation of NMDA receptor numbers on the cet!
surface, and that the D1/NR2A coupling may play a role in the regulation of NMDA
receptor expression on the ce!! surface. In addition, several previous findings also show
that amphetamine inhibits the NMDA receptor-mediated responses by directly interacting
with NMDA receptor/channel complex (Yeh et al., 2002) and a direct blockage of
NMDA chaimels by DA (Castro et ai, 1999).
The D1-like receptor agonist SKf 38393, but flot the D2-tike receptor agonist
quinpiro!e, mimicked the action of DA. Consistent with these results, the D2-like
antagonist sulpiride failed to inhibit the depressive effect of DA and the D2-!ike receptor
antagonist!antiosychotic drug clozapine as well. However, the D1-like receptor
antagonist SCH 23390 could block the action ofDA at a concentration of 10 j.iM, but not
of I or 5 iM. This relatively high concentration of SCH 23390 needed to antagonize the
action of DA may be explained by its competitive nature (Weiss et al., 1985). The
concentration of DA used in this study may be re!ated to the in vitro conditions of the
experirnent. The demonstrabie effects, however, were obtained afier 8-10 min of DA
perfusion. In addition, rapid oxidation (Sutor and ten Bruggencate, 1990) as well as
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uptake of DA may reduce the final concentration of DA at its site of action. In agreement
with other studies in the nAcb (Chergui and Lacey, 1999) and studies in the parabrachial
nucleus (Chen et al., 1999), we found that similar concentrations were necessary to elicit
effects ofDA on synaptic responses in in vitro conditions.
Fttnctionat implications
Our previous work on glutarnatergic receptors-mediated EPSCs (Zhang and
Warren, unpublished) and other studies in the distribution of D1 receptors (Tarazi et ai,
1999; Antonopoulos et al., 2002) have found that both NMDAR-EPSCs and D1 receptor
are predorninantly expressed in the nAcb during early postnatal development. The
synchronization ofNMDAR-EPSCs and Dl receptors during postnatal development may
play a pivot role in neural plasticity (Pennartz et al., 1991, 1993; Kombian and Malenka,
1994; Schramm et al., 2002). As appetitive instrumental leaming requires coincident
activation of NMDA and D1 receptors (Smith-Roe and Kelley, 2000) and D1 receptor
activation decreases the ethanol sensitivity of NMDA receptors in the nAcb (Maldve et
al., 2002); D1 and D5 receptor activation is required for LTP (Kerr and Wickens, 2000)
and D1 receptor-dependent trafficking of NMDA receptors to postsynaptic sites in the
neostriatum has also been found (Dunah and Standaert, 2001). These findings suggest
that NMDA receptors and 1 receptors are interactive, inter-regulated to maintain a
balance (Cepeda and Levine, 199$; Lee et al., 2002). Hyperactivity of NMDA receptor
mediated function may resuit in an excitotoxicity due to Ca2 overload (Dawson et al.,
1991; Chen et al., 1992; Ferreira, 1996; Aarts et al., 2002). On the other hand, an
excessive DA may attenuate NMDA receptor-mediated function and so decreases Ca2
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influx to the neurons during postnatal development, affecting plasticity. Recent
hypotheses about the pathophysiology of schizophrenia have posited defects in excitatory
amino acid transmission (e.g. Carlsson and Clarlsson, 1990; coyle, 1996; Olney and
Farber, 1995; Do et al., 1995; Faustrnan et al., 1999; Tsai et al., 1995; reviewed by
Meador-Woodruff and Healy, 2000). NMDA receptor antagonists produce effects in
normal human subjects that resemble schizophrenic symptoms (Krystal et al., 1999) and
drugs that alter glutamate transmission can ameliorate schizophrenic symptoms (Javitt et
al., 1994; Tsai et al., 199$), suggesting defects in excitatory amino acid transmission. As
schizophrenia is associated with a hyperfunction of the dopaminergic system (Gray et al.,
1995; Joyce, 1993; Joyce and Meador-Woodruff, 1997), an enhanced DA-induced
depression of the excitatory drive onto nAcb celis may cause imbalance in the related
neurocircuits in earlier ages. Considering the fact that antagonists at DA receptors have a
much higher antipsychotic potency, the nAcb may represent a potential site of such
action. Just as schizophrenia often emerges during late adolescence or early adulthood,
predominant NMDA receptors and DA receptors expressed in early postnatal
developrnent might play a pivotal role in the etiology ofthe schizophrenia.
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GENERAL DISCUSSION
Experimental aim and resuits
Schizophrenia is a severe mental disease that could resuit from abnormalities in
early brain development (Weinberger, 1995; Caimon, 1996; Woods, 1998; Isohanni et al.,
2001; Remsclmidt, 2002). The clinical syndrome produced by glutamatergic
dysfunction, especially more pronounced NMDA receptor hypofunction, has been
suggested as a possible substrate of the pathophysiology of schizophrenia (Carisson and
Carisson, 1991; Meador-Woodruff and Healy, 2000; Newcomer and Krystal, 2001). In
addition, discovering the distinct difference of physiological properties of the MS
neurons during postnatal development from adulthood (Belleau and Warren, 2000) as
well as an increased volume in the nAcb resulted from a neuronal death following
prenatal cortical neurodevelopmental disturbances (Lauer et al., 2001), is the major
motivation of the present work.
In the present study, we found that EPSCs evoked by local electrical stimulation
in the nAcb had both AMPAR- (early) and NMDAR- (late) components. The late
component increased to a maximum towards the end of the second postnatal week, and
then decreased until it could be hardly detected after the third week. However, during
pharmacological blocking of AMPAR-EPSCs, NMDAR-EPSCs could also be detectable
even during fourth week with a faster decay time than during the early postnatal period.
These resuits suggest that NMDAR-EPSCs are predominantly expressed during early
postnatal developrnent in the nAcb. Additionally, the ratio of amplitude of late to early
component was decreased during the same period, which is in agreement with the finding
that the expression of postsynaptic NMDA receptors is downregulated during postnatal
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development (Bellingham et al., 1998; Futai et al., 2001; Isaacson and Walmsley, 1995).
ACh decreased or increased glutamatergic transmission by respectively acting on
muscarinic and nicotinic receptors probably located on excitatory terminais. Muscarinic
depression of the EPSCs was mediated by M1/M4 receptors and nicotinic facilitation of
the EPSCs was mecamylamine-sensitive. In addition, the inhibitory effect of ACh on
NMDAR- but not on AMPAR-EPSC significantly increased during the first two postnatal
weeks. Acting on Dl receptors, DA strongly inhibited NMDAR-EP$Cs while
moderately reducing AMPAR-EP$Cs. The ratio of amplitude of the late component to
the early components was significantly decreased, and the PPR was increased by DA at
the hyperpolarized membrane potentials. Since the action of DA was resistant to the
protein kinase inhibitors H$9, Ro-32-0432 and the cAMP antagonist, QS22536,
suggesting the inhibitory action of DA was independent of an action mediated by
AC/PKA or PKC systems.
Expression of NMDA receptor subunits and the performances of EPSCs
Our results show that EPSCs evoked by local electrical stimulation in the nAcb
have both AMPAR- and NMDAR-components. NMDAR-component increased to a
maximum during the second postnatal week, and then decreased until it could hardly be
detected after the third postnatal week. However, during blockade of the AMPAR
component, the NMDAR-component could be detected at later ages but with a faster
decay time than that during the early postnatal period.
Our findings indicate that NMDAR-EPSCs are predominantly expressed during
postnatal development. The changes in NMDAR-EPSC kinetics in our observation is
consistent with the findings in other brain areas (Joshi and Wang, 2002; Flint et aL. 1997;
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Fox, 1995) and appear matched to the gene expression of NMDA receptor subunit
mRNA during postnatal development in the neostriatum (Lau et al., 2003), visual and
auditory cortex as well as in the thalamus (Cao et al., 2000; Hsieh et al., 2002). During
the development of glutamatergic transmission in the sensory cortex, the proportion of
synapses with detectable AMPAR-current increases, and the decay kinetics of NMDAR
current become faster. The change in NMDA receptor kinetics is believed to result from
a developmental switch in the subunit composition of NMDA receptors. The NRÏ
subunit combines with various NR2A-D subunits to produce receptor subtypes with
different kinetics. 0f these, NR2A subunit-containing NMDA receptors have the faster
decay times, whereas NR2B subunit-containing receptors have the siower decay times. A
general trend shows that the contribution of the NR2B subunit is decreasing during
development, which is associated with an increasing contribution of NR2A subunit
containing NMDA receptors to synaptic current. A graduai replacement or
supplementation ofNR2B by NR2A during postnatal development has been implicated in
the speeding of NMDAR-EP$C decay—a phenomenon often linked with the ability of
neuronal circuits to exhibit experience-dependent synaptic plasticity (Constantine-Paton
and Cime, 1998). We found that NMDAR-component increased to a maximum during
the second postnatal week, and then decreased, suggesting a graduai increase in NR2B
subunit-containing NMDA receptors until the end of the second postnatal week. These
late EPSCs during the second postnatal week are supposed to be distinctly decreased if
ifenprodil was used.
Following the second postnatal week, NMDAR-EPSCs could be detected with a
faster decay time, suggesting that the proportion of NR2A subunits-containing NMDA
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receptors increased and gradually replacing or supplementing NR2B subunits after the
second postnatal week. The kinetics ofNMDAR-EPSC became shorter gradually due to
more insertion of NR2A subunits so that its peak overlapped with the peak of AMPAR
EPSC in the compound EPSCs. Unmasked by AMPA receptor antagonist, NMDAR
EPSC was re-detectable even in later postnatal week.
A decrease in NMDAR-EPSC decay time with maturity has been described in
other regions of the CNS (Carmignoto and Vicini, 1992; Hestrin, 1992; Takahashi et al.,
1996). This decrease appears to be correlated with the appearance of NR2A subunits
(Flint et al., 1997; Takahashi et al., 1996), and the expression of NR2A is increased by
activity (Quinlan et al., 1999; Vallano et al., 1996). Thus, during postnatal development,
there is an increased proportion of the NR2A subunit-containing NMDA receptor
accompanied by a decreased proportion of NR2B (Yoshii et al., 2003). It has been
further shown that the mature kinetics (decay time constant, lOOms) are characteristic of
NMDA receptors composed of NR1 and NR2A subunits, whereas the immature form
(350ms) is the characteristic of the receptors with NRÏ and NR2B subunits (Williams et
al., 1993).
NMDA receptor and synapsogenesis
We found in the morphological study that MS neurons are essentially aspiny from
P0 to P10, and possess varicose dendrites, whereas they assume an adult spiny
appearance only toward the end of the third postnatal week. These changes are
concomitant with the evolution ofNMDAR-EPSCs during the development.
Ca2 influx through glutamate receptors is thought to play a critical role in
neuronal synaptogenesis and in the formation of neuronal circuitry during early
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development (McDonald and Johnston, 1990). The NMDA receptor has been proposed
to be the first glutamatergic receptor to appear during synaptogenesis (Baba et al., 2000;
Durand et al., 1996; Isaacet al., 1997; Petralia et al., 1999). A large body ofevidence has
shown that disturbing the function of the NMDA channel during development can
severely disrupt the wiring of defined neural circuits. It can also disrupt the
developmental upregulation of the receptor protein itself and possibly many other
molecular components of the synapse (Constantine-Paton, 1994). Studies further
demonstrated that NMDA receptor mediates control of protein synthesis at developing
synapses (Scheetz et al., 2000). Activation of NMDA receptors increases the translation
of Œ Ca2/ca1modu1in dependent kinase II and the phosphorylation of eukaryotic
elongation factor II during activity-dependent synaptic changes (Scheetz et al., 2000).
Activation of the NMDA receptor also plays a role in structural plasticity. Studies on the
development of axonal and dendritic arbors in the developing tectum also showed that
early synaptic activity mediated by NMDA receptors promotes the growth of dendritic
arbor in xenopus laevis tadpoles (Rajan and Cline, 199$), facilitating the formation of
additional synaptic contacts (Cline, 2001). The NMDA receptor antagonist suppressed
the transient increase in dendritic arbor at the beginning of the second postnatal week in
the supraoptic nucleus neurons of rats (Chevaleyre et al., 2002). Conversely, application
of NMDA increased dendritic branches in slices of P3-P6 rats. Their effects were
inhibited by blockade of electrical activity, voltage-gated Ca2 chaimels, or intracellular
Ca2 mobilization (Chevaleyre et al., 2002). Exposure of the developing brain during the
period of synaptogenesis to anesthetic agents that block NMDA receptors can trigger
widespread apoptotic neurodegeneration (Jevtovic-Todorovic et al., 2003). On the other
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hand, chronic blockade of NMDA receptors in hippocampal suce cultures during early
postnatal development resuits in a lower threshold for the induction of LTP ($avicc et al.,
2003) and leads to a substantial increase in synapse number and resuits in a more
complex dendritic arborization of CAl pyramidal celis (Luthi et al., 2001). Consistently,
chronic blockade of NMDA receptors delays the maturation of NMDA cunents and
increases the sprouting capacity of ipsilateral retinocollicular axons without disrupting
their early segregation (Colonnese et al., 2001; Colonnese et al., 2003). These opposing
resuits suggest that NMDA receptors may also be critical for the shaping and refinement
of the structural and functional properties of neuronal circuits during early postnatal
development (Luthi et al., 2001).
Glutamate promotes proliferation of striatal neuronal progenitors by an NMDAR
mechanism. Low concentrations of NMDA increased proliferation, whereas high
concentrations were toxic (Luk et aI., 2003). Moreover, nicotine sensitization increases
dendritic length and spine density in the nAcb (Brown and Kolb, 2001), suggesting it
plays an important role in the nAcb during postnatal development.
Paired-pulse ratio and presynaptic mechanisms
The paired-pulse protocol (PPP) has been widely applied to the identity of
presynaptic mechanisrns (Zucker, 1989, 1999; Kamiya and Zucker, 1994). It was used in
our project to distinguish pre or postsynaptic sites at which ACh and DA could modulate
EPSCs. The amplitudes of two EPSCs evoked by the PPP differ depending mainly on
release probability of transmitters including the synaptic state during the moment of the
anival of the second spike (Dittman et al., 2000; Saviane et al., 2002). In general, the
srnaller amplitude is the probability of release to the first pulse, the more facilitated
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amplitude is the response to the second pulse. This phenomenon is known as paired
pulse facilitation (PPf). In contrast, if the amplitude of the second response is depressed
or smaller than the first one, it is called the paired-pulse depression (PPD) (Steven and
Wesseling, 1998). Studies have shown that the probability of release depends on both
residual Ca2 and the size of the available vesicles pool. The interplay between these two
factors at the moment of arrival of the second spike would determine the direction of the
paired-pulse modulation, i.e. PPF or PPD. The PPF observed in the majority of neurons
in stationary conditions is accounted for by the residual Ca2 hypothesis, according to
which the small fraction of Ca2 entering the terminal during the first spike increases the
probability of transmitter release to a second action potential (Zucker, 1989) when
vesicles pool is in constant. The PPD is presented at an entry of release sites into
refractory states to depress transmitter release (Dittman et al., 2000; Dobrunz et al., 1997;
Steven and Wesseling, 199$). This could be due to either the depletion of the readily
releasable transmitter pool ($teven and Wesseling, 199$) or to residual Ca2 following
the first stimulus depressing the Ca2 influx produced by the second stimulus (Kirischuk
et al., 2002). Or both could occur afler sustained depolarization of the presynaptic
terminal (Wu and Borst, 1999; Dittman and Regehr, 1998). Obviously, both PPF and
PPD are presynaptic phenomenonna (Zucker, 1989; Wu & Saggau, 1997; Dittman et al.,
2000). Presynaptic inhibition of ellcited transmitter release is rnainly due to a reduction
of presynaptic Ca2 influx through specffic Ca2 channel types (Wu and Saggau, 1994,
1997). A reduction in release probability predicts an increase in the PPR that has shown
to be enhanced when the extracellular Ca2/Mg2 ratio was lowered (Debanne et al., 1996;
Canepari and Cherubini, 1998; Regehr and Stevens, 2001; Bellingham and Walmsley,
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1999). In our experiments, both ACh and DA altered PPR in MS neurons, indicating the
involvement of presynaptic mechanisms. Facilitation of PPR by DA suggests that DA
acts mainly through a reduction of the presynaptic Ca2 influx (Wu and Saggau, 1997).
The reduction in PPR produced by ACh can be attributed to either residual Ca2 binding
to a molecular site intimately involved in regulating the probability of vesicle release or
changes in size ofthe readily releasable pool ofvesicles (Wu & Saggau, 1997; Dittman et
al., 2000) or both factors. Additionally, depletion of a pool of readily releasable vesicles
during repetitive presynaptic activity is a basic mechanism for the induction of short-term
synaptic depression (Schneggenburger et al., 2002). Wu & Borst (1999) also found that
the maintained synaptic transmission during tetanic stimulation is due to a rapid
replenishment of reluctant vesicles into the releasable pool, the release of which is
facilitated by the increase in residual Ca2 during the train. In fact, the average release
probability of vesicles in the releasable pool is lower during synaptic depression. In
addition, our finding on PPR changes of AMPAR- but flot NMDAR-EPSCs probably
suggests that the effect of DA on NMDAR-EPSCs involved postsynaptic sites, because
presynaptic manipulations should produce parallel changes in AMPAR- and NMDAR
EPSCs (Poncer and Malinow, 2001).
Direct interaction betiveen NMDA receptor and Dl receptor
Synaptic NMDA receptors play critical roles during brain development, plasticity,
and pathology (Constantine-Paton and Cime, 1998; Dingledine et al., 1999; Zoghbi et al.,
2000). The NMDA receptor is not a static resident of the synapse. Rather, the number
and composition of synaptic NMDA receptors can be regulated (Wenthold et al., 2003),
suggesting that a rapid regulation of postsynaptic NMDA receptors is one of the
172
mechanisms underlying developmental plasticity in the brain. In the study of the
modulation of DA on NMDAR-EPSCs, we observed the ratio of amplitude of the late to
the early component of EPSCs was decreased by the presence of DA. This suggests that
the inhibitory action of DA on NMDAR-EPSCs was at least partially mediated by
postsynaptic mechanisrns. Since synaptic transmission affected from purely presynaptic
mechanisms should have produced parallel changes in AMPAR- and NMDAR-EPSCs
(Poncer and Malinow, 2001; Von Gersdorff et al., 1997; Tong and Jahr, 1994; Perkel and
Nicoll, 1993). One possibility is that postsynaptic effects of DA on Dl receptor are
voltage-dependent and are scarcely effective at —lOOmV, but at —4OrnV. Another
possibility is that DA causes a decrease in the number of NMDA receptors. A
downregulation in the number of NMDA receptors produced by DA has been
demonstrated in MS celis in the striatum (Lee et aI., 2002). Indeed, Dl receptors co
localized with NMDA receptors in the postsynaptic density (PSD) in the striatum suggest
a direct interaction between Dl and NMDA receptors (Salter, 2003; Lee et al., 2002;
Scott et al., 2002; Barria and Malinow, 2002; f iorentini et al., 2003). In particular, that
Dl receptor is apparently associated with both the NR1 and NR2A subunits, but flot with
the NR2B subunit (Fiorentini et al., 2003). The D1 receptor does not interact with NR2B
subunits in striatal PSD, probably explaining the postsynaptic effect of DA without
obviousÏy affecting the kinetics ofNMDAR-EPSCs in our resuits.
Several unes of evidence indicate that different levels of synaptic NMDA receptor
activation with corresponding degrees of Ca2 influx can lead to multiple effects. Low
level of NMDA receptor activation produces synaptic depression, while higher levels of
activation produce synaptic potentiation (Cummings et al., 1996; Zucker, 1999). Even
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higher levels of activation can Iead to ccli death (Choi, 1995). Thus, the number and
properties of NMDA receptors at a synapse must be under optimal control in order to
allow the appropriate amount of Ca2 entry. Therefore, the interaction between NMDA
and Dl receptors in MS neurons could be one ofthe mechanisms directing the trafficking
of Dl and NMDA receptors to specific subcellular compartments. Recent observation
shows that NMDA and Dl receptors partially overlap in the subcellular distribution and
are assembled as oligorneric units in the endoplasmic reticulum and transported to the ceil
surface as a preformed complex (fiorentini et al., 2003). Delivery ofboth Dl and NMDA
receptors to the synapses is dependent on glutamate transmission (Barria and Malinow,
2002; Scott et al., 2002), suggesting that direct protein-protein interactions might direct
the trafficking of these receptors to the same subcellular domain. Activation of Dl
receptor decreased the number of NMDA receptors, which resuits in the inhibition of
EPSCs (Lee et al., 2002). In contrast, activating NMDA receptors also alters the balance
between Dl and D2 receptor signaling recruiting Dl receptors to the plasma membrane
and spines without effecting on the distribution of D2 receptors (Scott et al., 2002). A
study has shown the NR2A rnRNA levels exhibited significant increases in DA
deficiency postnatal mice in the nAcb (fragioudaki et al., 2003), indicating that DA
exhibits an inhibitory control on the expression ofNMDA receptor subunits.
NMDA receptor trafficking and use-dependent expression
To remove or insert certain receptors or partial components of the receptors in
accordance with the requirement is one of the tasks of receptor trafficking. The gradual
replacement of NR2B subunits by NR2A during postnatal development is a typical use-
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dependent expression of regulation. Synaptic trafficking of NMDA receptors is tightiy
reguiated by synaptic activity and has subunit-specific fuies with functionally important
consequences (Barria and Malinow, 2002). for exampie, astrocytes express functional
NRI and NR2B afier anoxia in vitro or ischemia in vivo (Krebs et ai., 2003).
LTP and LTD strongiy depend on NMDA receptor activity and are
developmentally regulated in the nAcb (Peimartz et al., 1993; Kombian and Malenka,
1994; Schramm et al., 2002). However, LTP prornotes a rapid surface expression of
NMDA receptors in a PKC- and Src-family-dependent manner. Insertion of NMDA
receptors may 5e a key step in regulating synaptic piasticity (Grosshans et ai., 2002). It
was reported that activation of mGluRl regulates NMDA receptor trafficking by two
opposing processes, i.e. either activation of mGluR acceierates NMDA receptor
trafficking, resuiting in the insertion of NMDA receptors and increasing NR1 surface
expression (Lan et ai., 2001) or activation of rnGIuR stimuiates dendritic protein
synthesis and LTD, ieading to a rapid intemaiization of NMDA receptors from synapses
in the hippocampus (Snyder et ai., 2001).
Interaction of transmitters in the nucleus accumbens
In the nAcb, DA and glutamate, which come from extrinsic sources, as well as
ACh and GABA from iocai circuit neurons, are au capable of influencing the activity of
accumbal MS neurons. In the core region, the inputs onto spines and distai dendrites
generaiiy arise from extrinsic sources, whereas the synapses situated more proximaliy on
dendrites or perikarya corne from intrinsic sources (Meredith, 1999). The most common
sites of convergence for corticoaccumbal and dopaminergic terminais are dendritic shafis
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and spines of MS neurons with a distance between terminais of less than 2 microns
(Kotter, 1994). Glutamate transmission is inhibited by the activation of Dl or Ml
receptors and is potentiated by the activation of nicotinic receptors in the nAcb (Kalivas
and Duffy, 1997; Charara and Grace, 2003; Kombian et al., 2003; Chergui and Lacey,
1999; Harvey and Lacey, 1997; Harvey and Lacey, 1996; Beurrier and Malenka, 2002;
Nicola and Maïenka, 1998; Nicola et al., 1996; Pennartz et al., 1992; Thomas et al., 2001;
Zhang and Warren, 2002; de Rover et al., 2002; Sugita et ai., 1991; Pennartz and Lopes
da Siiva, 1994). The inhibitory effects of ACh on NMDAR- but not on AMPAR-EPSC
significantly increased during the first two postnatal weeks in our observation. This resuit
is parallel to the expression of NMDAR-EPSCs as well as to the appearance of dendritic
spines during early postnatal development. Possibly, the predominant expression of
NMDA receptors is capable of leading to a positive feedback of ACh release or promotes
the expression of muscarinic receptors in the nAcb. Other studies have shown that the
activation of NMDA receptors induced the release of ACh in the nAcb and striatum
(Jones et al., 1987; Buchholzer and Klein, 2002) as well as in the pontine reticular
formation (Lydic and Baghdoyan, 2002).
In addition to the interaction between NMDA and ACh, other interactions wiÏI be
helpful for us to understand nAcb sufficiently. Studies have shown that the cholinergic
celi ablation enhances long-lasting behavioral changes in cocaine addiction whereas ACh
enhancement prevented addictive behaviors to cocaine and morphine (Hikida et al., 2001,
2003). Systemic morphine decreases extracellular ACh and increases DA, indicating that
ACh and DA aci oppositely and that cholinergic activity could be under inhibitory DA
control in the nAcb (Ressell et al., 1989; Rada et al., 1991; Wedzony et al., 1988).
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Systemic administration of amphetamine leaded to an increase in extracellular ACh and
DA levels while the concentration of GABA gradually decreased (Lindefors et al., 1992;
Arnold et al., 2000). further study demonstrated that amphetamine administration in the
nAcb induced a bidirectional change in ACh release that was dependent on dose and
opposing effects of nAcb Dl and D2 activation. Comparatively, low doses of
amphetamine caused a Dl receptor-dependent increase in ACh release whereas higher
doses of amphetamine resulted in a D2 receptor-mediated decrease (Keys and Mark,
1998). In contrast, the activation of muscarinic M4 receptors exerted a direct inhibitory
control on Dl receptor signaling (Onali and Olianas, 2002), and stimulation ofMl/4 also
inhibited amphetarnine-induced DA release in the nAcb (Ichikawa, 2002).
Several studies have shown that the activation of nicotinic receptors increase
accumbal DA overflow in rats (Imperato et aI., 1986; Di and Imperato, 1988; Johnson et
aI., 2000) whereas mecamylamine decreased accumbal DA output in mice treated
chronically with nicotine (Gaddnas et al., 2002). Interestingly, nicotine-induced DA
release was flot only abolished by antagonist of nicotinic receptors in the nAcb (Niseil et
al., 1994; Fu et al., 2000) but could also be attenuated either by the administration of
NMDA or nicotinic receptors antagonists into the VTA (Schilstrom et al., 2000;
Schiistrom et al., 1998; Fu et al., 2000). DA response to a relatively low dose of nicotine
depends on the tonic activation of NMDA receptors in the VTA (fu et al., 2000).
Additionally, DA release resulting from NMDA receptor activation in the nAcb of rats is
partially rnediated by NO (01mo et al., 1995). Interestingly, recent studies have also
found that stimulating Dl receptors increases G1uR1 phosphorylation and G1uR1 surface
expression in postnatal nAcb MS neurons in culture (Chao et al., 2002a, b).
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NMDA receptors and shizophrenia
Schizophrenia is a chronic, severely disabling brain disorder with symptomatic
onset in early adulthood. Hyperdopaminergic and hypoglutamatergic mechanisms are
presently two basic hypotheses of schizophrenia (Zoghbi et al., 2000). Postmortem
studies have revealed variable alterations in glutamate receptors and their modulators in
schizophrenia. Several clinical trials indicate that agents enhancing NMDA receptor
function via the glycine modulatory site reduce negative symptoms and can improve
cognitive function in schizophrenics (Tsai and Coyle, 2002). Evidence implicating
dysfunction of glutamatergic neurotransmission rests largely on the finding that
antagonists of the NMDA receptor, especially the dissociative anesthetics like
phencyclidine and ketamine, reproduce the cardinal symptomatic features of
schizophrenia as well as the physiological manifestation of schizophrenia such as
hypofrontality, impaired prepulse inhibition and enhanced subcortical DA release (Tsai
and Coyle, 2002; Coyle et al., 2002; Marino and Coim, 2002; Millan, 2002; Greene,
2001). Recent studies have shown that NMDA receptor subunits (NR1, NR2B and
NR2C) and P$D proteins are abnormally expressed in some cortical regions in
schizophrenia and in the thalamic nuclei having reciprocal connection with limbic
regions that have been implicated in schizophrenia (Meador-Woodruff and Healy, 2000;
Hisham et al., 2000; Clinton et al., 2003), suggesting that glutamatergic dysfunction may
occur flot only at the level of receptor expression but also within intracellular signal
transduction pathways associated with NMDA receptor (Clinton et al., 2003; Kajimoto et
al., 2003). It has been suggested that early neonatal blockade of NMDA receptors in
intact anirnals leads to the developmental disturbances to situational perception and
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assessment of incoming sensory information (Latysheva and Raevskii, 2003; MiIlan,
2002; Ikonomidou et al., 1999; Deutsch et al., 199$). An endogenous peptide, N-acetyl
L-aspartyl-L-glutamate, Fias been found to antagonize NMDA receptors in a manner
similar to known psychotogenic agents like ketamine or phencyclidine (Greene, 2001).
$elective blockade of NMDA-dependent LTP of the recurrent inhibitory circuit may
disrupt particular aspects of information processing involving leaming andlor memory,
consistent with the generation of abnormal associations in the hippocampus (Greene,
2001).
Cholinergic functions appear also abnormal in schizophrenia. Muscarinic
receptor avaiïability was significantly less, and positive symptoms of schizoplirenia are
conelated negatively with muscarinic receptor availability in the striatum and frontal
cortex, indicating that the muscarinic system that modulates the NMDA receptor couïd be
involved in the pathophysiology of schizophrenia (Coppola and Weinberger, 2003).
Further, the presence of abnormal expression and function of the neuronal nicotinic
receptor gene family in schizophrenia bas been also reported (Leonard et al., 1998;
Simosky et al., 2002).
The DA hypothesis of schizophrenia bas been fruitful in producing a deeper
understanding of pathophysiology of schizophrenia. In CAl pyramidal neurons,
activation of D2 receptors depressed excitatory transmission mediated by NMDA
receptors. This depression resulted from the quinpirole-induced release of intracellular
Ca2 and enhanced Ca2-dependent inactivation of NMDA receptors. The DA receptor
mediated depression was dependent on the “transactivationt’ of platelet-derived growth
factor receptor [3. Therefore, receptor tyrosine kinases transactivation provides a novel
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mechanism of communication between dopaminergic and glutamatergic systems and
might help to explain how reciprocal changes in these systems could be linked to the
deficits in cognition, memory, and attention observed in schizophrenia and attention
deficit hyperactivity disorder (Kotecha et al., 2002). Additionally, the finding of DA
NMDA receptor complex and the direct interaction between DA and NMDA receptors in
limbic regions will probably be an important progress in the study of schizophrenia (Lee
et al., 2002; Scott et al., 2002; Fiorentini et al., 2003).
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fig. 1. Schematics showing the synaptic organization of the nAcb and a proposed
mechanism of action of DA to decrease evoked EPSCs and ACh to decrease or
increase EPSCs in the nAcb. The nAcb receives excitatory inputs from [imbic
areas, e.g., prefrontal cortex, amygdala, and hippocampus. It also receives a
dopaminergic input from the ventral tegmental area (VTA). Cholinergic neurons
are domestic in nAcb. Schematic also showing a proposed mechanism of change of
NMDA receptor subunit components during the postnatal development and while
DA receptors are activated in the nAcb. Arrows indicate the trafficking directions
of NMDA receptor subunits (expression on membrane surface or intemalization).
(+): potentiation; (-): depression.
Figure Ï
From domestic nAcb
(ACh)
From limbic areas
(Glutamate)
From VIA
(DA) s
s
NR1/NR2A
NR1/NR2B
AMPAR
nAChR
mACFiR
Presynaptic
— DA-R
*ACh
•DA
•GIu
()4, 1.L-
181
BIBLIOGRAPHY
Adem, A., Jolkkonen, M., Bogdanovic, N., Islam, A. and Karisson, E. 1997.
Localization of Ml muscarinic receptors in rat brain using selective muscarinic toxin-1.
Brain Res BuIl 44:597-601.
Akaike, A., Sasa, M., Takaori, S. 198$. Muscarinic inhibition as a dominant role in
cholinergic regulation of transmission in the caudate nucleus. J Pharmacol Exp Ther
246:1129-1136.
Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S. and Mizuno, N. 1994.
Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the
cerebellum ofdeveloping and aduit rats. J Comp Neurol 347:150-160.
Akins, P. T., Surmeier, D. J. and Kitai, S. T. 1990. Muscarinic modulation of a
transient K conductance in rat neostriatal neurons. Nature (Lond) 344:240-242.
Aikondon, M., Rocha, E.S., Maelicke, A., Albuquerque, E.X. 1996. Diversity of
nicotinic acetylcholine receptors in rat brain: V. a-Bungarotoxin-sensitive nicotinic
receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J.
Pharmacol Exp Ther278:1460-1471.
Apicella, P., Ljungberg, T., Sxarnati, E. and Schuliz, W. 199f. Responses to reward
in monkey dorsal and ventral striatum. Exp Brain Res 85:49 1-500.
Aramakis, V.B. and Metherate, R. 1998. Nicotine selectively enhances NMDA
receptor-rnediated synaptic transmission during postnatal development in sensory
neocortex. J Neurosci 18:8485-$495.
Arnold, H.M., Nelson, C.L., Neigh, G.N., Sarter, M., Bruno, J.P. 2000. Systemic and
intra-accumbens administration of amphetarnine differentially affects cortical
acetylcholine release. Neurosci 96:675-685.
Ascher, P., Bregestovskï, P. and Nowak, L. 198$. N-methyl-D-aspartate-activated
channels of mouse central neurons in magnesiurn-free solutions. J Physiol (Lond) 399:
207-226.
Aylward, R.L. and Totterdeli, S. 1993. Neurons in the ventral subiculum, amygdala
and entorhinal cortex which project to the nucleus accumbens: their input from
somatostatin- immunoreactive boutons. J Chem Neuroanat 6:31-42.
Baba, H., Doubeli, T.P., Moore, K.A., Woolf, C.J. 2000. Silent NMDA receptor
mediated synapses are developmentally regulated in the dorsal hom of the rat spinal cord
J Neurophysiol 83:955-962.
182
Balfour, D.J. 2002. Neuroplasticity within the mesoaccumbens dopamine system and its
role in tobacco dependence. Curr Dmg Target CNS Neurol Disord 1: 413-2 1.
Barria, A. and Malinow, R. 2002. Subunit-specific NMDA receptor trafficking to
synapses. Neuron 35:345-353.
Behe, P., Cloquhoun, D. and Wyllie, D.J. 1999 Activation of single AMPA- and
NMDA-type glutamate-receptor channels. In Ionotropic Glutamate Receptors in the
CNS. Edited by Jonas P, Monyer H. Springer; Berlin 175:218.
Belleau, M. and Warren, R.A. 1995. Electrophysiological aspects of postnatal
development ofnucleus accumbens in vitro. Soc Neurosci Abstr 21:2023.
Belleau, M. and Warren, R.A. 2000. Postnatal development of etectrophysiological
properties of rat nucleus accumbens. J Neurophysiol 84: 2204-22 16.
Bellingliam, M.C., Lim, R., Walmsley, B. 1998. Developmental changes in EPSC
quantal size and quantal content at a central glutamatergic synapse in rat. J Physiol
511:861-869.
Bellingham, M.C. and Walmsley, B. 1999. A novel presynaptic inhibitory mechanism
underlies paired pulse depression at a fast central synapse. Neuron 23:159-170.
Beninger, R.J., Phillips, A.G. and Fibiger, H.C. 1983. Pnor training and intermittent
retrainig attenuate pimozide-induced avoidance deficits. Pharmacol Biochem Behav
18:619-624.
Benowitz, N. L. 1996. Pharmacology of nicotine: addition and therapeutics. Ann Rev
Pharmacol Toxicol 36:597-613.
Berendse, H.W., Groenewegen, H.J. and Loliman, A.H. 1992. Compartmental
distribution of ventral striatal neurons projecting to the mesencephalon in the rat. J
Neurosci 12:2079-2103.
Bernard, V., Normand, E. and Bloch, B. 1992. Phenotypical characterization ofthe rat
striatal neurons expressing muscarinic receptor genes. J Neurosci 12:3591-3600.
Bernardi G., Fions V., Marciani M.G., Morocutti C. and Stanzione P. 1976. The
action of acetylcholine and L-glutamic acid on rat caudate neurons. Brain Res 114:134-
138.
Berridge, M.J. and Irvine, R.F. 1984. Insitol trisphosphate, a novel second messenger
in cellular signal transduction. Nature 312:315-321.
Blake, M.J., Appel, N.M., Joseph, J.A., Stagg, C.A., Anson, M., de Souza, E.B.,
Roth, G.S. 1991. Muscarinic acetylcholine receptor subtype mRNA expression and
ligand binding in the aged rat forebrain. Neurobiol Aging 12:193-199.
183
Bolam, J.P., Waïner, B.H. and Smith, A.D. 1984. Characterization of cholinergic
neurons in the rat striatum. A combination of choline acetyltransferase
immunocytochemistry, Golgi-impregnation and electron microscopy. Neurosci 12:711-
718.
Bordey, A., Feltz, P. and Trouslard, J. 1996. Nicotinic actions on neurons of the
central autonomic area in rat spinal cord slices. J Physiol 497:175-187.
Borges, K. and Dingledine, R 1998. AMPA receptors: molecular and functional
diversity. Prog Brain Res 116:153-170.
Bouyer, J.J., Park, D.H., Joli, T.H. and Pickel, V.M. 1984. Chemical and structural
analysis of the relation between cortical inputs and tyrosine hydroxylase-containing
terminais in rat neostriatum. Brain Res 302: 267-275.
Brog, J.S., Salyapongse, A., Deutch, A.Y. and Zahm, D.S. 1993. The pattems of
afferent innervation of the core and sheli in the “accumbens” part of the rat venttral
striatum: immunohistochemical detection ofretrogradely transported fluoro-gold. J Comp
Neurol 338:255-278.
Brown, D.A., Abogadïe, F.C., Allen, T.G., Buckley, N.J., Caulfield, M.P., Delmas, P.,
Haley, J.E., Lamas, lÀ. and Selyanko, A.A. 1997. Muscarinic mechnisms in nerve
cells. Life Sci 60:1137-1144.
Brown, R.W. and Kolb, B. 2001. Nicotine sensitization increases dendritic length and
spine density in the nucleus accumbens and cingulate cortex. Brain Res 899:94-100.
Brudzynski, S.M. and Gibson, C.J. 1997. Release of doparnine in the nucleus
accumbens caused by stimulation of the subiculum in freely moving rats. Brain Res Buil
42:303-308.
Buchhotzer, M.L. and Kleïn, J. 2002. NMDA-induced acetylcholine release in mouse
striatum: role of NO synthase isoforms. J Neurochem 82:1558-1560.
Burnashev, N., Monyer, H., Seeburg, P.H. and Sakmann, B. 1992. Divalent ion
permeability of AMPA receptor channels is dominated by the edited form of a single
subunit. Neuron 8:189—198.
Burrone, J., O’Byrne, M., Murthy, V.N. 2002. Multiple forms of synaptic plasticity
triggered by selective suppression ofactivity in individual neurons. Nature 420:414-8.
Caillé, I., Dumartin, B. and Bloch, B. 1996. Ultrastructural localization ofDldopamine
recweptor immunoreactivity in rat striatonigral neurons and its relation with
dopaminergic innervation. Brain Res 730:17-31.
184
Calabresï, P., Benedetti, M., Mercuri, N. B. and Bernardi, G. 198$. Endogenous
dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum:
intracellular studies from naïve and catecholamine-depleted rats. Neurosci 27:145-157.
Calabresi, P., Centonze, D., Gubellini, P., Pisani, A. and Bernardi, G. 1998.
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors
and PKC activation. Eur J Neurosci 10:1887-2895.
Calabresi, P., DeMurtas, M., Pisanni, A., Stefani, A., Sancesario, G., Mercuri, N.B.
and Bernardi, G. 1995. VulnerabiÏity of medium spiny striatal neurons to glutamate:
role ofNaJK ATPase. Eur J Neurosci 7:1674-1683.
Calabresi, P., Mercuri, N.B., Stanzione, P., Stefani, A. and Bernardi, G. 1987.
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in
vitro: evidence for Dl receptor involvement. Neurosci 20:757-771.
Canepari, M. and Cherubini, E. 1998. Dynamics of excitatory transmitter release:
analysis of synaptic responses in CA3 hippocampal neurons after repetitive stimulation of
afferent fibers. J Neurophysiol 79:1977-1988.
Cao, Z., Lin, L., Lickey, M. and Gordon, B. 2000. Development ofNR1, NR2A and
NR2B mRNA in NR1 immunoreactive celis of rat visual cortex. Brain Res 868:296-305.
Carisson, M. and Carisson, A. 1990a. Interactions between glutamatergic and
monoaminergic systems within the basal ganglia — Implications for schizophrenia and
Parkinson’s disease. Trends Neurosci 13: 272-276.
Carisson, M. and Carisson, A. 1990b. Schizophrenia: a subcortical neurotransmitter
imbalance syndrome? Schizophrenia Bulletin 16: 425-432.
Carmignoto, G. and Vicini, S. 1992. Activity-dependent decrease in NMDA receptor
responses during development of the visual cortex. Science 258:1007-11.
Casassus, G. and Mulle, C. 2002. Functional characterization of kainite receptors in the
mouse nucleus accumbens. Neuropharmacol 42:603-611.
Caulfield, M.P. 1993. Muscarinic receptors—characterization, coupling and function.
Pharmac Ther 58:319-379.
Caulfield, M.P. and Birdsall, N. M. 1998. International Union of Pharmacology. XVII.
Classification of muscarinic acetylcholine receptors. Pharmac Rev 50:279-290.
Cepeda, C., Buchwald, N. A. and Levine, M.S. 1993. Neuromodulatory actions of
dopamine in the neostriatum are dependent upon the excitatory amino acid receptor
subtypes activated. Proc Nati Acad Sci USA 90: 9576-9580.
185
Cepeda, C., Coiweil, C.S., Itri, J.N., Chandier, S.H. and Levine, M.S. 1998.
Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons
in suces: contribution of calcium conductances. J Neurophysiol 79:82-94.
Cepeda, C., Walsh, J.P., Buchwatd, N.A. and Levine, M.S. 1991. Neurophysiological
maturation of cat caudate fleurons: evidence from in vitro studies. Synapse 7: 278-290.
Chang, H. T. 1988. Dopamine-acetylcholine interaction in the rat striatum: a dual
labeling immunocytochemical study. Brain Res Bull 21:295-304.
Chang, HT. and Kitai, S.T. 1985. Projection neurons of the nucleus accumbens: an
intracellular labeling study. Brain Res 347:112-116.
Chao, S.Z., Ariano, M.A., Peterson, D.A., WoIf, M.E. 2002. Dl dopamine receptor
stimulation increases G1uR1 surface expression in nucleus accumbens neurons. J
Neurochem 83:704-712.
Chao, S.Z., Lu, W., Lee, H.K., Huganir, R.L., Wolf, M.E. 2002. Dl dopamine receptor
stimulation increases G1uR1 phosphorylation in postnatal nucleus accumbens cultures.
JNeurochem 81: 984-992.
Charara, A. and Grace, A.A. 2003. Dopamine receptor subtypes selectively modulate
excitatory afferents from the hippocampus and amygdala to rat nucleus accumbens
Neurons. Neuropsychopharmacol 22:1412-1421.
Chazot, P.L., Stephenson, F.A. 1997. Molecular dissection of native mammalian
forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration ofNMDA
receptors comprising NR1, NR2A, and NR2B subunits within the same complex. J
Neurochem 69:2138-2 144.
Chevaleyre, V., Moos, F.C., Desarmenien, M.G. 2002. Interplay between presynaptic
and postsynaptic activities is required for dendritic plasticity and synaptogenesis in the
supraoptic nucleus. J Neurosci 22:265-273.
Chol, D.W. 1992. Excitotoxic ccli death. J Neurobiol 23:1261-1276.
Choi, D.W. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends
Neurosci 18:58-60.
Chiodo, L.A. and Bunney, B.S. 1983. Typical and atypical neuroleptics: Differential
effects of chronic administration on the activity of A9 and AlO midbrain dopaminergic
neurons. J Neurosci 1:1607-1619.
Chittajallu, R., Braithwaite, S. P., Clarke, V R. J. and Henley, J.M. 1999. Kainate
receptors: subunits, synaptic localization and function. Trends in Pharmacol Sci 20:26-
35.
186
Clarke, P. B. and Pert, A. 1985. Autoradiographic evidence for nicotine receptors on
nigrostrital and mesolimbic dopaminergic neurons. Brain Res 348:355-35$.
Clarke, P., Hamïl, G., Nadi, N., Jacobowitz, D. and Pert, A. 1986. [3H]nicotine- and
[1251]alpha-bungarotoxin-labeled nicotinic receptors in the interpenduncular nucleus of
rats II. Effects ofhabenular deafferentation. J Comp Neurol 251:407-413.
Clarke, P.B. and Reuben, M. 1996. Release of 3[H]norepinephrine from rat
hippocampal s’naptosomes by nicotine: mediation by different nicotinic receptor
subtypes from [ H]dopamine release. Br J Pharmacol 117:595-606.
Clements, J.D., Lester, R.A.J., Tong, G., Jalir, C.E. and Westbrook, G.L. 1992. The
course of glutamate in the synaptic clefi. Science (Wash. DC) 258:1498-1501.
Cime, H.T. 2001. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol
11:118-126.
Clinton, S.M., Haroutunian, V., Davis, K.L., Meador-Woodruff, J.H. 2003. Altered
Transcript Expression of NMDA Receptor-Associated Postsynaptic Proteins in the
Thalamus ofSubjects With Schizophrenia. Am J Psychiatry 160:1100-1109.
Coggan, J.S., Paysan, J., Conroy, W.G., Berg, D.K. 1997. Direct recording of
nicotinic responses in presynaptic nerve terminals. J Neurosci 17:5798-5806.
Colle, L.M. and Wise, R.A. 1988. Effects ofnucleus accumbens amphetamine on lateral
hypothalamic brain stimulation reward. Brain Res 459:361-368.
Colonuese, M.T., Constantine-Paton, M. 2001. Chronic NMDA receptor blockade
from birth increases the sprouting capacity of ipsilateral retinocollicular axons without
disrupting their early segregation. J Neurosci 21:1557-1568.
Colonnese, M.T., Shi, J., Constantine-Paton, M. 2003. Chronic NMDA receptor
blockade from birth delays the maturation of NMDA currents, but does not affect
AMPAlkainate currents. J Neurophysiol 89:57-68.
Constantïne-Paton, M. 1994. Effects of NMDA receptor antagonists on the developing
brain Psychopharmacol Bull 30:561-565.
Constantine-Paton, M. and Cline, HT. 199$. LTP and activity-dependent
synaptogenesis: the more alike they are, the more different they become. Curr Opin
Neurobiol 8:139-148.
Contant, C., Umbriaco, D., Garda, S., Watkins, KC. and Descarries, L. 1996.
Ultrastraucrural characterization of the acetylchole innervation in aduit rat neostriatum.
Neurosci 71:937-947.
187
Contractor, A., Swanson, G.T., Sailer, A., O, Gorman, S. and Heinemann, S.F. 2000
Identification of the kainite receptor subunits underÏying modulation of excitatory
synaptic transmission in the CA3 region ofthe hippocampus. J Neurosci 20:8269-8278.
Coppola, R. and Weinberger, D.R. 2003. In vivo determination of muscarinic
acetylchoÏine receptor availability in schizophrenia. Am J Psychiatry 160:118-127.
Coyle, J.T., Tsai, G., Goff, D.C. 2002. Ionotropic glutamate receptors as therapeutic
targets in schizophrenia. Curr Drug Target CNS Neurol Disord 1:183-189.
Craig, A.M., Blackstone, C.D., Huganir, R.L. and Banker, G. 1993. The distribution
of glutamate receptors in cultured rat hippocampal fleurons: postsynaptic clustering of
AMPA-selective subunits. Neuron 10:1055-1062.
Crowder, T.L. and Weiner, J.L. 2002. functional characterization of kainate receptors
in the rat nucleus accumbens core region. J Neurophysiol 88:41-4$.
CuJl-Candy, S., Brickley, S., Farrant, M. 2001. NMDA receptor subunits: diversity,
development and disease. Curr Opin Neurobiol 11:327-335.
2+Cummrngs, J.A., Mulkey, R.M., Nicoli, R.A., Malenka, R.C. 1996. Ca signaling
requirements for long-term depression in the hippocampus. Neuron 16:825-833.
Dani, J.A. 2003. Roles of dopamine signaling in nicotine addiction. Mol Psychiatry
8:255-256.
Das, S., Sasaki, Y.F., Rothe, I., Premkumar, L.S., lakasu, M., Crandali, J.E.,
Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., Chen, H.S., Lipton, S.A.
Nakanishi, N. 1998. Increased NMDA current and spine density in mice lacking the
NMDA receptor subunit NR3A. Nature 393:377-38 1.
Debanne, D., Guerineau, N.C., Gahwiler, B.H. and Ihompson, S.M. 1996. Paired
pulse facilitation and depression at unitary synapses in rat hippocampus: quantal
fluctuation affects subsequent release. J Physiol 491:163-176.
De Olmos, J.S. and Heimer, L. 1999. The concepts ofthe ventral striatopallidal system
ans extended amygdala. AnnNY Acad Sci 877:1-32.
De Rover, M., Lodder, J.C., Kits, K.S., Schoffelmeer, A. N. and Brussaard, A.B.
2002. Cholinergic modulation of nucleus accumbens medium spiny fleurons. Eur J
Neurosci 16:2279-2290.
De Viltiers, 5.11., Lindblom, N., Kalayanov, G., Gordon, S., Malmerfeit, A.,
Johansson, A.M. and Svensson, T.H. 2002. Active immunization against nicotine
suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell.
Respiration 69:247-253.
188
Deutsch, S.I., Mastropaolo, J., Rosse, R.B. 1998. Neurodevelopmental consequences
of eariy exposure to phencyclidine and related drugs. Clin Neuropharmacol 21:320-332.
Di Chiara, G. and Imperato, A. 1988. Drugs abused by humans preferentially increase
synaptic dopamine concentrations in the mesolimbic system of freeiy moving rats. Proc
Nati Acad Sci U S A 85:5274-5278.
Dingledine, R., Borges, K, Bowie, D. and Traynelis, S.F. 1999. The glutamate receptor
ion channeis. Pharmacol Rev 5 1:7-61.
Dittman, J.S., Kreitzer, A.C. and Regehr, W.G. 2000. Interplay between facilitation,
depression, and residual calcium at three presynaptic terminais. J Neurosci 20:1374-1385.
Dobrunz, L.E., Huang, E.P. and Stevens, C.F. 1997. Veiy short-term plasticity in
hippocampal synapses. Proc Nati Acad Sci U S A 94:14843-14847.
Dobrunz, L.E and Stevens, C.F. 1999. Response of hippocampai synapses to natural
stimulation pattems. Neuron 22:157-166.
Dobrunz, LE and Stevens, C.F. 1997. Heterogeneity of release probability, facilitation,
and depietion at central synapses. Neuron 12:995-100$.
Dodt, H. U. and Misgeld, U. 1986. Muscarinic slow excitation and muscarinic inhibition
ofsynaptic transmission in the rat neostriatum. J Physiol (Lond) 380:593-608.
Dube, L., Smith, A.D. and Botam, J.P. 1988. Identification of synaptic terminais of
thalamic or cortical origin in contact with distict medium-size spiny neurons in the rat
neostriatum. J Comp Neuroi 267:455-471.
Dunah, A.W. and Standaert, D.G. 2001. Dopamine Dl receptor-dependent trafficking
of striatai NMDA glutamate receptors to the postsynaptic membrane. J Neurosci
21:5546-555$.
Durand, G.M., Kovalchuk, Y., Konnerth, A. 1996. Long-term potentiation and
functional synapse induction in deveioping hippocampus. Nature 381:71-75.
Dzubay, J.A. and Jahr, C.E. 1996. Kinetics of NMDA channel opening. J Neurosci
16:4129-4134.
E1-Bizri, H. and C]arke, P. B. S. 1994. Blockade of nicotine receptor-mediated reiease
of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br J
Pharmacoi 111:414-418.
Ericson, M., Molander, A., Lof, E., Engel, J.A., Soderpaim, B. 2003. Ethanol elevates
accumbai dopamine levels via indirect activation of ventral tegmental nicotinic
acetyichoiine receptors. Eur J Pharmacoi 467:85-93.
189
Fantin, G. and Bottecchia, D. 1984. Effect of nucleus accumbens destruction in rat.
Experientia (Base!). 40: 573-5 75.
Farrant, M., Feldmeyer, D., Takahashi, T. and CuII-Candy, S.G. 1994. NMDA
receptor channel diversity in the developing cerebellum. Nature (Lond) 368:335-339.
Felder, C.C. 1995. Muscarinic acetylcholine receptors: signal transduction through
multiple effectors. fedn Am. Socs. Exp Biol J 9:619-625.
Finch, D.M. 1996. Neurophysiology of converging synaptic inputs from the rat
prefrontal cortex, amygdala, midiine thalamus, and hippocampal formation onto single
neurons ofthe caudate/putamen and nucleus accumbens. Hippocampus 6:495-5 12.
Fiorentini, C., Gardoni, F., Spano, P., Di Luca, M., Missale, C. 2003. Regulation of
Dopamine Dl Receptor Trafficking and Desensitization by Oligomerization with
Glutamate N-Methyl-D-aspartate Receptors. J Biol Chem 278:20196-20202.
Fislier, J.L. and Dani, J.A. 2000. Nicotinic receptors on hippocampal cultures can
increase synaptic glutamate currents while decreasing the NMDA-receptor component.
Neuropharmacol 39:2756-2769.
Fisher, R.S., Buchwatd, N.A., Huit, C.D. and Levine, M.S. 1986. The gabaergic
striatonigral neurons of the cat: demonstration by double peroxidase labling. Brain Res
398:148-156.
Fleck, M.W., Bahrïng, R., Patneau, D.K. and Mayer, M.L. 1996. AMPA receptor
heterogeneity in rat hippocampal neurons revealed by differential sensitivity to
cyclothiazide. J Neurophysiol 75: 2322-2333.
Flint, A.C., Maisch, U.S., Weishaupt, J.H., Kriegsteïn, A.R., Monyer, H. 1997.
NR2A subunit expression shortens NMDA receptor synaptic currents in developing
neocortex. J Neurosci 17:2469-2476.
Flores, C.M., Rogers, S.W., Pabreza, L.A., Wolff, B.B. and Kellar, K.J. 1992. A
subtype of nicotinic cholinergic receptor in rat brain is composed of alpha4-subunit and is
upregulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
Fox, K., Henley, J., Isaac, J. 1999. Experience-dependent development of NMDA
receptor transmission. Nat Neurosci 2:297-299.
Fragioudaki, K., Kouvelas, E.D., Mïtsacos, A. 2003. Differential effect of dopamine
deficiency on the expression of NMDA receptor subunits in the weaver mouse brain. Fur
J Neurosci 17:2056-2064.
Frerking, M. and Nicoll, R.A. 2000. Synaptic kainite receptors. Curr Opinion in
Neurobiol 10:342-351.
190
Frerking, M., Schmitz, D., Zhou, Q., Johansen, J. and Nicoti, RA. 2001. Kainate
receptors depress excitatory synaptic transmission at CA3-->CA1 synapses in the
hippocampus via a direct presynaptic action. J Neurosci 21:2958-2966.
Freund, T. F., Poweil, J.F. and Smith, A.D. 1984. Tyrosine hydroxylase
immunoreactive boutons in synaptic contact with identified striatonigral neurons, with
particularreference to dendritic spines. Neurosci 13:1189-1215.
Fu, Y., Matta, S.G., Gao, W., Brower, V.G., Sharp, B.M. 2000a. Systemic nicotine
stimulates dopamine release in nucleus accumbens: re-evaluation of the role ofN-methyl
D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294:458-465.
Fu, Y., Matta, S.G., Gao, W., Sharp, B.M. 2000b. Local aipha-bungarotoxin-sensitive
nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine
secretion in vivo. Neurosci 101:369-375.
Gaddnas, H., Piepponen, T.P. and Ahtee, L. 2002. Mecamylamine decreases accumbal
dopamine output in mice treated chronically with nicotine. Neurosci Lett 330:219-222.
Gauchy, C., Desban, M., Krebs, M.O., Glowinski, J. and Kemel, M.L. 1991. Role of
dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine
evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus.
Neurosci 41: 449-458.
Girod, R., Barazangi, N., McGehee, D. and Role, L.W. 2000. Facilitation of
gÏutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors.
Neuropharmacol 39:2715-2725.
Grady, S., Marks, M. J., Wonnacott, S. and Coltins, A.C. 1992. Characterization of
nicotinic receptor-mediated 3H dopamine release from synaptosomes prepared from
mouse striatum. J Neurochem 59: 848-856.
Grady, S., Meinerz, N.M., Cao, J., Reynolds, A.M., Picciotto, M.R., Changeux, J.P.,
Mclntosh, J.M., Marks, M.J. and Collins, A.C. 2001. Nicotinic agonists stirnulate
acetylcholine release from mouse interpeduncular nucleus: a function mediated by a
different nAChR than dopamine release from striatum. J Neurochem 76:258-268.
Gray, N.S., Pilowsky, L.S., Cray, J.A. and Kerwin, R.W. 1995. Latent inhibition in
dmg naïve schizophrenics: relationship to duration of illness and dopamine D2 binding
using SPET. Schizophr Res 17: 95-107.
Gray, R., Rajan, A.S., Radcliffe, K.A., Yakehiro, M., Dani, J.A. 1996. Hippocampal
synaptic transmission enhanced by low concentration of nicotine. Nature 383:713-716.
Graybiel, A.M. 1990. Neurotransmitters and neuromodulators in the basal ganglia.
Trends Neurosci 13:133-154.
191
Green, T.A., Crooks, P.A., Bardo, M.T. and Dwoskin, L.P. 2001. Contributory role for
nomicotine in nicotine neuropharmacology: nomicotine-evoked [3H]dopamine overflow
from rat nucleus accumbens suces. Biochem Pharmacol 62:1597-1603.
Greene, R. 2001. Circuit analysis ofNMDAR hypofunction in the hippocampus, in vitro,
and psychosis of schizophrenia. Hippocampus 11:569-577.
Groenewegen, H.J. 1991. Functional anatomy of the ventral, limbic system-inervated
striatum. In The Mesolimbic Doparnine Systems fromMotivation to Action. P. Willner&
J. Scheel-Kruger, Eds: 19-59. John Wiley & Sons. Chichester. U.K.
Groenewegen, H.J. and Russchen, F.T. 1984. Organization of the efferent projections
of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a
tracing and immunohistochemical study in the cat. J Comp Neurol 223:347-367.
Groenewegen, ll.J., Room, P., Witter, M.P. and Lohman, A.H. 1982. Cortical
afferents of the nucleus accumbens in the cat, studied with anterograde and retrograde
transport techniques. Neurosci 7:977-996.
Groenewegen, H.J., Vermeulen-Van der Zee, E., Kortschot, A. and Witter, M.P.
1987. Organization of the projections from the subiculum to the ventral stritum in the rat.
A study using anterograde transport of phaseolus vulgaris leucoaggiutinin. Neurosci
23:103-120.
Grosshans, D.R., Clayton, D.A., Coultrap, S.J., Browning, M.D. 2002. LTP leads to
rapid surface expression of NMDA but flot AMPA receptors in aduÏt rat CAl. Nat
Neurosci 5:27-33.
Guo, J. Z., Tredway, T. L. and Chiappinetli, V. A. 1998. Glutarnine and GABA
release are enhanced by differrent subtypes of presynaptic nicotinic receptors in the
lateral geniculate nucÏeus. J Neurosci 18: 1963-1969.
Hakan, R.L., Berg, G.I. and Henriksen, S.J. 1992. Electrophysiological evidence for
reciprocal connectivity between the nucleus accumbens septi and ventral palÏidaÏ region.
Brain Res 581:344-350.
Harvey, J. and Lacey, M.G.1996. Endogeneous and exogenous dopamine depress
EPSCs in rat nucleus accumbens in vitro via Dl receptor activation. J Physiol 292:143-
154.
Harvey, J. and Lacey, M.G. 1997. A postsynaptic interaction between doparnine Dl
and NMDA receptors promotes presynaptic inhibition in the rat nucleous accumbens via
adenosine release. J Neurosci 17:5271-5280.
192
Hedreen, J.C. 1981. Neurons of the nucleus accumbens and other striatal regions in rats.
In the Neurobiology of the nucleus accumbens. R.B. Chronister & J.F. DeFrance Eds. :82-
96. The Haer Institute for Electrophysiological Research. Brunswick, ME.
Heimer, L., Alheid, G.F., de Olmos, J.S., Groenewegen, H.J., Haber, S.N., Harlan,
R.E., Zahm, D.S. 1997. The accumbens: beyond the core-sheli dichotomy. J
Neuropsychiatry Clin Neurosci Rev 9:354-38 1.
Heïmer, L. and Wilson, R.D. 1975. The subcortical projections of the allocortex:
similarities in the neural associations of the hippocampus, the pirform cortex, and
neocortex. In Golgi Centennial Symposium: Perspectives in Neurobiology, ed. M Santini,
PP.177-193. New York: Raven.
Heimer, L., Switzer, R.D. and Van Hoesen, G.W. 1994. Ventral striatum and ventral
pallidum: components ofthe motor system? Trends Neurosci 5: 83-87.
Heimer, L., Zahm, D.S., Churchill, L., Kalivas, P.W. and Wohltmann, C. 1991.
Specificity in the projection pattems of accumbal core and sheli in the rat. Neurosci
41:89-125.
Hersch, S.M., Gutekunst, C.A., Rees, H.D., Heilman, C.J. and Levey, A.!. 1994.
Distribution of ml-m4 muscarinic receptor proteins in the rat striatum: light and electron
microscopic immunocytochemstry using subtype-specific antibodies. J Neurosci
14:3351-3363.
Hestrin, s. 1992. Developmental regulation of NMDA receptor-mediated synaptic
currents at a central synapse. Nature 357: 686-689.
Hestrin, S., Sah, P. and NicolI, RA. 1990. Mechanisms generating the time course of
dual component excitatory synaptic currents recorded in hippocampal suces. Neuron
5:247-253.
Hikida, T., Kaneko, S., Isobe, T., Kitabatake, Y., Watanabe, D., Pastan, I.,
Nakanishi, S. 2001. Increased sensitivity to cocaine by cholinergic ceil ablation in
nucleus accumbens. Proc Nati Acad Sci USA. 98:13351-13354.
Hikida, T., Kitabatake, Y., Pastan, I., Nakanishi, 5. 2003. Acetylcholine enhancement
in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc
NatI Acad Sci USA 100:6169-6173.
Hill, J.A. Jr, Zou, M., Bourgeois, J.p. and Changeux, J.?. 1993. Immunocytochemical
localization of a neuronal nicotinic receptor: The 2 subunit. J Neurosci 13:1551-1568.
193
Hisham, M., Ibrahim, M.D., Alan, J., Hogg, Jr., B.S.E., Daniel, J., Healy, M.D.,
Marino, M.J. and Conn, P.J. 2002. Direct and indirect modulation of the N-methyl D
aspartate receptor. Curr Drug Target CNS Neurol Disord 1:1-16.
Hollmann, M. 1999. Structure of ionotropic glutamate receptors. In Ionotropic
Glutamate Receptors in the CNS. Edited by Jonas P. Monyer H. Berlin:Springer; 1-98.
Hollmann, M. and Heinemann, S. 1994. Cloned glutamate receptors. Ann Rev
Neurosci 17:31-108.
Holimanu, M., Hartley, M. and Heinemann, S. 1991. Ca2 permeability ofKA-AMPA
-gated glutamate receptor channels depends on subunit composition. Science 252:85 1—
853.
Hollmann, M., O’Shea-Greenfield, A., Rogers, S.W. and Heinemann, S. 1989.
Cloning by functional expression of a member of the glutamate receptor family. Nature
(Lond) 342:643-648.
bit, D.J., Herman, M.M., Hyde, T.M., Kieinman, J.E. Sinton, C.M., German, D.C.,
Hersh L.B., Graybiel, A.M. and Saper, C.B. 1999. Evidence for a deficit in cholinergic
intemeurons in the striatum in schizophrenia. Neurosci 94:21-31.
Honoré, I., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. and
Nielsen, F.E. 1988. Quinoxalinediones: potent competitive non-NMDA glutamate
receptor antagonists. Science (Wash.DC) 241:701-703.
Howe, A.R. and Surmeler, D.J. 1995. Muscarinic receptors modulate N-, P-, and L-type
Ca2+ currents in rat striatal neurons through parallel pathways. J Neurosci 15:458-469.
Urabetova, S., Serrano, P., Blace, N., Tse, H.W., Skifter, D.A., Jane, D.E.,
Monaghan, D.T. and Sacktor, T.C. 2000. Distinct NMDA receptor subpopulations
contribute to long-term potentiation and long-term depression induction. J Neurosci
20:RC8Ï.
Hsieh, C.Y., Chen, Y., Leslie, F.M. and Metherate, R. 2002. Postnatal development of
NR2A and NR2B mRNA expression in rat auditory cortex and thalamus. J Assoc Res
Otolaryngol 3:479-487.
Hsu, K.5. Huang, C.C., Yang, C.H. and Gean, P.W. 1995. Dopaminergic receptors
mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res 690:
264-68.
Hsu, K.S., Yang, C.H., Huang, CC. and Gean, P.W. 1996. Carbachol induces inward
current in neostriatal neurons through M1-like muscarinic receptors. Neurosci 73:751-
760.
194
Huang, R.C. and Lin, J.Y. 1998. Voltage- and use-dependent inhibition by
amphetamine of field potentials and Na+ current in rat nucleus accumbens fleurons.
Neurosci Lett 252:65-68.
Huang, Q., Zhou, D., Chase, K., Gusella, J.F., Aronin, N. and DiFiglia, M. 1992.
Immunohistochemical localization of the Dl dopamine receptor in rat brain reveals its
axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia,
limbic system, and thalamic reticular nucleus. Proc Nati Acad Sci USA 89:11988-11992.
Hutme, E.C. 1990. Muscarinic acetyÏcholine receptors: typical G-coupled receptors.
Symp Soc Exp Bio 44:39-54.
Hume, R.L, Ding]edine, R. and Heinemann, S.F. 1991. Identification of a site in
glutamate receptor subunits that controls calcium permeability. Science 253:1028-1031.
Ikeda, K., Nagasawa, M., Mon, H., Araki, K., Sakimura, K., watanabe, M., moue,
Y. and Mïshina, M. 1992. Cloning and expression of the 4 subunit of the NMDA
receptor channel. FEBS Lett 313: 34-38.
Ishii, T., Moriyoshï, K., Sugihara, H., Sakurada,K., Kadotani, H., Yokoi, M.,
Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M., Nakanishi, S. 1993. Molecular
characterization of the family of the N-metyl-d-aspartate receptor subunits. J Biol Chem
26$: 2836-2843.
Izzo, P.N. and Bolam, J.P. 1988. Cholinergic synaptic input to different parts of spiny
striatonigral neurones in the rat. J Comp Neurol 269:219-234.
Jahr, C.E. and Stevens, CF. 1987. Glutamate activates multiple single channel
conductances in hippocampal neurons. Nature (Lond) 325:522-525.
James, M. K. and Cubeddu, L. X. 1987. Pharmacological characterization and
functional role of muscarinic autoreceptors in the rabbit striatum. J Pharmacol Exp Ther
240:203-215.
Jayaraman, A. 1985. Organization of thalamic projections in the nucleus accumbens
and the caudate nucleus in cats and its relation with hippocampal and other subcortical
afferents. J Comp Neurol 231:396-420.
Jevtovic-Todorovic, V., Hartman, R.E., Izumi, Y., Benshoff, N.D., Dikranian, K.,
Zorumski, C.F., Olney, J.W., Wozniak, D.F. 2003. Early exposure to common
anesthetic agents causes widespread neurodegeneration in the developing rat brain and
persistent learning deficits. J Neurosci 23:876-882.
Jiang, L., Sun, S., Nedergaard, M. and Kang, J. 2000. Paired-pulse modulation at
individual GABAergic synapses in rat hippocampus. J Physiol 523 :425-439.
195
Johnson, J.H., Zhao, C., James, J.R. and Rosecrans, J.A. 2000. Individual variability
of dopamine release from nucleus accumbens induced by nicotine. Brain Res BulI
51:249-253.
Jolinson, J.W. and Ascher, P. 1987. Glycine potentiates the NMDA response in
cultured mouse brain fleurons. Nature (Lond) 325:529-531.
Johnson, L.R., Aylward, R.L., Hussain, Z., Totterdeli, S. 1994. Input from amygdala
to the rat nucleus accumbens: its relationship with tyrosine hydroxylase immunoreactivity
and identified fleurons. Neurosci 61: 851-865.
Jones, K.A. and Baughman, R.W. 1991. Both NMDA and non-NMDA subtypes of
glutamate receptors are concentrated at synapses on cerebral cortical neurons in culture.
Neuron 7:593-603.
Jones, S.M., SneII, L.D., Johnson, K.M. 1987. Inhibition by phencyclidine ofexcitatory
amino acid-stimulated release of neurotransmitter in the nucleus accumbens.
Neuropharmacol 26:173-179.
Jongen-Relo, A.L., Docter, G.J., Jonker, A.J., Vreugdenhil, E., Groenewegen, H.J.
and Voorn, P. 1994. Differential effects of dopamine depletion on the binding and
mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens.
Mol Brain Res 25:333-343.
Joshi, I. and Wang, L.Y. 2002. Developmental profiles of glutamate receptors and
synaptic transmission at a single synapse in the mouse auditory brainstem. J Physiol
540:861-873.
Joyce, J.N. 1993. The dopamine hypothesis of schizophrenia: limbic inactions with
serotonin and norepinephrine. Psychopharmacol (Berl) 112: S 16-34.
Joyce, J.N. and Meador-Woodruff, J.H. 1997. Linking the family of D2 receptors to
neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacol 16:
375-384.
Kalivas, P.W. and Duffy, P. 1997. Dopamine regulation of extracellular glutamate in the
nucleus accumbens. Brain Res 76 1:173-177.
Kamiya, H. and Zucker, R.S. 1994. Residual Ca2 and short-terni synaptic pÎasticity.
Nature 371: 603-606.
Kajimoto, Y., Shirakawa, O., Lin, X.H., Hashïmoto, T., Kitamura, N., Murakami,
N., Takumi, T., Maeda, K. 2003. Synapse-associated protein 90/postsynaptic density
95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats
and is increased in the nucleus accumbens of patients with schizophrenia.
Neuropsychopharmacol 28:1831-1839.
196
Kawaguchi, Y. 1992. Large aspiny ceils in the matrix of the rat neostriatum in vitro:
physiological identification, relation to the compartments and excitatory postsynaptic
currents. J Neurophysiol 67:1669-1682.
Kawaguchi, Y. 1993. Physiological, morphological, and histochemical characterization
ofthree classes ofintemeurons in rat neostriatum. J Neurosci 13:4908-4923.
Kawaguchi, Y., Wilson, C.J. and Emson, P.C. 1989. Intracellular recording of
identiafied neostriatal patch and matrix spiny ceils in a slice preparation preserving
cortical inputs. J Neurophysiol 62:1052-106$.
Kawaguchi, Y., Wilson, C.J. and Emson, P.C. 1990. Projection subtypes of rat
neostriatal mati-ix ceils revealed by intracellular injection of biocytin. J Neurosci
10:3421-343$.
Keller, B.U., Konnerth, A. and Yaari, Y. 1991. Patch clamp analysis of excitatory
synaptic currents in granule celis of rat hippocampus. J Physiol 435:275-293.
KeIIey, A.E. and Domesick, V.B. 1982. The distribution of the projection from the
hippocampal formation to the nucleus accumbens in the rat: an anterograde- and
retrograde-horseradi sh peroxidase study. Neurosci 7: 2321-2335.
Kelley, A.E. and Stinus, L. 1984. The distribution ofthe projection from the parataenial
nucleus of the thalamus to the nucleus accumbens in the rat: an autoradiographic study.
Exp Brain Res 54:499-5 12.
KeIIey, A.E., Domesick, V. and Nauta, W.J.H. 1982. The amygdalostriatal projection in
the rat: an anatomical study by anterograde and retrograde tracing methods. Neurosci 7:
615-630.
Keiz, M.B., Chen, J., Carlezon, W.A. Jr, Whisler, K., Gilden, L., Beckmann, A.M.,
Steffen, C., Zhang, Y.J., Marotti, L., Self, D.W., Tkatch, T., Baranauskas, G.,
Surmeier, D.J., Neye, R.L., Duman, R.S., Picciotto, M.R., Nestier, E.J. 1999.
Expression of the transcription factor deltaFosB in the brain controls sensitivity to
cocaine. Nature 401:272-276.
Kemp, J.A., Foster, A.C., Leeson, P.D., Priestley, T., Tridgett. R., Iversen, L.L.,
Woodruff, G.N. 198$. 7-Chlorokynurenic acid is a selective antagonist at the glycine
modulatoiy site of the N-methyl-D-aspartate receptor complex. Proc Nati Acad Sci U S A
85:6547-6550.
Keys, A.S. and Mark, G.P. 1998. Dl and D2 dopamine receptor mediation of
amphetamine-induced acetylcholine release in nucleus accumbens. Neurosci 26:521-531.
Kirischuk, S., Clements, J.D. and Grantyn, R. 2002. Presynaptic and postsynaptic
mechanisms underlie paired pulse depression at single GABAergic boutons in rat
collicular cultures. J Physiol 543:99-116.
197
Kohier, E.C., Messer, W.S. and Jr, Bingman, V.P. 1995. Evidence for muscarinic
acetylcholine receptor subtypes in the pigeon telencephalon. J Comp Neurol 362:271-
282.
Kombian, S.B., Ananthaiakshmi, K.V., Parvathy, S.S., Matowe, W.C. 2003.
Substance P depresses excitatory synaptic transmission in the nucleus accumbens through
dopaminergic and purinergic mechanisms. J Neurophysiol 89:728-737.
Kombian S. B. and Maleuka R.C. 1994. Simultaneous LTP ofnon-NMDA and LTD of
NMDA-receptor-mediated responses in the nucleus accumbens. Nature 368:242-246.
Koob, G.F. and Nestier, E.J. 1997. The neurobiology of drug addiction. J
Neuropsychiatr Clin Neurosci 9: 482-497.
Kotecha, S.A., Oak, J.N., Jackson, M.F., Perez, Y., Orser, B.A., Van Toi, 11.11.,
MacDonaid, J.F. 2002. A D2 class dopamine receptor transactivates a receptor tyrosine
kinase to inhibit NMDA receptor transmission. Neuron 35:1111-1122.
Kotter, R. 1994. Postsynaptic integration of glutamatergic and dopaminergic signais in
the striatum. Prog Neurobiol 44:163-196.
Krayniak, P.F., Meibacli, R.C. and Siegei, A. 1981. A projection from the entorhinal
cortex to the nucleus accumbens in the rat. Brain Res 209:427-431.
Krebs, C., Fernandes, ll.B., Sheidon, C., Raymond, L.A., Baimbrïdge, K.G. 2003.
Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo
and anoxia in vitro. J Neurosci 23:3364-3372.
Kubota, Y., Inagaki, S., Shimada, S., Kito, S., Eckenstein, F. and Tohyama, M. 1927.
Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons.
Brain Res 413:179-184.
Kushida, C.A., Zoitoski, R.K. and Gïiiin, J.C. 1995. The expression of M1-M3
muscarinic receptor mRNAs in rat brain following REM sleep deprivation. Neuroreport
6:1705-1708.
Kutsuwada, T., Kashiwabuchi, N., Mon, H., Sakimura, K., Kushiya, E., Araki, K.,
Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M., Mishina, M. 1992. Molecular
diversity ofNMDA receptor channel. Nature 358: 36-41.
Ichikawa, J., Chung, Y.C., Li, Z., Dai, J., Meltzer, H.Y. 2002. Cholinergic modulation
of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and
nucleus accumbens. Brain Res 958:176-184.
198
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vockier, J., Dikranian, K.,
Tenkova, T.I., Stefovska, V., Turski, L., Olney, J.W. 1999. Blockade of NMDA
receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74.
Imperato, A., Mutas, A., Di Chiara, G. 1986. Nicotine preferentially stimulates
dopamine release in the limbic system of freeiy moving rats. Eur J Pharmacol 132:337-8.
Isaac, J.T., Crair, M.C., Nicol], R.A., Malenka, R.C. 1997. Suent synapses during
development ofthalamocortical inputs. Neuron 18:269-280.
Isaacson, J.S. and Walmsley, B. 1995. Receptors underiying excitatory synaptic
transmission in suces of the rat anteroventrai cochiear nucleus. J Neurophysiol 73:964-
973.
Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M.,
Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M. and Nakanisji, 5. 1993. Moiecular
characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem
268:2836-2843.
Izzo, P.N. and Botam, J.P. 1988. Cholinergic synaptic input to different parts of spiny
striatonigrai neurons in the rat. J Comp Neurol 269:219-234.
Lambe, E.K., Picciotto, M.R. and Aghajanian, G.K. 2003. Nicotine induces glutamate
release ftom thalamocorticai terminais in prefrontal cortex. Neuropsychopharmacol
28:216-225.
Lan, J.Y., Skeberdis, V.A., Jover, T., Zheng, X., Bennett, M.V., Zukïn, R.S. 2001.
Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking.
J Neurosci 2 1:6058-6068.
Lapper, S.R. and Botam, J.P. 1992. Input from the frontal cortex and the parafascicular
nucieus to cholinergic intemeurons in the dorsal striatum ofthe rat. Neurosci 5 1:533-545.
Latysheva, N.V. and Raevskii, K. 5. 2003. Behaviorai anaiysis of the consequences of
chronic blockade ofNMDA-type glutamate receptors in the early postnatal period in rats.
Neurosci Behav Physiol 33:123-131.
Lauer, M., Senitz, D., Beckmann, H. 2001. Increased volume ofthe nucieus accumbens
in schizophrenia. J Neurai Transm 108:645-660.
Laurïe, D.J. and Seeburg, P.H. 1994. Regional and developmental heterogeneity in
splicing ofthe rat brain NMDAR1 mRNA. J Neurosci 14:3180-3194.
Lau, W.K., Lui, P.W., Wong, C.K., Chan, Y.S. and Yung, K.K. 2003. Differentiai
expression of N-methyl-D-aspartate receptor subunit messenger ribonucleic acids and
immunoreactivity in the rat neostriatum during postnatal development. Neurochem Int
43:47-65.
199
Lawrence, J.J. and Trussell, L.O. 2000. Long-term specification of AMPA receptor
properties afler synapse formation. J Neurosci 20: 4864-4870.
Le Greves, P., Huang, W., Johansson, P., Thornwall, M., Zhou, Q. and Nyberg, F.
1997. Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor
NR1, NR2A and NR2B subunit rnRNAs in brain regions of the male rat. Neurosci Lett
226: 61-64.
Le Novère, N. and Chaugeux, J.P. 1995. Molecular evolution of the nicotinic
acetylcholine receptor: An example of multigene family in excitable cells. J Mol Evol
40:155-172.
Lehéricy, S., Hirsch, E.C., Cervera, P., Hersh, L.B., Hauw, J.J., Ruberg, M. and
Agid, Y. 1989. Selective loss of cholinergic neurons in the ventral striatum of patients
with Alzheimer disease. Proc Nati Acad Sci USA 86: 8580-8584.
Leonard, S., Gault, J., Adams, C., Breese, C.R., Rollins, Y., Adier, L.E., Oliucy, A.,
Freedman, R. 199$. Nicotinic Receptors, Smoking and Schizophrenia. Restor Neurol
Neurosci 12:195-201.
Lester, R.A. and Jahr, C.E. 1992. NMDA channel behavior depends on agonist
affinity. J Neurosci 12:635-643.
Lester, R.A.J., Clements, J.D., Westbrook, G.L. and Jahr, C.E. 1990. Chaimel
kinetics determine the time course of NMDA receptor-mediated synaptic currents.
Nature 346:565-567.
Levine M.S. Li Z., Cepeda C., Cromwelt H.C. and Altemus K.L 1996b.
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in
suces. Synapse 24:65-78.
Levïne M.S., Altemus K.L., Cepeda C., Cromwell H.C., Crawford C., Ariano C.,
Drago J., Sibley D.R. and Westphal H. 1996a. Modulatory actions of dopamine on
NMDA receptor-mediated responses are reduced in D1A-deficient mice. J Neurosci 16:
5870-5882.
Lindefors, N., Hurd, Y.L., O’Connor, W.T., Brene, S., Persson, H., Ungerstedt, U.
1992. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus
accumbens 48:439-448.
Lindstrom, J. 1997. Nicotinic acetylcholine receptors in health and disease. Mol
Neurobiol 15: 195-222.
Lipska, B.K., AL-Amin, H.A. and Weinberger, D.R. 1998. Excitotoxic lesions ofthe
rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal
hippocampal damage. Neuropsychophamiacol 19: 451-464.
200
Lipska, B.K., Jaskiw, G.E. and Weinberger, D.R. 1993. Postpubertal emergence of
hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal
damage: a potential animal model ofschizophrenia. Neuopsychopharmacol 9: 67-75.
Lipton, S.A. and Rosenberg, P.A. 1994. Excitatoiy amino acids as a final common
pathway for neurologic disorders. N Engi J Med 330:613-622.
Lloyd, G. K., Menzaghi, F., Bontempi, B. Suto, C. Siegel, R., Akong, M.,
Stauderman, K., Velicelebi, G., Johnson, E., Harpold, M.M., Rao, T.S., Sacaan, A.!.,
Chavez-Noriega, L.E., Wasliburn, M.S., Vernier, J.M., Cosford, N.D., McDonald,
L.A. 1998. The potential of subtype-selective neuronal nicotinic acetylcholine receptor
agonists as therapeutic agents. Life Sci 62:1601-1606.
Lopes da Silva, F.H., Arnolds, D.E. and Neijt, H.C. 1984. A functional link between
the limbic cortex and ventral striatum: physiology of the subiculum accumbens pathway.
Exp Brain Res 55:205-2 14.
Lu, X.Y., Ghasemzadeh, M.B. and Kalivas, P.W. 1998. Expression of D1 receptor, D2
receptor, substance P and enkephlin messenger RNAs in the neurons projecting from the
nucleus accumbens. Neurosci 82: 767-780.
Lubïn, M. and Aokie, C. 1998. Ultrastructural immunolocalization ofthe Œ7 nAChR
Subunit in Guinea pig pre-frontal cortex. 1n Molecular and Functional Diversity of Ion
Channels and Receptors. (Abstr. II-21). Ann NY Acad Sci.
Luetje, C.W. and Patrick, J. 1991. Both alpha- and beta-subunits contribute to the
agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845.
Luk, K.C., Kennedy, T.E., Sadikot, A.F. 2003. Glutamate promotes proliferation of
striatal neuronal progenitors by an NMDA receptor-mediated mechanism. J Neurosci 23:
2239-2250.
Luthi, A., Schwyzer, L., Mateos, J. M., Gahwiler, B.H., McKinney, R. A. 2001.
NMDA receptor activation lirnits the number of synaptic connections during
hippocampal development. Nat Neurosci 4:1102-1 107.
Lydic, R. and Baghdoyan, H.A. 2002. Ketamine and MK-801 decrease acetylcholine
release in the pontine reticular formation, slow breathing, and disrupt sleep. $leep. 25:
617-622.
MacDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J., Barker, J.L. 1986.
NMDA-receptor activation increases cytoplasmic calcium concentration in cultured
spinal cord neurones. Nature 321:519-522.
MacDermott, A.B., Role, L.W. and Siegelbaum, S.A. 1999. Presynaptic ionotropic
receptors and the control oftransmitter release. Ann Rev Neurosci 22: 443-485.
201
Maleuka, R. C. and Kosis, J. D. 1988. Presynaptic actions ofcarbachol and adenosine
on corticostriatal synaptic transmission studied in vitro. J Neurosci 8:3750-3756.
Malenka, R.C. and Nicoli, RA. 1999. Long-term potentiation--a decade of progress?
Science 285:1870-1874.
Mansvelder, H.D., McGehee, D.S. 2002. Cellular and synaptic mechanisms of nicotine
addiction. J Neurobiol 53:606-17.
Marks, M. J., Farmham, D. A., Grady, S. and Collins, A. C. 1993. Nicotinic receptor
function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J
Pharmacol Exp Thr 264:542-552.
Marshall, D., Soliakov, L., Redfern, P., Wannacott, S. 1996. Tetrodotoxin-sensitivity
of nicotine-evoked dopamine release from rat striatum. Neuropharmacol 35:1531-1536.
Masli, D.C. and Potter, L.T. 1986. Autoradiographic localization of Ml and M2
muscarine receptors in the rat brain. Neurosci 19:55 1-564.
Mayer, M.L. and Westbrook, G.L. 1987. Permeation and block of N-methyl-D-aspartic
acid receptor channels by divalent cations in mouse cultured central neurons. J Physiol
394: 501-527.
Mayer, M.L., Westbrook, G. and Guthrie, P.B. 1984. Voltage-dependent block by
Mg + ofNIVIDA responses in spinal cord neurones. Nature 309:261-263.
McGeer, P.L, McGeer, E.G., Fibiger, H.C. and Wickson, V. 1971. Neostriatal
choline acetylase and cholinesterase following selective brain lesions. Brain Res 35:308-
314.
McGehee, D. S. and Rote, L. W. 1996. Presynaptic ionotropic receptors. Curr Opin
Neurobiol 6:342-349.
McGehee, D., Health, M., Gelber, S., Devay, P. and Role, L. W. 1995. Nicotine
enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.
Science 269:1692-1696.
Meador-Woodruff, J.H. and Healy, D.J. 2000. Glutamate receptor expression in
schizophrenic brain. Brain Res Rev 31: 288-294.
Meguro, H., Mon, H., Araki, K., Kushiya, E., Kutsuwada, I., Yamazakï, M.,
Kumanishi, T., Arakawa, M., Sakimura, K. and Mishina, M. 1992. Functional
characterization of a heteromeric NMDA receptor channel expressed from cloned
cDNAs. Nature 357: 70-74.
202
Meredith, G.E. 1999. The synaptic framework for chemical signalling in nucleus
accumbens. AnnNY Acad sci 877:140-156.
Meredith, G.E. and Chang, ll.T. 1994. Synaptic relationships of enkephaïinergic and
cholinergic neurons in the nucleus accumbens ofthe rat. Brain Res 667: 67-76.
Meredith, OEE., Pennartz, C.M. and Groenewegen, H.J. 1993. The celÏuÏar ftamework
for chemical signalling in the nucleus accumbens. Prog Brain Res 99:3-24.
Mereditli, G.E., Wouterlood, F.G. and Pattiselanno, A. 1990. Hippocampal fibers
make synaptic contacts with glutamate decarboxylase-immunoreactive neurons in the rat
nucleus accumbens. Brain Res 5 13:329-334.
Meredith, G.E., Blank, B. and Groenewegen, H.J. 1989. The distribution and
compartmental organization of the cholinergic neurons in nucleus accumbens of the rat.
Neurosci 31:327-345.
Merlo Pich, E., Pagliusï, S.R., Tessari, M., Talabot-Ayer, D., Hooft van
Huijsduijnen, R. and Chiamulera, C. 1997. Common neural substrates for the
addictive properties of nicotine and cocaine. Science 275:83-$6.
Mifsud, J.C., Hernandez, L. and Hoebel, B.G. 1989. Nicotine infused into the nueleus
accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res
478:365-367.
Millan, M.J. 2002. N-methyl-d-aspartate receptor-coupled glycine (b) receptors in the
pathogenesis and treatment of schizophrenia: a critical review. Curr Drug Target CNS
NeurolDisord 1:191-213.
Misgeld, U., Calabresi, P. and Dodt, H.U. 1986. Muscarinic modulation of calcium
dependent plateau potentials in the rat neostriatal fleurons. Pflugers Arch Physiol 407:
482-487.
Misgeld, U. and Dodt, H.U. 1986. Muscarinic slow excitation and muscarinic inhibition
ofsynaptic transmission in the rat neostriatum. J Physiol 380: 593-608.
Mogenson, G.J., Jones, D.L. and Yim, C.Y. 1980. From motivation to action:
functional interface between the limbic system and the motor system. Neurobiol 14:69-
97.
Mogenson, G.J. and Yim, C.Y. 1981. Electrophysiological and neuroparmacological
behavioural studies of the nucleus accumbens: implications for its role as a limbic-motor
interface. In: The neurobiology of Nucleus accumbens, edited by R.B.Chronister and
J.F.Defrance. Brunswick, M.A: Haer Inst., p.2l0-229.
203
Mogenson, G.J., Swanson, L.W. and Wu, M. 1983. Neural projections from nucleus
accumbens to globus pallidus, substantia innominata and lateral preoptic-lateral
hypothalamic area: An anatomical and electrophysiological investigation in the rat. J
Neurosci 3:189-201.
Mogg, A.J., Whiteaker, P., Mclntosh, J.M., Marks, M., Collins, A.C. and
Wonnacott, 5. 2002. Methyllycaconitine is a potent antagonist of aipha-conotoxin-Mil
sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J Pharmacol Exp
Ther 302:197-204.
Montaron, M.F., Denïau, J.M., Menetrey, A., Glowinski, J. and Thierry, A.M. 1996.
Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neurosci
71:371-382.
Monyer, H., Burnashev, N., Laurïe, D.J., Sakmann, B., Seeburg, P.H. 1994.
Developmental and regional expression in the rat brain and functional properties of four
NMDA receptors. Neuron 12: 529-540.
Monyer, H., Seeburg, P.H. and Wisden, W. 1991. Glutamate-operated channels:
developmentally early and mature forms arise by alternative spiicing. Neuron 6: 799-810.
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H.,
Burnashev, N., Sakmann, B., Seeburg, P.H. 1992. Heteromeric NMDA receptors:
molecular and functional distinction ofsubtypes. Science 256: 1217-1221.
Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., Nakanishi, S. 1991.
Molecular cloning and characterization ofthe rat NMDA receptor. Nature 354:31-37.
Mosbacher, J., Schoepfer, R., Monyer, H., Burnashev, N., Seeburg, P.H.,
Ruppersberg, J.P. 1994. A molecular determinant for submillisecond desensitization in
glutamate receptors. Science (Wash. DC) 266: 1059-1062.
Nakanishi, S. 1992. Molecular diversity of glutamate receptors and implications for
brain function. Science (Wash. DC) 258:597-603.
Napier, T.C., Coyle, S., Breese, G.R. 1985. Ontogeny of striatal unit activity and
effects of single or repeated haloperidol administration in rats. Brain Res 333:35-44.
Natua, W.J.H., Smith, G.P., Fauli, R.LM. and Domesick, V.B. 1978. Efferent
connections and nigral afferents of the nucleus accumbens septi in the rat. Neurosci 3:
385-401.
Newman, R. and Winans, S.S. 1980. An experimental study of the ventral striatum of
the golden hamster. I. Neuronal connections of the nucleus accumbens. J Comp Neurol
191:167-192.
204
Nicola, S.M. and Malenka, R. C. 1998. Modulation of synaptic transmission by
dopamine and norepinephrine in ventral but flot dorsal striatum. J Neurophysiol 79:1768-
1776.
Nicola, S.M. and Malenka, R.C. 1997. Dopamine depresses excitatory and inhibitory
synaptic transmission by distinct mechanisms in the nucleus accumbens J Neurosci
17:5697-5710.
Nicola, S.M., Kombian, S.B. and Malenka, R.C. 1996. Psychostimulants depress
excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like
dopamine receptors J Neurosci 16:1591-1604.
Niseli, M., Nomikos, G.G., Svensson, T.H. 1994. Systemic nicotine-induced dopamine
release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral
tegmental area. Synapse 16:36-44.
Nisenbaum, E.S. and Wilson, C.J. 1995. Potassium currents responsible for inward and
outward rectification in rat neostriatal spiny projection neurons. J Neurosci 15:4449-
4463.
Nisenbaum, E.S., Xu, Z.C. and Wilson, C.J. 1994. Contribution of a slowly
inactivating potassium current to the transition to firing of neostriatal spiny projection
neurons. J Neurophysiol 71: 1174-1189.
Nowak, L., Bregestovski, P., Herbet, A. and Prochïantz, A. 1984. Magnesium gates
glutamate-activated channels in mouse central neurones. Nature 307:462-465.
Nye, H.E and Nestier, E.J. 1996. Induction of chronic Fos-related antigens in rat brain
by chronic morphine administration. Mol Pharmacol 49: 636-645.
OIds, M.E. 1990. Enhanced dopamine receptor actiation in accumbens and frontal
cortex has opposite effects on medial forebrain bundles self-stimulation. Neurosci 35:
313-325.
O’Donnell, P. and Grace, A.A. 1995. Synaptic interactions among excitatory afferents
to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J
Neurosci 15:3622-3639.
O’Donnell, P. and Grace, A.A. 1993. Physiological and morphological properties of
accumbens core and shell neurons recorded in vitro. Synapse 13:135-160.
O’Donnell, P., Greene, J., Pabello, N., Lewis, B. and Grace, A.A. 1999. Modulation
ofcell firing in the nucleus accumbens. Ann NY Acad sci 877:157-175.
205
Ohno, M., Arai, L, Watanabe, s. 1995. N-methyl-D-aspartate stimulates dopamine
release through nitric oxide formation in the nucleus accumbens of rats. Brain Res
699:332-335.
Olney, J.W. and Farber, N.B. 1995. Glutamate receptor dysfunction and schizophrenia.
Arch Gen Psychia 52: 998-1007.
Onali, P. and Olianas, M.C. 2002. Muscarinic M4 receptor inhibition ofdopamine Dl
like receptor signalling in rat nucleus accumbens. Eur J Pharmacol 448:105-111.
Ozawa, S., Kamiya, H. and Tsuzuki, K. 1998. Glutamate receptors in the mammalian
central nervous system. Progress in Neurobiol 54:581-618.
Parkinson, J., Fudge, J., Hurd, Y Cyriel, P. and Peoples, L. 2000. Finding motivation
at Seabrook island: the ventral striatum, learning and plasticity TINS 23:1-2.
Paternain, A.V., Morales, M. and Lerma, J. 1995. Selective antagonism of AMPA
receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron
14:185-189.
Partin, K.M., Bowie, D., Mayer, Mi. 1995. Structural determinants of allosteric
regulation in altemativeÏy spliced AMPA receptors. Neuron 14: 833-843.
Paxinos, G. and Watson, C 1986. The rat brain atlas in stereotaxic co-ordinates (2’ ed.)
Orlando F.L: Academic Press.
Pellegrïni-Giampïetro, D.E., Bennett, M.V. and Zukin, R.5. 1991. Differential
expression of three glutamate receptor genes in developing rat brain: an in situ
hybridization study. Proc Nati Acad Sci USA 88:4157-4161.
Pellegrinï-Giampietro, D.E., Bennett, M.V. and Zukin, R.S. 1992. Are Ca2-penneable
kainate/AMPA receptors more abundant in immature brain? Neurosci Lett 144:65—69.
Pellegrini-Giampietro, D.E., Gorter, J. A., Michael V. L., Bennett and Zukin, RS.
1997. The GÏuR2 (G1uR-B) hypothesis: Ca2-permeable AMPA receptors in
neurological disorders. Trends in neurosci 20: 464-470.
Pennartz, C. M., Ameerun, R. F., Groenewegen, H.J., Lopes da Silva, F. H. 1993.
Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens. Eur J
Neurosci 5:107-117.
Pennartz, C.M., Dolleman-Van der WeeI, M.J., Kitai, 5.T., Lopes da Silva, F.H.
1992. Presynaptic dopamine Dl receptors attenuate excitatoiy and inhibitoiy limbic
inputs to the sheil region of the rat nucleus accumbens studied in vitro. J Neurophysiol
67:1325-1334.
206
Pennartz, C.M. and Lopes da Silva, F.H. 1994. Muscarinic modulation of synaptic
transmission in suces of the rat ventral striatum is dependent on the frequency of afferent
stimulation. Brain Res 645:231-239.
Pennartz, C. M. and Kitai, 5.1. 1991. Hippocampal inputs to identified neurons in an in
vitro suce preparation ofthe rat nucleus accumbens: evidence for feed-forward inhibition.
J Neurosci 11:2838-2847.
Pennartz, C. M., Boeijinga, P.H., Kitai, 5.1. and Lopes da Silva, F.H. 1991.
Contribution of NMDA receptors to postsynaptic potentials and paired-pulse facilitation
in identified neurons ofthe rat nucleus accumbens in vitro. Exp Brain Res $6: 190-19$.
Pennartz, C.M., Groenewegen, H.J. and Lopes da Silva, F.H. 1994. The nucleus
accumbens as a complex of functionally distinct neuronal ensembles: an integration of
behavioral, electrophysiological and anatomical data. Prog Neurobiol 42:719-761.
Penny, G.R., Afsharpour, S. and Kitai, S.T. 1986. The glutamate decarboxylase-,
leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in
the neostriatum of the rat and cat: evidence for partial population overlap. Neurosci
17:1011-1045.
Perez-Otano, I., Schulteis, C.T., Contractor, A., Lipton, S.A., Trimmer, J.S., Sucher,
N.J. and Heinemaun, S.F. 2001. Assembly with the NR1 subunit is required for surface
expression ofNR3A-containing NMDA receptors. J Neurosci 21:1228-1237.
Perkel, D.J. and Nicoil, R.A. 1993. Evidence for all-or-none regulation of
neurotransmitter release: implications for long-term potentiation. J Physiol 471:481-500.
Petralia, R.S., Esteban, J.A., Wang, Y.X., Partridge, J.G., Zhao, H.M., Wenthold,
R.J., Malinow, R. 1999. Selective acquisition of AMPA receptors over postnatal
development suggests a molecular basis for suent synapses. Nat Neurosci 2:31-36.
Phelps, P.E., Houser, C.R. and Vaughn, J.E. 1985. Immunocytochemcal localization
of choline acetyltransferase within the rat neostriatum: a correlated light and electron
microscopic study ofcholinergic neurons and synapses. J Comp Neurol 23 8:286-307.
Phillipson, 0.1. and Griffiths, A.C. 1985. The topographic order of inputs to nucleus
accumbens in the rat. Neurosci 16:275-296.
Picciotto, M.R., Zou, M., Rimondini, R., Léna, C., Marubio, L.M., Merlo Pich, E.,
Fuxe, K. and Changeux J.P. 1998. Acetylcholine receptors containing the beta-2
subunit are involved in the reinforcingproperties of nicotine. Nature 391: 173-177.
Picciotto, M.R., Zou, M., Léna, C., Bessis, A., Lallemand, Y., Le Novère, N., Vincen,
P., Merlo Pich, E., Brulet, P.and Changeux, J.P. 1995. Abnormal acoidance leaming
in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374: 65-67.
207
Pidoplichko, V.I., Debiasi, M., Williams, J.T. and Dani, J.A. 1997. Nicotine activates
and desensizes midbrain dopamine neurons. Nature 396: 40 1-404.
Plant, T., Schirra, C., Garaschuk, O., Rossier, J. and Konnerth, A. 1997. Molecular
deterrninants of NMDA receptor function in GABAergic neurons of rat forebrain. J
Physiol (Lond) 499: 47-63.
Poncer, J.C. and Malinow, R. 2001. Postsynaptic conversion of suent synapses during
LTP affects synaptic gain and transmission dynamics. Nat Neurosci 4:989-996.
Poweit, E.W. and Leman, R.B. 1976. Connections ofthe nucleus accumbens. Brain Res
105: 389-403.
Quinlan, E.M., Olstein, D.H. and Bear, M.F. 1999a. Bidirectional, experience
dependent regulation of N-methyl-D-aspartate receptor subunit composition in the rat
visual cortex during postnatal development. Proc Nati Acad Sci USA 96:12876-12880.
Quinlan, E.M., Phi]pot, B.D., Huganir, R.L. and Bear, M.F. 1999b. Rapid, experience
dependent expression of synaptic NMDA receptors in visual cortex in vivo. Nat Neurosci
2:352-357.
Quirion, R., Richard, J. and Wilson, A. 1994. Muscarinic and nicotinic modulation of
cortical acetylcholine release monitored by in vivo microdialysis in freely moving aduit
rats. Synapse 17:92-100.
Rada, P., Mark, G.P., Pothos, E., Hoebel, B.G. 1991. Systemic morphine
simultaneously decreases extracellular acetylcholine and increases dopamine in the
nucleus accumbens of freely moving rats. Neuropharmacol 30:1133-1136.
Radcliffe, K.A. and Dani, J.A. 1998. Nicotinic stimulation produces multiple forms of
increased glutamatergic synaptic transmission, J Neurosci 18: 7075-7083.
Raedler, T.J., Knable, M.B., Weinberger, D.R. 1998. Schizophrenia as a
developrnental disorder of the cerebral cortex. Curr Opin Neurobiol 8:157-161.
Raedler, T.J., Knable, M.B., Joncs, D.W., Urbina, R.A., Gorey, J.G., Lee, K.S.,
Egan, M.F., Coppola, R., Weinberger, D.R. 2003. In vivo determination ofmuscarinic
acetylcholine receptor availability in schizophrenia. Am J Psychiatry 160:118-127.
Rajan, I. and Cime, H.T. 1998. Glutamate receptor activity is required for normal
development oftectal celi dendrites in vivo. J Neurosci 18:7836-7846.
Rapier, C., Lunt, G. G. and Wonnacott, S. 1988. Stereoselective nicotine-induced
release of dopamine from striatal synaptosomes: concentration dependence and repetitive
stimulation. J Neurochem 50:1123-1130.
20$
Rapier, C., Lunt, G. G. and Wonnacott, s. 1990. Nicotine modulation of
3[H]dopamine release from striatal synaptosome: pharrnacological characterization. J
Neurochem 54: 937-945.
Ravenscroft, P. and Brotchïe, J. 2000. NMDA receptors in the basal ganglia. J Anat
196:577-585.
Reid, M.S., Fox, L. Ho, L.B. and Berger, S.P. 2000. Nicotine stimulation of
extracellular glutamate levels in the nucleus accumbens: Neuropharmacological
characterization. Synapse 35: 129-136.
Robbins, T.W. and Everïtt, B.J. 1996. Neurobehavioural mechanisms of reward and
motivation. Curr Opin Neurobiol 6: 228-236.
Roweli, P.P. 1995. Nanomalar concentrations of nicotine inrease the release of 3[H]
dopamine ftom rat striatal synaptosomes. Neurosci Lett 189:171-175.
Rumbaugh, G., Prybylowski, K., Wang, J.F. and Vicini, S. 2000. Exon 5 and spermine
regulate deactivation ofNMDA receptor subtypes. J Neurophysiol 83:1300-1306.
Russeli, V.A., Alun, R., Lamm, M.C., Taljaard, J.J. 1989. Jncreased dopamine D2
receptor-mediated inhibition of [14C] acetylcholine release in the dorsomedial part of the
nucleus accumbens. Neurochem Res 14:877-88 1.
Sacaan, A.!., Dunlop, J.L., Lioyd, G.K. 1995. Pharmacological characterization of
neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine
and striatal dopamine release from rat brain suces. J Pharmacol Exp Ther 274: 224-230.
Salïn-Pascual, R.J. and Drucker-Colin, R. 1998. A novel effect of nicotine on mood
and sleep in major depression. NeuroReport 9: 57-60.
Sandor, N. T., Kiss, J. P., Lendvai, B., Sandor, A. and Vizi, E. S. 1991a. Naloxone
enhanced the release of acetylcholine from cholinergic intemeurons of the striatum if the
dopaminergic input is impaired. Brain Res 552: 343-345.
Sandor, N. T., Zeltes, T., Kiss, J. P., Sershen, H., Torocsik, A., Lajtha, A. and Vizi, E.
5. 1991b. Effect of nicotine on dopaminergic-cholinergic interaction in the striatum.
Brain Res 567: 313-316.
Sans, N., Prybylowski, K., Petralia, R.S., Chang, K., Wang, Y.X., Racca, C., Vicini,
S., Wenthold, R.J. 2003. NMDA receptor trafficking through an interaction between
PDZ proteins and the exocyst complex. Nat Cell Biol 5:520-530.
Sargent, P.B. 1993. The diversity of neuronal nicotinic acetycholine receptors. A Rev
Neurosci 16: 403-443.
209
Saviane, C., Savtchenko, L.P., Raffaelli, G., Voronin, L.L. and Cherubini, E. 2002.
Frequency-dependent shifi from paired-pulse facilitation to paired-pulse depression at
unitaiy CA3-CA3 synapses in the rat hippocampus. J Physiol 544:469-476.
Savicc, N., Luuthi, A., Gaahwiler, B.H., McKinney, R. A. 2003. N-methyl-D-aspartate
receptor blockade during development lowers long-term potentiation threshold without
affecting dynarnic range of CA3-CAY synapses. Proc Nati Acad Sci USA 100:5503-
550$.
Scheetz, A.J., Nairn, A.C. and Constantine-Paton, M. 2000. NMDA receptor-mediated
control ofprotein synthesis at developing synapses. Nat Neurosci 3:211-216.
Schiffmann, S.N., Liedo, P.M., Vincent, J.D. 1995. Dopamine Dl receptor modulates
the voltage-gated sodium current in rat striatal neurones through a protein kinase A. J
Physiol 483:95-107.
Schuistrom, B., De Vi]liers, S., Malmerfeit, A., Svensson, 1.11., Nomikos, G.G. 2000.
Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal
cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
Synapse 36:314-321.
Schiistrom B., Nomikos G.G., Niseil M., Hertel P. and Svensson T.H. 1998a. N
methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the
systemic nicotine-induced dopamine release in the nucleus accumbens. Neurosci 82:781-
789.
Schuistrom, B., Svensson, H.M., Svensson, T.H., Nomikos, G.G. 199$b. Nicotine and
food induced dopamine release in the nucleus accumbens of the rat: putative role of
alpha7 nicotinic receptors in the ventral tegmental area. Neurosci 85:1005-1009.
Schmitt, A., Zink, M., Muller, B., May, B., Herb, A., Jatzko, A., Braus, D.F., Henn,
F.A. 2003. Effects of long-term antipsychotic treatment on NMDA receptor binding and
gene expression ofsubunits. Neurochem Res 28:235-241.
Schneggenburger, R., Sakaba, T. and Neher, E. 2002. Vesicle pools and short-term
synaptic depression: lessons from a large synapse. Trends Neurosci 25:206-2 12.
Schramm, N.L., Egli, R.E., Winder, D.G. 2002. LTP in the mouse nucleus accumbens
is developmentally regulated. Synapse 45:213-219.
Schwartz, J.C., Diaz, J., Bordet, R., Griffon, N., Perachon, S., Pilon, C., Ridray, S.,
Sokoloff, P. 1998. Functional implications of multiple dopamine receptor subtypes: the
D1/D3 receptor coexistence. Brain Res Rev 26: 236-242.
210
Schwartz, R.D., Lehmann, J. and Kellar, K.J. 1984. Presynaptic nicotinic cholinergic
receptors labeled by 3[H] acetylcholine on catecholamine and serotonin axons in brain. J
Neurochem 42:1495-1498.
Scott, L., Kruse, M.S., Forssberg, H., Brismar, H., Greengard, P., Aperia, A. 2002.
Selective up-regulation of dopamine Dl receptors in dendritic spines by NMDA receptor
activation. Proc Nati Acad Sci USA 99:1661-1664.
Seeburg, P.H. 1993. The molecular bioiogy ofmarnmalian glutamate receptor channeis.
Trends Neurosci 16:359-365. Rev.
Seifert, G., Zhou, M., Dietrich, D., Schumacher, T.B., Dybek, A., Weiser, T.,
Wienrich, M., Wilhelm, D. and Steinhauser, C. 2000. Deveiopmental regulation of
AMPA-receptor properties in CAl pyramidal neurons of rat hippocampus.
Neuropharmacol 39:931-942.
Seppa, T. and Ahtee, L. 2000. Comparison of the effects of epibatidine and nicotine on
the output of dopamine in the dorsal and ventral striatum of freely-moving rats. Naunyn
Schmiedebergs Arch Pharmacol 362:444-447.
Sesack, S.R and Pickel, V.M. 1990. In the rat medial nucleus accumbens, hippocampal
and catecholaminergic terminais converge on spiny neurons and are in apposition to each
other. Brain Res 527:266-279.
Sesack, S.R, Deutch, A.Y., Roth, R.H. and Bunney, B.S. 1989. Topographicai
organization of the efferent projections of the mediai prefrontal cortex in the rat: an
anterograde tract-tracing study with phaseolus vulgaris Ïeucoagglutinin. J Comp Neurol
290:213-242.
Sgard, F., Charpantier, E., Barneoud, P., Besnard, F. 1999. Nicotinic receptor
subunit mRNA expression in dopaminergic neurons of the rat brain. Mn N Y Acad Sci
868:633-635.
Shim, I., Javaïd, J.I., Wirtshafter, D., Jang, S.Y., Shin, K.H., Lee, H.J., Chung, Y.C.
and Chun, B.G. 2001. Nicotine-induced behavioral sensitization is associated with
extracelluiar dopamine reiease and expression of c-fos in the striatum and nucieus
accumbens ofthe rat. Behav Brain Res 12 1:137-147.
Sïbley, D.R. 1995. Molecuiar biology of dopamine receptors. In: Molecular and celiuiar
mechanisms ofneostriatal function (Ariano MA, Surmeier D.J, eds), pp 255-272. Austin,
TX: Landes.
Sidhu, A. 1998. Coupiing of Dl and D5 dopamine receptors to multiple G proteins:
Implications for understanding the diversity in receptor-G protein coupling. Mol
Neurobiol 16:125-134. Rev.
211
Simosky, J.K., Stevens, K.E., Freedman, R. 2002. Nicotinic agonists and psychosis.
Curr Drug Target CNS Neurol Disord 1:149-162.
Snyder, E.M., Phulpot, B.D., Huber, K.M., Dong, X., Fallon, J.R., Bear, M.F. 2001.
Intemalization of ionotropic glutamate receptors in response to mGluR activation. Nat
Neurosci 4:1079-1085.
Sokoloff, P., Martres, M.P., Giros, B., Bouthenet, M.L. and Schwartz, J.C. 1992. The
third dopamine receptor D3 as novel target for antipsychotics. Biochem. Pharmacol. 43:
659-666.
Soliakov, L. and Wonnacott, s. 1996. Voltage-sensitive Ca2 channels involved in
nicotinic receptor-mediated [3H]dopamine release from rat striatal synaptosomes. J
Neurochem 67: 163-170.
Solomon, P.R. and Staton,D.M. 1982. Differental effects of microinjections of D
amphetamine into the nucleus accumbens or the caudate putamen on the rat’s ability to
ignore an irrelevant stimulus. Biol Psychia 17: 743-756.
Sommer, B., Keinanen, K., Verdooru, T.A., Wisden, W., Burnashev, N., Herb, A.,
Kohier, M., Takagi, T., Sakmann, B. and Seeburg, P.H. 1990. Flip and flop: a celi
specific functional switch in glutamate-operated channels of the CNS. Science (Wash.
DC) 249: 1580-1585.
Standley, S., Tocco, G., Tourigny, M.F., Massicotte, G., Thompson, R.F. and
Baudry, M. 1995. Developmental changes in alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionate receptor properties and expression in the rat hippocampal formation.
Neurosci 67:881-892.
Stem, E.A., Jaeger, D. and Wilson, C.J. 1997. Spontaneous subthreshold membrane
potential fluctuations and action potential variability of rat corticostriatal and striatal
neurons in vivo. J Neurophysiol 77: 1697-1715.
Stem, P., Behe, P., Schoepfer, R. and Colquhoun, D. 1992. Single channel
conductances of NMDA receptors expressed from cloned cDNAs: comparison with
native receptors. Proc R Soc Lond B Biol Sci 250: 27 1-277.
Sugihara, H., Moriyoshi, K., Ishii, T., Masu, M. and Nakanishi, S. 1992. Structures
and properties of seven isoforms of the NMDA receptor generated by alternative splicing.
Biochem Biophys Res Commun 185:826-832.
Sugita, S. Uchimura, N., Jiang, Z.G., North, R.A. 1991. Distinct muscarinic receptors
inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian
brain. Proc Natl Acad Sci USA 88:2608-2611.
212
Swanson, L.W. and Cowan, W.A. 1975. A note on the connections and development of
the nucleus accumbens. Brain Res 92: 324-330.
Swerdlow, N.R. and Koob, G.F. 1987. Lesions of the dorsomedial nucleus of the
thalamus, medial prefrontal cortex and pedunculoopontine nucleus: effects on locomotor
activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res 412:233-
243.
Sziraki I., Sershen H., Benuck M., Hashim A. Lajtha A. 1998. Receptor systems
participating in nicotine-specific effects. Neurochem Int 33: 445-457.
Sziraki, I., Sershen, H., Hashim, A., Lajtha, A. 2002. Receptors in the ventral tegmental
area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem
Res 27:253-26 1.
Takahashi, T., Forsythe, I.D., Tsujimoto, T., Barnes-Davies, M., Onodera, K. 1996.
Presynaptic calcium current modulation by metabotropic glutamate receptor. Science
274:594-597.
Takagi, M. and Yamamoto, C. 1978. Suppressing action ofcholinergic agents on
synaptic transmission in the corpus striatum of rats. Exp Neurol 62: 433-443.
Tarazi, F.I, Campbell, A., Yeghiayan, S.K., Baldessarini, R.J. 1998. Localization of
dopamine receptor subtypes in caudate-putamen and nuvleus accumbens septi of rat
brain: Comparison ofD-D2- and D4-like receptors. Neurosci 83:169-176.
Tepper, J.M. and Trent, F. 1993. In vivo studies of the postnatal development of rat
neostriatal fleurons. Prog Brain Res 99: 35-50.
Tepper, J.M., harpe, N.A., Koos, T.Z. and Trent, F. 1998. Postnatal development of
the rat neostriatum: electrophysiological, light- and electron-microscopic studies. Dey
Neurosci 20: 125-145.
Thomas, M.J., Beurrier, C., Bonci, A., Malenka, R.C. 2001. Long-term depression in
the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat
Neurosci 4:1217-1223.
Thomson, A.M., Deuchars, J. and West, D.C. 1993. Large, deep layer pyramid-pyramid
single axon EPSPs in slices of rat motor cortex display paired pulse and ftequency
dependent depression, mediated presynaptically and self-facilitation, mediated
postsynaptically. J Neurophysiol 70:2354-2369.
Tong, G. and Jahr, C.E. 1994. Multivesicular release from excitatory synapses of
cultured hippocampal neurons. Neuron 12:51-59.
213
Torrao, A.S., Lindstrom, J.M. and Britto, L.R. 1996. Presumptive presynaptic
nicotinic acetylcholine receptors in the click tectum: effects of lesions of the lateral
spiriform nucleus. Brain Res 743:154-161.
Toth, E., Vizi, E.S., Lajtha, A. 1993. Effect of nicotine on the levels of extracellular
amino acids in regins ofthe rat brain in vivo. Neuropharmacol 32: 827-832.
Totterdeli, S. and Smith, A.S. 1989. Convergence of hippocampal and Da-ergic input
onto identified neurons in the nucleus accumbens of the rat. J Chem Neuroanat 2:285-
29$.
Traynelis, S.F., Hartley, M. and Heinemann, S.f. 1995. Control of proton sensitivity of
the NMDA receptor by RNA spiicing and polyamines. Science 268:873-876.
Tsai, G. and Coyle, J. T. 2002. Glutamatergic mechanisms in schizophrenia. Annu Rev
Pharmacol Toxico! 42:165-179.
Tsuzuki, K., Mochizuld, S., lino, M., Mon, H., Mïshina, M., Ozawa, 5. 1994. Ion
permeation properties of the c!oned mouse epsilon 2/zeta I NMDA receptor channel.
Brain Res Mol Brain Res 26:37-46.
Uchimura, N., Higashi, H. and Nishi, S. 1986. Hyperpolarizing and depolarizing actions
of dopamine via D-1 and D-2 receptors on nucleus accumbens neurons. Drain Res
375:368-372.
Uchimura, N. and North, R. A. 1990. Muscarine reduces inwardly rectifying potassium
conductance in rat nucleus accumbens neurons. J Physiol (Lond) 422: 369-380.
Ungerstedt, U. 1971. Striatal dopamine release after amphetamine or nerve degeneration
revea!ed by rotational behaviour. Acta Physiol Scand Suppi 3 67:49-68.
Vahram Haroutunian, Ph.D., Kenneth L. Davis, M.D., James, H., Meador
Woodruff, M.D. 2000. Ionotropic glutamate receptor binding and subunit mRNA
expression in thalamic nuclei in schizophrenia Am J Psychiatry 157:1811-1823.
Vallano, M.L., Lambolez, B., Audinat, E., Rossier, J. 1996. Neuronal activity
differentia!ly regulates NMDA receptor subunit expression in cerebellar granule celis. J
Neurosci 16:631-639.
Van den Bos, R., Charria, Ortiz, G.A., Bergmans, A.C. and Cools, A.R. 1991.
Evidence that dopamine in the nucleus accumbens is invo!ved in the ability of rats to
switch to cue-directed behaviors. Behav Drain Res 42: 107-114.
Verdoorn, T.A., Burnashev, N., Monyer, H., Seeburg, P.H. and Sakmann, B. 1991
Structura! determinants of ion flow through recombinant glutamate receptor channels.
Science 252:1715—1718.
214
Verhage, M., Mala, A.S., Plomp, J.J., Brussaard, A.B., Heeroma, J.H., Vermeer, H.,
Toonen, R.F., Hammer, R.E., van den Berg, T.K., Missier, M., Geuze, H.J., Sudhof,
T.C. 2000. Synaptic assembly of the brain in the absence of neurotransmitter secretion.
Science 287:864-869.
Vicini, S., Wang, J.F., Li, J.H., Zhu, W.J., Wang, Y.H., Luo, J.H., Wolfe, B.B. and
Grayson, D.R. 1998. Functional and pharmacological differences between recombinant
N-methyl-D-aspartate receptors. J Neurophysiol 79:555-566.
Vizi, E.S. and Somogyi, T.G.T. 1989. Prejunctional modulation ofacetylcholine release
from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative
(muscarinic)- feedback modulation. Br J Pharmacol 97:65-70.
Vogt, K.E. and Regehr, W.G. 2001. Cholinergic modulation of excitatoiy synaptic
transmission in the CA3 area ofthe hippocampus. J Neurosci 21:75-83.
von Gersdorff, H., Schneggenburger, R., Weis, S., Neher, E. 1997. Presynaptic
depression at a calyx synapse: the small contribution of metabotropic glutamate
receptors. J Neurosci 17:8137-8146.
Vyklicky, L. Jr., Benveniste, M. and Mayer, M.L. 1990. Modulation ofN-methyl-D
aspartic acid receptor desensitization by glycine in mouse cultured hippocampal fleurons.
J Physiol (Lond) 428: 313-331.
Wada, K., Boulter, J., deneris, E., Heinemann, S., Patrick, J. and Swanson, L.W.
1989. Distribution of Alpha2, Alpha3, Alpha4, and Beta2 neuronal nicotinic subunit
mRNAs in the central nervous system: A hybridization histochemical study in rat. J
Comp Neurol 284:314-335.
Walker, E.F. 1994. Developmentally moderated expressions of the neuropathology
underlying schizophrenia. Schizophr. Buil. 20: 453—480.
Watanabe, M., moue, Y., Sakimura, K. and Mishina, M. 1992. Developmental
changes in distribution of NMDA receptor channel subunit mRNAs. NeuroReport 3:
113$-1140.
Watt, N.F. 1978. Pattems of childhood social development in adult schizophrenia. Arch
Gen Psychiatry 35:160—165.
Wedzony, K., Limberger, N., Spath, L., Wichmann, T., Starke, K. 1988.
Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-
receptors. Naunyn Schmiedebergs Arch Pharmacol 338:250-255.
Weinberger, D.R. 1995. From neuropathology to neurodevelopment. Lancet 346:552—
557.
215
Weinberger, D.R. and Lipska, B.K. 1995. Cortical maldevelopment, anti-psychotic
drugs, and schizophrenia: a search for common ground. Schizophr Bu!! 16: 87-110.
Weiner, S.M., Levey, A.I. and Brar, J. 1990. Expression of muscarinic acety!choline
and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-
7054.
Wenthold, R.J., Prybylowski, K., Standley, S., Sans, N., Petralîa, R.S. 2003.
Trafficking ofnmda receptors. Annu Rev Pharmacol Toxico! 43:335-358.
White, F.J. and Wang, R.Y. 1983. Differential effects of c!assical and atypical
antipsychotic druges on A9 and AlO dopamine neurons. Science 221: 1054-1057.
Witding, T.J. and Huettner, J.E. 1995. Differentia! antagonism of alpha-amino-3-
hydroxy-5-methyl-4-isoxazoleproprionic acid-preferring and kainate-preferring receptors
by 2,3 benzodiazepines. Mol Pharmacol 47:582-587.
Wilson, C.J. Chang, H.T. and Kitai, S.T. 1990. firing pattems and synaptic potentials
ofidentified giant aspiny intemeurons in the rat neostriatum. J Neurosci 10:508-5 19.
Wilson, C.J. and Kawaguchi, Y. 1996. The origins of two-state spontaneous membrane
potentia! fluctuations ofneostriatal spiny neurons. J Neurosci 16:2397-24 10.
Wise, R.A. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend
51:13-22.
Wonnacott, S. 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
Wonnacott, S., Irons, J., Rapier, C., Thorne, B. and Lunt, G.G. 1989. Presynaptic
modulation of transmitter release by nicotinic receptors. li Nordberg A, FuxeK,
Holmstedt B.
Wu, E.G. and Borst, J.G. 1999. The reduced release probability of re!easabÏe vesic!es
during recovery from short-terni synaptic depression. Neuron 23:821-832.
Wu, E.G. and Saggau, P. 1997. Presynaptic inhibition of elicited neurotransmitter
release. Trends Neurosci 20:204-2 12.
Wu, E.G. and Saggau, P. 1994. Presynaptic calcium is increased during norma! synaptic
transmission and paired-pu!se facilitation, but flot in !ong-term potentiation in area CAl
of hippocampus. J Neurosci 14:645-654.
WyIIie, D.J, Behe, P. and Colquhoun, D. 1998. Sing!e-channel activations and
concentration jumps: comparison of recombinant NRI a!NR2A and NR1aJNR2D NMDA
receptors. J Physiol 5 10:1-18.
216
Wyllie, D.J., Behe, P., Nassar, M., Schoepfer, R. and Colquhoun, D. 1996. Single
channel currents from recombinant NMDA NR1aINR2D receptors expressed in Xenopus
oocytes. Proc R Soc Lond B Biol Sci 263:1079-1086.
Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutclîffe, C., Armstrong, D., Patrick,
J., Role, L., Beaudet, A. and De Biasi, M. 1999. Multiorgan autonomic dysfunction in
mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetycholine
receptors. J Neurosci 19:9298-9305.
Yan, Z. and Surmeier, D.J. 1996. Muscarinic (m2/m4) receptors reduce N- and P-type
Ca2 Currents in rat neostriatal cholinergic interneurons through a fast, membrane
delimited, G-protein pathway. J Neurosci 16:2592-2604.
Yan, Z. and Surmeïer, D.J. 1997. D5 dopamine receptors enhance Zn2-sensitive
GABAA currents in striatal cholinergic intemeurons through a PKA/PPI cascade. Neuron
19: 1115-1 126.
Yang, C.R. and Mogenson, G.J. 1984. Electrophysiological responses of neurones in
the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory
responses by the mesolimbic dopaminergic system. Brain Res 324:69-84.
Yang, C.R. and Mogenson, G.J. 1985. An electrophysiological study of the neural
projections from the hippocampaus to the ventral pallidum and the subpallidaï areas by
way of the nucleus accumbens. Neurosci 15:1015-1024.
Yim, C.Y. and Mogenson, G.J. 1982. Response of nucleus accumbens neurons to
amygdala stimulation and its modification by dopamine. Brain Res 239: 40 1-415.
Yim, C.Y. and Mogenson, G.J. 1988. Neuromodulatory action of dopamine in the
nucleus accumbens: an in vivo intracellular study. Neurosci 26:403-415.
Yoshii, A., Sheng, M.H., Constantine-Paton, M. 2003. Eye opening induces a rapid
dendritic localization of PSD-95 in central visual neurons. Proc Nati Acad Sci USA
100:1334-1339.
Zahm, D.S. and Brog, J.S. 1992. On the significance of subterritories in the
“accumbens” part ofthe rat ventral striatum Neurosci 50:751-767.
Zahm, D.S. and Heimer, L. 1990. Two transpallidal pathways originating in the rat
nucleus accumbens. J Comp Neurol 302:437-446.
Zahm, D.S. and Heimer, L. 1993. Specificity in the efferent projections ofthe nucleus
accumbens in the rat: comparison ofthe rostral pole projection pattems with those ofthe
core and sheil. J Comp Neurol 327:220-232.
Zhang, L.I. and Poo, M.M. 2001. Electrical activity and development ofneural circuits.
Nat Neurosci Suppl:1207-1214.
217
Zhang, L.M, Belleau, M. and Warren, R.A. 1998. Postnatal development of membrane
properties and postsynaptic currents in nucleus accumbens neurons. Soci Neurosci Abstr
24:1641.
Zliang, L.M. and Warren, R.A. 1999. Postnatal development of the excitatory
postsynaptic currents in nucleus accumbens neurons and their modulation by dopamine.
Soci Neurosci Abstr 25: 1654.
Zhang, LM. and Warren, R.A. 2002. Muscarinic and nicotinic presynaptic modulation
of EPSCs in the nucleus accumbens during postnatal development. J Neurophysiol
88:3315-3330.
Zhang, L., Spigelman, I. and Carlen, P.L. 1991. Development of GABA-mediated,
chloride-dependent inhibition in CAl pyramidal neurons of immature rat hippocampal
slices. J Physiol (Lond) 444: 25-49.
Zhang, X.F., Hu, X.T. and White, F.J. 1998. Whole-cell plasticity in cocaine
withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci 18:488-
498.
Zhang, X.F., Cooper, D.C. and White, F.J. 2002. Repeated cocaine treatment decreases
whole-cell calcium current in rat nucleus accumbens fleurons. J Pharmacol Exp Ther
301:1119-1125.
Zhou, F.M., Wilson, C.J. and Dani, J.A. 2002. Cholinergic intemeuron
characteristicsand nicotinic properties in the striatum. J Neurobiol 53:590-605.
Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Strïcker, E.M.
1990. Compensations after lesions of central dopaminergic neurons: some clinical and
basic implications. Trends Neurosci 13:290-296.
Zoghbi, H.Y., Gage, F.H., Choi, D.W. 2000. Neurobiology of disease. Curr Opin
Neurobiol 10:655-660.
Zou, M., Le Novère, N. Hill, J.A. and Changeux, J.P. 1995. Developmental regulation
of nicotinic receptor subunit mRNAa in the rat central and peripheral nervous systems. J
Neurosci 15:1912-1939.
Zorumski, C.f., Olney, J.W., Wozniak, D.F. 2003. Early exposure to common
anesthetic agents causes widespread neurodegeneration in the developing rat brain and
persistent leaming deficits. J Neurosci 23:876-882.
Zucker, R.S. 1989. Short-term synaptic plasticity. Annu Rev Neurosci 12:13-3 1.
Zucker, R.S. 1999. Calcium- and activity-dependent synaptic plasticity. Cun Opin
Neurobiol 9:305-3 13.
